<SEC-DOCUMENT>0001193125-18-017359.txt : 20180123
<SEC-HEADER>0001193125-18-017359.hdr.sgml : 20180123
<ACCEPTANCE-DATETIME>20180123160640
ACCESSION NUMBER:		0001193125-18-017359
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20180123
DATE AS OF CHANGE:		20180123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rapid7, Inc.
		CENTRAL INDEX KEY:			0001560327
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		IRS NUMBER:				352423994
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-218189
		FILM NUMBER:		18542465

	BUSINESS ADDRESS:	
		STREET 1:		100 SUMMER STREET
		STREET 2:		13TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110-2131
		BUSINESS PHONE:		617-247-1717

	MAIL ADDRESS:	
		STREET 1:		100 SUMMER STREET
		STREET 2:		13TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110-2131

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rapid7 Inc
		DATE OF NAME CHANGE:	20121015
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d529415d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="2"><B>Filed pursuant to Rule 424(b)(5) <BR> Registration No. 333-218189 </B></FONT></P>
<p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:ARIAL" SIZE="2" COLOR="#cb2d5e"><B>This preliminary prospectus supplement and the accompanying
prospectus relate to an effective registration statement under the Securities Act of 1933, but the preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not
an offer to sell these securities and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="2" COLOR="#cb2d5e">Subject to Completion, dated January&nbsp;23, 2018 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:arial" SIZE="3">PROSPECTUS SUPPLEMENT </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">(To Prospectus dated June&nbsp;2, 2017) </FONT></P>
<P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="5">5,180,000 Shares </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g529415g25q05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="6"><B>Rapid7, Inc. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:arial" SIZE="5">Common Stock </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">We are offering 1,500,000 shares of our common stock, and the selling stockholders identified in this prospectus supplement, including our Chief Executive Officer
and the Chairman of our Board of Directors, are offering an aggregate of 3,680,000 shares of our common stock pursuant to this prospectus supplement and the accompanying prospectus. We will not receive any proceeds from the sale of shares of common
stock by the selling stockholders. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">Our common stock is listed on The Nasdaq Global Market under the symbol &#147;RPD.&#148; On January&nbsp;22, 2018,
the last reported sale price for our common stock on The Nasdaq Global Market was $21.98 per share. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">We are an &#147;emerging growth company&#148; as
defined under the U.S. federal securities laws and have elected to comply with certain reduced public company disclosure and reporting requirements. See &#147;Prospectus Summary&#151;Implications of Being an Emerging Growth Company.&#148;
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="4"><I>Investing in our common stock involves a high degree of risk. See &#147;<A HREF="#suprom529415_3">Risk Factors</A>&#148; beginning on page <FONT
STYLE="white-space:nowrap">S-10</FONT> of this prospectus supplement, beginning on page 5 of the accompanying prospectus and in the documents incorporated by reference into this prospectus supplement. </I></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:arial" SIZE="2"><B>Per&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:arial" SIZE="2"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:arial" SIZE="3">Public offering price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:arial" SIZE="3">Underwriting discounts and commissions</FONT><FONT STYLE="font-family:arial" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:arial" SIZE="3"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:arial" SIZE="3">Proceeds to Rapid7 (before expenses)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:arial" SIZE="3">Proceeds to selling stockholders (before expenses)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:arial" SIZE="3">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:arial" SIZE="3">See &#147;Underwriting&#148; beginning on page <FONT STYLE="white-space:nowrap">S-24</FONT> for a description of the compensation payable to the underwriters.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">The underwriters have an option to purchase a maximum of 770,000 additional shares of common stock from certain of the selling
stockholders at the public offering price, less underwriting discounts and commissions, within 30 days from the date of this prospectus supplement. See &#147;Underwriting&#148; for more information. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:arial" SIZE="3">We expect that delivery of
the shares of common stock will be made to investors in book-entry form through The Depository Trust Company on or about&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="5"><B>Barclays</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="5"><B>RBC&nbsp;Capital&nbsp;Markets</B></FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:4px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:arial" SIZE="4"><B>KeyBanc Capital Markets</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="4"><B>Stifel</B></FONT></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="22%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:arial" SIZE="3"><B>Cowen</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:arial" SIZE="3"><B>Raymond&nbsp;James</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;William&nbsp;Blair</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:arial" SIZE="3"><B>BTIG</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="2">Prospectus Supplement
dated&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="94%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Prospectus Supplement</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_1">About this Prospectus Supplement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-ii</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_2">Prospectus Supplement Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_4">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_6">Price Range of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_7">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_8">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_9">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_10">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_11">Material U.S. Federal Income Tax Considerations for <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_12">Underwriting </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_13">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_14">Experts </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_15">Where You Can Find More Information </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#suprom529415_16">Incorporation of Certain Information by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">S-31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Prospectus</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_1">About this Prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_2">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_3">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_4">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_6">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_7">Selling Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_8">Plan of Distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_9">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_10">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_11">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_12">Incorporation of Certain Information by Reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_1"></A>ABOUT THIS PROSPECTUS SUPPLEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the Securities and Exchange
Commission, or SEC, using a shelf registration process. Both this prospectus supplement and the accompanying prospectus include or incorporate by reference important information about us, our common stock and other information you should know before
investing. You should read both this prospectus supplement and the accompanying prospectus and the documents incorporated herein and therein by reference (see the sections entitled &#147;Incorporation of Certain Information by Reference&#148;), as
well as any additional information described under &#147;Where You Can Find More Information&#148; in this prospectus supplement before making an investment decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the selling stockholders have not, and the underwriters have not, authorized anyone to provide any information other than that
contained or incorporated by reference in this prospectus supplement, in the accompanying prospectus or in any free writing prospectus that we have authorized for use in connection with this offering. Neither we nor the selling stockholders, nor the
underwriters, take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or the
solicitation of an offer to buy any securities other than the securities described in this prospectus supplement or an offer to sell or the solicitation of any offer to buy such securities in any circumstances in which such offer or solicitation is
unlawful. You should assume that the information appearing in this prospectus supplement and the accompanying prospectus, the documents incorporated by reference into this prospectus supplement and the accompanying prospectus, and in any related
free writing prospectus that we have authorized for use in connection with this offering, is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may have changed materially since those
dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement may add to, update or change the information in the accompanying prospectus. To the extent there is a
conflict between the information contained in this prospectus supplement, on the one hand, and the information contained in the accompanying prospectus or in any document incorporated by reference that was filed with the SEC before the date of this
prospectus supplement, on the other hand, you should rely on the information in this prospectus supplement. If any statement in one of these documents is inconsistent with a statement in another document having a later date, the statement in the
document having the later date modifies or supersedes the earlier statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context otherwise indicates, references in this
prospectus supplement and accompanying prospectus to &#147;Rapid7,&#148; &#147;we,&#148; &#147;our,&#148; &#147;us&#148; and &#147;the Company&#148; refer, collectively, to Rapid7, Inc., a Delaware corporation, and its subsidiaries on a consolidated
basis. Our principal executive offices are located at 100 Summer Street, Boston, Massachusetts 02110 and our telephone number is (617) <FONT STYLE="white-space:nowrap">247-1717.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-ii </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_2"></A>PROSPECTUS SUPPLEMENT SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following summary highlights selected information contained or incorporated by reference elsewhere in this prospectus supplement and
does not contain all of the information that you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus supplement, the accompanying prospectus and any related free
writing prospectus that we have authorized for use in connection with this offering, including the information under the caption &#147;Risk Factors&#148; herein and therein and under similar headings in the documents that are incorporated by
reference herein or therein. You should also carefully read the other information incorporated by reference into this prospectus supplement, including our consolidated financial statements and the related notes, and the exhibits to the registration
statement of which this prospectus supplement and the accompanying prospectus is a part. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rapid7, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Organizations of all
sizes are faced with a more sophisticated and motivated set of cyber attackers. Coupled with an increasingly complex IT environment and expanding attack surface, driven by mobility and a shift to the cloud, security and IT teams are struggling to
maintain adequate levels of cyber security, provide visibility to their management teams, and meet increasing regulatory requirements. At the same time, they must navigate a shortage of capable cyber security professionals. Out of these challenges,
the concept of Security Operations, or SecOps, is emerging. SecOps is a movement that recognizes that Security and IT Operations must work together to deliver better security and more nimbly adapt to emerging threats, without adding significant
resources. SecOps requires solutions that provide visibility, analytics and automation that enable IT, Security and DevOps to work together to achieve significantly higher levels of productivity and success. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Rapid7 is a leading provider of security and IT analytics and automation solutions for SecOps, and is trusted by professionals around the
world to provide visibility, analytics and automation to help manage risk, simplify IT complexity and drive innovation. Our solutions, which include vulnerability management, incident detection and response, security information and event
management, or SIEM, application security testing, log analytics, and security orchestration and automation all focus on the critical needs of enterprises for greater visibility into their environments, analytics that provide context to complex
data, and automation that enables SecOps teams to scale and more efficiently to address critical security and IT tasks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We combine our
extensive experience in collecting data from an ever-expanding IT environment, our deep insight into attacker behaviors and techniques, and our powerful and proprietary analytics to provide solutions that can quickly and efficiently identify and
prioritize risks and active threats in an enterprise&#146;s IT environment. Our broad data collection capabilities encompass endpoints, servers, applications, users, cloud-based assets, client devices, network activity, log data and information from
third-party applications. We also provide workflows and automations that can enable and accelerate remediation of these risks and active threats. We have designed our solutions to be easy to deploy and use for security and IT teams of all sizes.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We offer analytic solutions across three core areas. Our Vulnerability Management offerings include our industry-leading vulnerability
management, web application security testing and attack simulation products. These solutions provide enterprises with comprehensive, yet prioritized, visibility into potential cyber risks across their IT environment. We have also added remediation
workflows to help ensure that these risks can be easily mitigated. Our Incident Detection and Response solutions are designed to enable organizations to rapidly detect and respond to cyber security incidents and breaches across physical, virtual and
cloud assets, including those posed by the behaviors of their users. These solutions combine the collection of massive amounts of data with our core analytics and machine-learning-driven user behavioral analytics to simplify the task of identifying
</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and responding to potential breaches. Our IT Analytics and Automation solutions are designed to allow operations teams to quickly gain visibility into their IT environment and facilitate
automated workflows to eliminate repetitive, manual and labor-intensive tasks. Finally, to complement our SecOps products, we offer a range of services, including managed services based on our software solutions, incident response services, security
advisory services, and deployment and training. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017, we had more than 7,000 customers, including 52% of the
Fortune 100. We have experienced strong revenue growth, with revenue increasing from $46.0&nbsp;million in 2012 to $157.4&nbsp;million in 2016, representing a 36% compound annual growth rate. In the third quarter of 2017, 71% of our revenues were
recurring revenues. We incurred net losses of $49.9&nbsp;million, $49.0&nbsp;million and $32.5&nbsp;million in 2015, 2016 and the nine months ended September&nbsp;30, 2017, respectively, as we continued to invest for long-term growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Analytics and Automation Cloud </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g529415g72e01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Rapid7 Insight Platform is at the core of our security and IT analytics product offerings. The platform
was built in the cloud using our extensive experience in collecting and analyzing data to enable our customers to create and manage active, analytics-driven cyber security and IT operations management programs. Our robust data collection
architecture supports gathering a wide swath of organizational and environmental data from endpoints to the cloud, including key data about user-specific behavior. By utilizing our powerful, proprietary analytics to assess and understand the context
and relationships around users, IT assets and cyber threats within a customer&#146;s environment, our solutions can provide our customers with specific, actionable insights critical for their SecOps approach. We designed the Rapid7 Insight Platform
to allow customers to collect their data once and leverage that same data across multiple solutions, providing shared visibility across teams, improved and automated workflows, and reducing time to value for additional solutions. The design and
development of our Insight Platform includes the following key features and benefits: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Holistic Dataset for Managing IT Operations
and Cyber Security. </I></B>Our Insight Platform collects information from across an organization&#146;s environment into a unified dataset. Our platform also applies context to events, including user and asset level details. We overlay this against
our comprehensive and continuously expanding set of known vulnerabilities, exploits and threat intelligence, providing SecOps professionals a holistic view of their IT environment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Agentless and Agent-Based Architecture. </I></B>We developed our platform with flexible processing technologies that employ both
agentless data collection and our own internally-developed endpoint agent technology, which </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
enables rapid and seamless integration of our products into our customers&#146; IT environments and provides IT professionals with instant visibility into their dynamic and rapidly-expanding IT
ecosystem. This means it is much easier to deploy our Insight agent, potentially increasing the time to value for not just one of our products, but many of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Fast Search.</I></B> Our search technology enables IT and security professionals to search across their entire IT environment including
endpoints and, unlike other machine search solutions, provides live access without having to wait for lengthy indexing processes. These capabilities, along with real time and easily accessible search across raw logs and endpoints for known patterns
with intuitive search queries, can enable IT security professionals to access their data for operational purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>User Behavior
Analytics. </I></B>Our Insight Platform creates a behavior profile for each user in a customer&#146;s IT environment and correlates every event with a user, asset or application. User behavior profiles can then be automatically analyzed to identify
suspicious user behavior and compromised user credentials. Our ability to provide rapid context around users and assets involved in an incident can significantly reduce investigation time, enabling organizations to more quickly respond to, contain
and mitigate breaches. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Live Dashboards, Remediation Workflows and Automation. </I></B>Our Insight Platform includes live dashboards
which provide customers real-time, dynamic visibility into their risks, potential threats and progress to remediation all based on a shared reporting and visualization service. Remediation workflows enable customers to initiate, manage, prioritize
and monitor the progress of vulnerability remediation. We also provide the ability to create automated workflows that can accelerate incident detection, response, and resolution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Robust Platform and Customer Data Security.</I></B> Our Insight Platform was designed to provide a secure environment for both our data
and that of our customers. We deploy a variety of technologies and industry-leading practices such as physical and logical customer data segregation, network segmentation, audited and monitored access level controls, data anonymization, encryption
and separated development-staging-production environments to help ensure that the data collected from a customer&#146;s environment remains proprietary and secure. We have achieved Service Organization Control, or SOC, II Type 2 certification for
the foundation of our platform and are continuing to expand the specific compliance regimes for which we are audited. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Enterprise-Grade Scalability. </I></B>Our Insight Platform provides a high level of horizontal scalability. We leverage <FONT
STYLE="white-space:nowrap">on-premise</FONT> deployment models and Amazon Web Services, or AWS, to achieve a high degree of redundancy, fault tolerance and cost-effective operations. Our automated deployment technologies enable us to add new AWS
instances or additional services rapidly. Our infrastructure architecture is designed to process large amounts of data and easily incorporate new data sources, including on premise, cloud and mobile. Our platform is designed to support customers
with large numbers of users or with geographically dispersed environments, and we have scaled to meet the needs of customers with over 2.5&nbsp;million active assets and 700,000 active users as of December&nbsp;31, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extensible Modern Platform.</I></B> Our Insight Platform provides a rich set of application program interfaces, or APIs, and services
that enable customers, partners and developers to import and export data and utilize our analytics capabilities. This allows us to easily integrate with other security tools in the customer&#146;s environment and also enables customers to build
bespoke applications and analysis on top of the data that we gather. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Market Opportunity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our estimate, based on International Data Corporation, or IDC, data, is that the overall market for IT and security analytics and automation
solutions was a $6.9&nbsp;billion opportunity in 2017. Included in our estimates are all or a portion of the markets for Vulnerability Assessment, Policy and Compliance, Security Information and Event Management, Forensics and Incident Management,
IT Operations Analytics-Public Cloud, IT Automation </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and Configuration Management Software and IT Operations Management Software. As our solutions expand to address more of the SecOps opportunity, we believe we may be able to address portions of
the broader IT Operations Management Software market, as well as the IT Automation and Configuration Management Software market, which would expand our estimated overall market opportunity in 2017 to $22.2&nbsp;billion, based on IDC data. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This recent
developments section includes forward-looking statements. All statements contained herein other than statements of historical facts, including, without limitation, statements regarding our expectations regarding our financial and operating results
for the year and three months ended December&nbsp;31, 2017 and our future financial and business performance, are forward-looking statements. The words &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148; &#147;estimate,&#148;
&#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;will&#148; and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections
about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements
are subject to a number of risks and uncertainties, including, without limitation, risks related to our rapid growth and ability to sustain our revenue growth rate, risk related to the timing of our recognition of deferred revenue, the ability of
our products and professional services to correctly detect vulnerabilities, competition in the markets in which we operate, market growth, our ability to innovate and manage our growth. For additional information regarding the various risks and
uncertainties inherent in estimates of this type, see &#147;Special Note Regarding Forward-Looking Statements&#148; elsewhere in this prospectus supplement. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preliminary Financial Results </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following preliminary financial information for the three months and the year ended December&nbsp;31, 2017 is based upon our estimates
and subject to completion of our financial closing procedures. Moreover, these data have been prepared solely on the basis of currently available information by, and are the responsibility of, Rapid7. Our independent registered public accounting
firm, KPMG&nbsp;LLP, has not audited or reviewed, and does not express an opinion with respect to, these data. This summary is not a comprehensive statement of our financial results for this period, and our actual results may differ materially from
these estimates due to the completion of our financial closing procedures, final adjustments, completion of the audit of our financial statements and other developments that may arise between now and the time the audit of our financial statements is
completed. Our actual results for the three months and the year ended December&nbsp;31, 2017 will not be available until after this offering is completed. There can be no assurance that these estimates will be realized, and estimates are subject to
risks and uncertainties, many of which are not within our control. </I></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have prepared estimates of the following preliminary financial data for the three months
and the year ended December&nbsp;31, 2017. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended</B><br><B>December&nbsp;31, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>% Change</B><br><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(year-over-year)</FONT></FONT></B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;months&nbsp;ended</B><br><B>December&nbsp;31, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>% Change</B><br><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(year-over-year)</FONT></FONT></B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Low&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;High&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="30" ALIGN="center"><B>(dollars in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>GAAP Data</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(46.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(45.8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><U>Other Data</U></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calculated billings<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">255.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annualized recurring revenue<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">164.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">163.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">164.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> loss from operations<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Calculated billings is a <FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure that we define as total revenue recognized in accordance with generally accepted accounting principles, or GAAP, plus the change in
deferred revenue from the beginning to the end of the period. We consider calculated billings to be a useful metric for management and investors, as a supplement to the corresponding GAAP measure of total revenue, because billings drive deferred
revenue, which is an important indicator of the health and visibility of trends in our business, and represents a significant percentage of future revenue. We regularly monitor calculated billings because we believe the measure offers information
regarding the performance of our business. With the expansion of our subscription, cloud-based product offerings (InsightVM, InsightIDR, InsightAppSec, and InsightOps) on the Insight platform,&nbsp;we may realize a shortening of our average contract
duration, which should be taken into consideration when evaluating calculated billings. Our use of calculated billings has limitations as an analytical tool and should not be considered in isolation or as a substitute for revenue recognition or
revenue measurement, or an analysis of our results as reported under GAAP. Also, it is important to note that other companies, including companies in our industry, may not use calculated billings, may compute billings differently, may have different
billing frequencies, or may use other financial measures to evaluate their performance, all of which could reduce the usefulness of calculated billings as a comparative measure. The following table presents a reconciliation of calculated billings to
revenue, the most directly comparable GAAP measure, for each of the periods indicated: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;months&nbsp;ended</B><br><B>December&nbsp;31, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred revenue, beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">188.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">188.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Calculated billings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">254.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">255.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">92.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Annualized recurring revenue is defined as the annual value of all recurring revenue related to contracts in place at the end of the period. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> loss from operations is a
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> measure that we define as loss from operations calculated in accordance with GAAP plus stock-based compensation expense, amortization of acquired intangible assets and acquisition-related expense. We
consider <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations to be a useful metric for management and investors, as a supplement to the corresponding GAAP measure of loss from
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
operations, because <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations excludes <FONT STYLE="white-space:nowrap">non-cash</FONT> charges that we do not believe to be indicative
of our core operating results. We regularly monitor <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations because we believe the measure offers valuable information regarding the performance of our business and will help investors
better understand our operating performance on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> basis. Our use of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations has limitations
as an analytical tool and should not be considered in isolation or as a substitute for an analysis of our results as reported under GAAP. Also, it is important to note that other companies, including companies in our industry, may not use <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations, may compute <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations differently or may use other financial measures to evaluate their performance, all of which could
reduce the usefulness of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations as a comparative measure. The following table presents a reconciliation of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations to loss
from operations calculated in accordance with GAAP, the most directly comparable GAAP measure, for each of the periods indicated: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year ended<BR>December&nbsp;31,&nbsp;2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;months&nbsp;ended</B><br><B>December&nbsp;31,&nbsp;2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Low&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;High&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations (GAAP)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(49.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of acquired intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition-related expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below we have provided information regarding comparisons to prior year and quarters for context. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Revenue </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase in revenue for the
year and three months ended December&nbsp;31, 2017 was driven by increased adoption across our solutions globally. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>GAAP and <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our loss from operations on both a GAAP and <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> basis for the year ended December&nbsp;31, 2017 reflected our revenue growth, partially offset by increased costs of goods sold and increased sales and marketing expense. Our loss from operations on both a
GAAP and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> basis for the three months ended December&nbsp;31, 2017, reflected our revenue growth, partially offset by increased costs of goods sold and increased commissions as a result of our increased
calculated billings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Net loss </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
net loss for the year ended December&nbsp;31, 2017 reflected our revenue growth, partially offset by increased costs of goods sold and increased sales and marketing expense. Our net loss for the three months ended December&nbsp;31, 2017, reflected
our revenue growth, partially offset by increased costs of goods sold and increased commissions as a result of our increased calculated billings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Cash
flow from operating activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our increased cash flow from operating activities for the year ended December&nbsp;31, 2017 was driven
by increased collections as a result of our increased calculated billings, partially offset by higher cost of goods sold and higher sales and marketing expense. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Calculated billings </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase in calculated billings for the year and three months ended December&nbsp;31, 2017 was driven by strong adoption across our
solutions globally. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Annualized recurring revenue </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The increase in annualized recurring revenue for the year ended December&nbsp;31, 2017 was driven by strong adoption across our solutions
globally, as evidenced by our calculated billings growth, and the increased shift of our customers to a subscription pricing model. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preliminary
Guidance </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on available information, we anticipate the following results for the year ending December&nbsp;31, 2018 calculated
in accordance with <I>Accounting Standards Codification </I>605 and without giving effect to the impact of the adoption of <I>Accounting Standards Codification </I>606: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">year-over-year annualized recurring revenue growth of at least 30% compared to the year ended December&nbsp;31, 2017; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">calculated billings slightly up relative to the year ended December&nbsp;31, 2017 due to shorter anticipated contract lengths and the impact of the anticipated continued shift from perpetual to subscription licenses;
going forward, we believe that calculated billings may be less useful as a measure of the growth of our business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">year-over-year revenue growth of approximately 20% compared to the year ended December&nbsp;31, 2017 driven by the anticipated continued transition to subscription licenses with respect to our vulnerability management
product line; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">slightly improved <FONT STYLE="white-space:nowrap">non-GAAP</FONT> loss from operations compared to the year ended December&nbsp;31, 2017; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cash flows from operating activities consistent with those for the year ended December&nbsp;31, 2017. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> guidance excludes estimates for stock-based compensation expense, amortization of acquired
intangible assets and acquisition-related expenses. Rapid7 has provided a reconciliation of historical <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures to the most comparable GAAP measures above. A reconciliation of <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> guidance measures to the most comparable GAAP measures is not available on a forward-looking basis as a result of the uncertainty regarding, and the potential variability of, many of the costs and expenses
that we may incur in the future. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were initially incorporated in July 2000 in Delaware. Rapid7 LLC, a limited liability company organized under the laws of the Commonwealth
of Massachusetts, was formed in January 2004. In August 2004, pursuant to an exchange agreement among Rapid7 LLC and the stockholders of Rapid7, Inc., the stockholders exchanged their shares in Rapid7, Inc. for equity interests in Rapid7 LLC, after
which Rapid7, Inc. was dissolved. In August 2008, Rapid7 LLC was merged with and into Rapid7 LLC, a newly-formed Delaware limited liability company. Rapid7, Inc. was reincorporated in Delaware in October 2011. In a series of transactions in November
2011, equity holders of Rapid7 LLC exchanged their equity interests in Rapid7 LLC for capital stock in Rapid7, Inc. and Rapid7 LLC became a wholly-owned subsidiary of Rapid7, Inc., which is the registrant. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive offices are located at 100 Summer Street, Boston, Massachusetts. Our
telephone number <FONT STYLE="white-space:nowrap">is&nbsp;(617)&nbsp;247-1717.&nbsp;Our</FONT> website address is&nbsp;www.rapid7.com.&nbsp;The information contained on, or that can be accessed through, our website is not incorporated by reference
into this prospectus supplement or the accompanying prospectus, and you should not consider any information contained on, or that can be accessed through, our website as part of this prospectus supplement or the accompanying prospectus or in
deciding whether to purchase our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Rapid7,&#148; the Rapid7 logo, and other trademarks or service marks of Rapid7, Inc.
appearing in this prospectus supplement and the accompanying prospectus are the property of Rapid7, Inc. This prospectus supplement and the accompanying prospectus contain additional trade names, trademarks and service marks of others, which are the
property of their respective owners. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;or TM symbols. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An
emerging growth company may take advantage of relief from certain reporting requirements and other burdens that are otherwise applicable generally to public companies. We have chosen to take advantage of some but not all of these reduced burdens. To
the extent that we continue to take advantage of these reduced burdens, the information that we provide stockholders may be different than you might obtain from other public companies in which you hold equity interests. As an emerging growth
company: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we have availed ourselves of the exemption from the requirement to obtain an attestation and report from our auditors on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act
of 2002; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will provide less extensive disclosure about our executive compensation arrangements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we will not require stockholder <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory votes on executive compensation or golden parachute arrangements. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may use these provisions until the last day of our fiscal year following the fifth anniversary of our initial public offering. However, if
certain events occur prior to the end of such five-year period, including if we become a &#147;large accelerated filer,&#148; our annual gross revenues exceed $1.07&nbsp;billion or we issue more than $1.0&nbsp;billion of <FONT
STYLE="white-space:nowrap">non-convertible</FONT> debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Offering </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock offered by us </B></P></TD>
<TD>1,500,000 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock offered by selling stockholders </B></P></TD>
<TD>3,680,000 shares (or 4,450,000 shares of common stock if the underwriters exercise their option to purchase additional shares from certain of the selling stockholders in full). </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Option to purchase additional shares </B></P></TD>
<TD>The underwriters have been granted an option to purchase up to an aggregate of 770,000 shares of our common stock from certain of the selling stockholders. This option is exercisable, in whole or in part, for a period of 30 days following the
date of this prospectus supplement. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Common stock to be outstanding immediately after this offering </B></P></TD>
<TD>45,357,005 shares. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Use of proceeds</B> </P></TD>
<TD>We currently expect to use the net proceeds from this offering for working capital and general corporate purposes. See &#147;Use of Proceeds&#148; on page <FONT STYLE="white-space:nowrap">S-12</FONT> for additional information. We will not
receive any proceeds from the sale of shares of common stock by the selling stockholders. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Risk factors </B></P></TD>
<TD>See &#147;Risk Factors&#148; on page <FONT STYLE="white-space:nowrap">S-10</FONT> and the other information included or incorporated by reference in this prospectus supplement and the accompanying prospectus for a discussion of factors you
should carefully consider before deciding to invest in our common stock. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Global Market symbol </B></P></TD>
<TD>&#147;RPD&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding after this offering is based on 43,857,005
shares of common stock outstanding as of September&nbsp;30, 2017 and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">4,778,250 shares of our common stock issuable upon the exercise of options to purchase our common stock under (i)&nbsp;our 2011 Stock Option and Grant Plan, (ii)&nbsp;our 2015 Equity Incentive Plan and (iii)&nbsp;the
RevelOps, Inc. 2014 Stock Incentive Plan (which options were assumed by us in connection with our acquisition of RevelOps, Inc.), at a weighted-average exercise price of $9.61 per share; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,069,623 shares of our common stock issuable upon the settlement of restricted stock units issued under our 2015 Equity Incentive Plan; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">905,981 shares of our common stock reserved for future issuance under our 2015 Equity Incentive Plan; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,047,444 shares of our common stock reserved for future issuance under our 2015 Employee Stock Purchase Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise indicated herein, all information in this prospectus supplement, including the number of shares that will be outstanding
after this offering, does not assume or give effect to the exercise of options outstanding as of September&nbsp;30, 2017. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below,
together with all of the other information contained in this prospectus supplement, the accompanying prospectus and in our filings with the Securities and Exchange Commission, or SEC, that we have incorporated by reference in this prospectus
supplement and the accompanying prospectus. In particular, we urge you to consider carefully the factors set forth below and under Item 8.01 &#147;Other Events&#151;Risk Factors&#148; in our Current Report on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on January&nbsp;23, 2018, which is incorporated by reference herein. If any of these risks actually occur, our business, prospects, operating results and financial condition could suffer
materially. In such event, the trading price of our common stock could decline and you might lose all or part of your investment. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Risks Related to this Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>We will have broad discretion in the use of proceeds from this offering and may invest or spend the proceeds in ways with which you do
not agree and in ways that may not yield a return. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will have broad discretion over the use of proceeds from this offering. You
may not agree with our decisions, and our use of the proceeds may not yield any return on your investment in us. Our failure to apply the net proceeds of this offering effectively could result in financial losses that could materially impair our
ability to pursue our growth strategy, cause the price of our common stock to decline or require us to raise additional capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Purchasers in this offering will incur immediate and substantial dilution in the book value of their investment as a result of this
offering. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since the public offering price for our common stock in this offering is substantially higher than the net tangible book
value per share of our common stock outstanding prior to this offering, you will suffer immediate and substantial dilution in the net tangible book value of the common stock you purchase in this offering. See the section entitled
&#147;Dilution&#148; below for a more detailed discussion of the dilution you will incur if you purchase shares in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
issuance of additional shares of our common stock could be dilutive to stockholders if they do not invest in future offerings. In addition, we have a significant number of options to purchase shares of our common stock outstanding. If these options
are exercised, you may incur further dilution. Moreover, to the extent that we issue additional options or warrants to purchase, or securities convertible into or exchangeable for, shares of our common stock in the future and those options, warrants
or other securities are exercised, converted or exchanged, stockholders may experience further dilution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_4"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement, the accompanying prospectus, the documents incorporated by reference herein and therein and any free writing
prospectus that we may authorize for use contain &#147;forward-looking statements&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&nbsp;21E of the Securities Exchange Act of
1934, as amended, or the Exchange Act. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not
always, made through the use of words or phrases such as &#147;may,&#148; &#147;could,&#148; &#147;should,&#148; &#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148;
&#147;predicts,&#148; &#147;projects,&#148; &#147;potential,&#148; &#147;continue,&#148; and similar expressions, or the negative of these terms, or similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties
which could cause actual results to differ materially from those expressed in them. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. We discuss many of these risks and uncertainties in
greater detail in the risk factors incorporated by reference herein under the heading section captioned &#147;Risk Factors&#148; in this prospectus supplement, the accompanying prospectus and the documents incorporated herein and therein by
reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Forward-looking statements are based on our management&#146;s belief and assumptions and on information currently available to
our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to
be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could
differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate the net proceeds to us from the shares offered by us in this offering will be approximately $30.9&nbsp;million, after payment of
estimated underwriting discounts and commissions and estimated offering expenses payable by us, based on an assumed offering price of $21.98 per share, the last reported sale price of our common stock on The Nasdaq Global Market on January&nbsp;22,
2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00 increase or decrease in the assumed public offering price of $21.98 per share, which was the closing price of our common
stock on The Nasdaq Global Market on January&nbsp;22, 2018, would increase or decrease the net proceeds to us from this offering by approximately $1.4&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of
this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each 1,000,000 share increase or
decrease in the number of shares offered by us would increase or decrease the net proceeds to us from this offering by approximately $21.0&nbsp;million, assuming that the assumed public offering price remains the same, and after deducting
underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will not receive any of the proceeds from the
sale of the shares of our common stock by the selling stockholders (including any shares sold by certain of the selling stockholders pursuant the underwriters&#146; option to purchase additional shares). However, we have agreed to pay expenses
incurred by the selling stockholders in connection with the offering, other than the underwriting discounts and commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
principal purposes of this offering are to increase our financial flexibility, facilitate an orderly distribution of our shares by selling stockholders and increase our public float. Although we have not yet determined with certainty the manner in
which we will allocate the net proceeds of this offering from the sale of our common stock by us, we expect to use the net proceeds from this offering for working capital and other general corporate purposes, including to build out our future
corporate headquarters in Boston, Massachusetts. We may also use a portion of the proceeds from this offering from the sale of our common stock by us for acquisitions or strategic investments in complementary businesses or technologies, although we
do not currently have any plans for any such acquisitions or investments. We have not allocated specific amounts of net proceeds for any of these purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expected use of net proceeds from this offering from the sale of our common stock by us represents our intentions based upon our present
plans and business conditions. We cannot predict with certainty all of the particular uses for the proceeds of this offering or the amounts that we will actually spend on the uses set forth above. Accordingly, our management will have significant
flexibility in applying the net proceeds of this offering. The timing and amount of our actual expenditures will be based on many factors, including cash flows from operations and the anticipated growth of our business. Pending their use, we intend
to invest the net proceeds of this offering in a variety of capital-preservation investments, including short- and intermediate-term, interest-bearing investment-grade securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_6"></A>PRICE RANGE OF COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock has been listed on The Nasdaq Global Market under the symbol &#147;RPD&#148; since July&nbsp;17, 2015. Prior to that date,
there was no public trading market for our common stock. The following table sets forth the reported high and low sales prices of our common stock for the periods indicated, as quoted on The Nasdaq Global Market: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Year Ended December&nbsp;31, 2018:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter (through January&nbsp;22, 2018)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22.58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Year Ended December&nbsp;31, 2017:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>High</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Low</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Year Ended December&nbsp;31, 2016:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Second quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fourth quarter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;22, 2018, the closing price of our common stock as reported on The Nasdaq Global Market was
$21.98 per share. As of such date, there were approximately 114 holders of record of our common stock. Because many of our shares are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of
stockholders represented by these record holders. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid, and do not anticipate declaring or paying in the foreseeable future, any cash dividends on our common stock.
Any future determination as to the declaration and payment of dividends, if any, will be at the discretion of our board of directors, subject to applicable laws, and will depend on then existing conditions, including our financial condition,
operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_8"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows our cash, cash equivalents and short-term investments and our capitalization as of September&nbsp;30, 2017: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on an actual basis; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on an as adjusted basis, giving effect to our issuance and sale of 1,500,000 shares of common stock in this offering, at an assumed public offering price of $21.98 per share, the last reported sale price of our common
stock on The Nasdaq Global Market on January&nbsp;22, 2018, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this table together with &#147;Use of Proceeds&#148; as well as our &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; and our financial statements and the related notes incorporated by reference into this prospectus supplement and the accompanying prospectus from our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2016 and Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended September&nbsp;30, 2017, each as incorporated by reference
herein. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of September&nbsp;30, 2017</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As<BR>Adjusted</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands, except<BR>share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and short-term investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">83,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; Equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, par value $0.01 per share; 10,000,000 shares authorized, no shares issued or
outstanding, actual and as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.01 par value: 100,000,000 shares authorized, actual and as adjusted; 44,337,203
shares issued, actual; 43,857,005 shares outstanding, actual; 45,837,203 shares issued, as adjusted; 45,357,005 shares outstanding, as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Treasury stock, at cost, 480,198 shares at September&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,645</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,645</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">457,904</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">488,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421,909</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421,909</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares our common stock set forth in the above table excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">4,778,250 shares of our common stock issuable upon the exercise of options to purchase our common stock under (i)&nbsp;our 2011 Stock Option and Grant Plan, (ii)&nbsp;our 2015 Equity Incentive Plan and (iii)&nbsp;the
RevelOps, Inc. 2014 Stock Incentive Plan (which options were assumed by us in connection with our acquisition of RevelOps, Inc.), at a weighted-average exercise price of $9.61 per share; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,069,623 shares of our common stock issuable upon the settlement of restricted stock units issued under our 2015 Equity Incentive Plan; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">905,981 shares of our common stock reserved for future issuance under our 2015 Equity Incentive Plan; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,047,444 shares of our common stock reserved for future issuance under our 2015 Employee Stock Purchase Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each $1.00 increase or decrease in the assumed public offering price of $21.98 per share, which was the closing price of our common stock on
The Nasdaq Global Market on January&nbsp;22, 2018, would increase or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
decrease each of as adjusted cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; equity and total capitalization by
approximately $1.4&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses
payable by us. We may also increase or decrease the number of shares we are offering. Each 1,000,000 share increase or decrease in the number of shares offered by us would increase or decrease each of as adjusted cash and cash equivalents,
additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; equity and total capitalization by approximately $21.0&nbsp;million, assuming that the assumed public offering price remains the same, and after deducting
underwriting discounts and commissions and estimated offering expenses payable by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_9"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you purchase shares in this offering, your interest will be diluted immediately to the extent of the difference between the public offering
price per share and the net tangible book value per share of our common stock after this offering. Net tangible book value per share represents our total tangible assets less total liabilities, divided by the number of shares of our common stock
outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of September&nbsp;30, 2017, our net tangible book value was $(68.6) million, or $(1.56) per share of common stock. After
giving effect to our issuance and sale of 1,500,000 shares of common stock in this offering at an assumed public offering price of $21.98 per share, the last reported sale price of our common stock on The Nasdaq Global Market on January&nbsp;22,
2018, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our as adjusted net tangible book value as of September&nbsp;30, 2017 would have been $(37.7) million, or $(0.83) per share. This
represents an immediate increase in as adjusted net tangible book value to existing stockholders of $0.73 per share of common stock and an immediate dilution to new investors purchasing common stock in this offering of $22.81 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table illustrates this per share dilution to the new investors purchasing shares of common stock in this offering: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net tangible book value per share at September&nbsp;30, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.56</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">As adjusted net tangible book value per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.83</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution in net tangible book value per share to investors in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The dilution information discussed above is illustrative only and will change based on the actual initial
public offering price and other terms of this offering determined at pricing. Each $1.00 increase or decrease in the assumed public offering price of $21.98 per share, which was the closing price of our common stock on The Nasdaq Global Market on
January&nbsp;22, 2018, would increase or decrease the as adjusted net tangible book value per share by $0.03 per share and the dilution per share to investors participating in this offering by $0.97 per share, assuming that the number of shares
offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions payable by us. We may also increase or decrease the number of shares we are offering. A 1,000,000 share
increase in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase the as adjusted net tangible book value per share by $0.47 per share and decrease the dilution per share to investors participating in
this offering by $0.47 per share, assuming the assumed public offering price remains the same and after deducting underwriting discounts and commissions payable by us. A 1,000,000 share decrease in the number of shares offered by us, as set forth on
the cover page of this prospectus, would decrease the as adjusted net tangible book value per share after this offering by $0.49 per share and increase the dilution per share to new investors participating in this offering by $0.49 per share,
assuming the assumed public offering price remains the same and after deducting underwriting discounts and commissions payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
table and calculations above exclude: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">4,778,250 shares of our common stock issuable upon the exercise of options to purchase our common stock under (i)&nbsp;our 2011 Stock Option and Grant Plan, (ii)&nbsp;our 2015 Equity Incentive Plan and (iii)&nbsp;the
RevelOps, Inc. 2014 Stock Incentive Plan (which options were assumed by us in connection with our acquisition of RevelOps, Inc.), at a weighted-average exercise price of $9.61 per share; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,069,623 shares of our common stock issuable upon the settlement of restricted stock units issued under our 2015 Equity Incentive Plan; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">905,981 shares of our common stock reserved for future issuance under our 2015 Equity Incentive Plan; and </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1,047,444 shares of our common stock reserved for future issuance under our 2015 Employee Stock Purchase Plan. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that any outstanding options are exercised, new options or shares of restricted stock are issued under the 2015 Equity Incentive
Plan, new shares are issued under our 2015 Employee Stock Purchase Plan, or we otherwise issued additional shares of common stock in the future, at a price less than the public offering price, there would be further dilution to the investors in this
offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_10"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The selling stockholders are former holders of our preferred stock and current holders of our common stock originally acquired through several
private placements consummated prior to or concurrently with the completion of our initial public offering, or IPO, in July 2015, as well as current holders of our common stock acquired through the exercise of options granted under our 2011 Stock
Option and Grant Plan. All shares of preferred stock converted into shares of our common stock in connection with our IPO and, immediately prior to the closing of the IPO, holders of our Series D preferred stock, including certain selling
stockholders, received additional shares of our common stock pursuant to provisions of our certificate of incorporation as in effect immediately prior to the closing of the IPO. In addition, entities affiliated with Technology Crossover Ventures
acquired 312,500 shares of our common stock in a private placement concurrent with the completion of our IPO. The entities affiliated with Technology Crossover Ventures and the entities affiliated with Bain Capital Venture Investors, LLC are
associated with our directors, Timothy P. McAdam and J. Benjamin Nye, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are party to an investors&#146; rights agreement
with the selling stockholders named in this prospectus supplement, which provides the selling stockholders and the other holders of our common stock party thereto with certain rights with respect to the registration of shares of common stock held by
them under the Securities Act. Additional information regarding such registration rights is contained in the accompanying prospectus under the heading &#147;Description of Capital Stock&#151;Registration Rights.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except for the ownership of the shares of common stock that may be offered and sold by the selling stockholders, the participation in the
transactions described above, the investors&#146; rights agreement, the positions that Messrs. Matthews, McAdam, Nye and Thomas hold on our board of directors and the positions that Mr.&nbsp;Thomas holds as an officer of our company, the selling
stockholders have not had any material relationship with us or our affiliates within the past three years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table below, including the
footnotes, sets forth the selling stockholders and other information regarding the beneficial ownership of the shares of common stock held by each of the selling stockholders based on information provided to us by the selling stockholders.
Generally, a person &#147;beneficially owns&#148; shares of our common stock if the person has or shares with others the right to vote those shares or to dispose of them, or if the person has the right to acquire voting or disposition rights within
60 days. The percent of shares beneficially owned prior to the offering is based on 44,053,736 shares of our common stock issued and outstanding as of December&nbsp;31, 2017. The percent of shares beneficially owned by the selling stockholders after
the offering, assumes the sale of 1,500,000 shares of common stock by us. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially</B><br><B>Owned Prior to</B><br><B>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>Shares</B><br><B>to&nbsp;be&nbsp;Sold if</B><br><B>Underwriters&#146;</B><br><B>Option is not</B><br><B>Exercised</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially</B><br><B>Owned After</B><br><B>Offering if</B><br><B>Underwriters&#146;</B><br><B>Option is not</B><br><B>Exercised</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Additional</B><br><B>Shares</B><br><B>to be Sold if</B><br><B>Underwriters&#146;</B><br><B>Option</B><br><B>is
Exercised</B><br><B>in Full</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Beneficially</B><br><B>Owned After</B><br><B>Offering if</B><br><B>Underwriters&#146;&nbsp;Option</B><br><B>is Exercised in Full</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:97.00pt; font-size:8pt; font-family:Times New Roman"><B>Name of Selling Stockholder</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Entities affiliated with Technology Crossover
Ventures<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,538,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,615,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,923,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,538,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Entities affiliated with Bain Capital Venture Investors,&nbsp;LLC<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,682,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,615,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,067,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">385,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,682,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Corey E. Thomas<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,566,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,366,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,366,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">The Corey E. Thomas Irrevocable Trust of
2016<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Alan Matthews<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,141,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,941,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,941,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">The shares of common stock reported to us as beneficially owned prior to this offering by entities affiliated with
Technology Crossover Ventures consist of (i) 4,278,661 shares directly held by TCV VII, L.P. (&#147;TCV VII&#148;), (ii) 2,222,011 shares directly held by TCV VII (A), L.P. (&#147;TCV VII(A)&#148;), and (iii) 37,371 shares directly held by TCV
Member Fund, L.P. (&#147;Member Fund&#148;). TCV VII is selling 1,056,897 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
shares of common stock (or 1,308,851 shares if the underwriters exercise their option to purchase additional shares in full), TCV VII(A) is selling 548,872 shares of common stock (or 679,717
shares if the underwriters exercise their option to purchase additional shares in full) and Member Fund is selling 9,231 shares of common stock (or 11,432 shares if the underwriters exercise their option to purchase additional shares in full).
</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:3%; font-size:8pt; font-family:Times New Roman">Technology Crossover Management VII, Ltd. (&#147;TCM VII&#148;), as the ultimate general partner of TCV VII and TCV VII(A)
and a general partner of Member Fund, and Technology Crossover Management VII, L.P. (&#147;Management VII&#148;), as the direct general partner of TCV VII and TCV VII(A), may be deemed to have the sole power to dispose or direct the disposition of
the shares of common stock held by TCV VII and TCV VII(A) and, with respect to TCM VII, the shares held by Member Fund and have the sole power to direct the vote of such shares. Messrs. Jay C. Hoag, Richard H. Kimball, John L. Drew, Jon Q. Reynolds,
Jr., David L. Yuan, Robert W. Trudeau, Christopher P. Marshall, Timothy P. McAdam and John C. Rosenberg are the Class&nbsp;A Directors of TCM VII and may be deemed to have the shared power to dispose or direct the disposition of the shares held by
TCV VII, TCV VII(A) and Member Fund and the shared power to direct the vote of such shares. Each of TCM VII and Management VII and the Class&nbsp;A Directors disclaims beneficial ownership of the shares of common stock owned of record by TCV VII,
TCV VII(A) and Member Fund except to the extent of their respective pecuniary interest therein. The address of these entities and individuals is c/o Technology Crossover Ventures, 528 Ramona Street, Palo Alto, California 94301. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The shares of common stock reported to us as beneficially owned by entities affiliated with Bain Capital Venture Investors, LLC consists of (i) 5,841,509 shares of common stock held by Bain Capital Venture Fund 2007,
L.P. (&#147;BCVF&#148;), (ii) 830,820 shares of common stock held by BCIP Venture Associates (&#147;BCIPVA&#148;) and (iii) 10,384 shares of common stock held by BCIP Venture <FONT STYLE="white-space:nowrap">Associates-B</FONT> (&#147;BCIPVB&#148;
and, together with BCVF and BCIPVA, the &#147;Bain Capital Entities&#148;). BCVF is selling 1,411,708 shares of common stock (or 1,748,245 shares if the underwriters exercise their option to purchase additional shares in full), BCIPVA is selling
200,783 shares of common stock (or 248,648 shares if the underwriters exercise their option to purchase additional shares in full) and BCIPVB is selling 2,509 shares of common stock (or 3,107 shares if the underwriters exercise their option to
purchase additional shares in full). The governance, investment strategy and decision-making process with respect to the investments held by the Bain Capital Entities is directed by the Executive Committee of Bain Capital Venture Investors, LLC
(&#147;BCVI&#148;), which consists of Michael Krupka and Ajay Agarwal. By virtue of these relationships, BCVI and Messrs. Krupka and Agarwal may be deemed to share voting and dispositive power over the shares held by the Bain Capital Entities. The
address of the Bain Capital Entities is 200 Clarendon Street, Boston, Massachusetts 02116. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) 1,436,486 shares of common stock issuable upon the exercise of options exercisable within 60 days of December&nbsp;31, 2017 and (ii) 10,001 shares of common stock issuable upon the settlement of restricted
stock units within 60 days of December&nbsp;31, 2017. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Represents 200,000 shares of common stock held directly by the Corey E. Thomas Irrevocable Trust of 2016, which is administered by independent trustees. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Includes (i) 15,174 shares of common stock issuable upon the exercise of options exercisable within 60 days of December&nbsp;31, 2017 and (ii) 3,126,312 shares of common stock held directly by Mr.&nbsp;Matthews
(1,800,000 of which are pledged as security for a loan). </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_11"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material U.S. federal income tax consequences to
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below) of the acquisition, ownership and disposition of our common stock acquired pursuant to this offering. This discussion is not a complete analysis of all potential U.S.
federal income tax consequences relating thereto, does not address the potential application of the Medicare contribution tax and does not address any estate or gift tax consequences or any tax consequences arising under any state, local or foreign
tax laws, or any other U.S. federal tax laws. This discussion is based on the Internal Revenue Code of 1986, as amended, or the Code, Treasury Regulations promulgated thereunder, judicial decisions and published rulings and administrative
pronouncements of the Internal Revenue Service, or IRS, all as in effect as of the date of this prospectus supplement. These authorities may change, possibly retroactively, resulting in U.S. federal income tax consequences different from those
discussed below. We have not requested a ruling from the IRS with respect to the statements made and the conclusions reached in the following summary, and there can be no assurance that the IRS will agree with such statements and conclusions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is limited to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders who purchase our common stock pursuant to this offering
and who hold our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not address all of the U.S. federal income tax consequences that may be
relevant to a particular holder in light of such holder&#146;s particular circumstances. This discussion also does not consider any specific facts or circumstances that may be relevant to holders subject to special rules under the U.S. federal
income tax laws, including, without limitation, certain former citizens or long-term residents of the United States, partnerships or other pass-through entities and the equity holders therein, &#147;controlled foreign corporations,&#148;
&#147;passive foreign investment companies,&#148; corporations that accumulate earnings to avoid U.S. federal income tax, banks, financial institutions, investment funds, insurance companies, brokers, dealers or traders in securities, <FONT
STYLE="white-space:nowrap">tax-exempt</FONT> organizations, <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plans, persons subject to the alternative minimum tax, persons that own, or have owned, actually or constructively, more
than 5% of our common stock and persons holding our common stock as part of a hedging or conversion transaction or straddle, or a constructive sale, or other risk reduction strategy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an entity or arrangement that is classified as a partnership for U.S. federal income tax purposes holds our common stock, the U.S. federal
income tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. Partnerships holding our common stock and the partners in such partnerships are urged to consult their tax advisors as to
particular U.S. federal income tax consequences to them of holding and disposing of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PROSPECTIVE INVESTORS SHOULD
CONSULT THEIR TAX ADVISORS REGARDING THE PARTICULAR U.S. FEDERAL INCOME TAX CONSEQUENCES TO THEM OF ACQUIRING, OWNING AND DISPOSING OF OUR COMMON STOCK, AS WELL AS ANY TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL OR FOREIGN TAX LAWS AND ANY OTHER
U.S. FEDERAL TAX LAWS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Definition of <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is any beneficial owner of our common stock that is
not a &#147;U.S. person&#148; or a partnership (including any entity or arrangement treated as a partnership and the equity holders therein) for U.S. federal income tax purposes. A U.S. person is any of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an individual citizen or resident of the United States; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States, any state thereof or the District of Columbia; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a trust (1)&nbsp;whose administration is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or
(2)&nbsp;that has a valid election in effect under applicable Treasury Regulations to be treated as a U.S. person. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Distributions on our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we make cash or other property distributions on our common stock, such distributions will constitute dividends for U.S. federal income tax
purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute a return of capital and
will first be applied against and reduce a holder&#146;s tax basis in our common stock, but not below zero. Any excess will be treated as gain realized on the sale or other disposition of our common stock and will be treated as described under the
section of this prospectus supplement titled &#147;&#151;Gain on disposition of our common stock&#148; below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion
below regarding backup withholding and FATCA, dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of our common stock generally will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the
dividends, or such lower rate specified by an applicable income tax treaty. To receive the benefit of a reduced treaty rate, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must generally furnish to us or our paying agent a valid IRS Form <FONT
STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or applicable successor form) including a U.S. taxpayer identification number and certifying such
holder&#146;s qualification for the reduced rate. This certification must be provided to us or our paying agent prior to the payment of dividends and must be updated periodically. If the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds
the stock through a financial institution or other agent acting on the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s behalf, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be required to provide appropriate
documentation to the agent, which then will be required to provide certification to us or our paying agent, either directly or through other intermediaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders that do not timely provide the required certification, but that qualify for a reduced
treaty rate, may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder holds our common stock in connection with the conduct of a trade or business in the United&nbsp;States, and dividends paid on our common stock are effectively connected with such holder&#146;s U.S.
trade or business (and are attributable to such holder&#146;s permanent establishment in the United States if required by an applicable tax treaty), the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be exempt from U.S. federal
withholding tax. To claim the exemption, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must generally furnish a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or applicable successor form). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any dividends paid on our common stock that are effectively connected with a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s
U.S. trade or business (and if required by an applicable income tax treaty, are attributable to a permanent establishment maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States) generally will be subject to
U.S. federal income tax on a net income basis at the regular U.S. federal income tax rates in the same manner as if such holder were a resident of the United States. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a foreign
corporation also may be subject to an additional branch profits tax equal to 30% (or such lower rate specified by an applicable income tax treaty) of its effectively connected earnings and profits for the taxable year, as adjusted for certain items.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding any applicable income tax treaties that may provide for different rules. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Gain on disposition of our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussion below regarding backup withholding and FATCA, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally
will not be subject to U.S. federal income tax on any gain realized upon the sale or other disposition of our common stock, unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business in the United&nbsp;States, and if required by an applicable income tax treaty, is
attributable to a permanent establishment maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual present in the United States for 183 days or more during the taxable year of the disposition, and certain other requirements
are met; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our common stock constitutes a &#147;United States real property interest&#148; by reason of our status as a United&nbsp;States real property holding corporation, or USRPHC, for U.S. federal income tax purposes at any
time within the shorter of the five-year period preceding the disposition or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period for our common stock, and our common stock is not regularly traded on an established
securities market during the calendar year in which the sale or other disposition occurs. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The determination of whether we
are a USRPHC depends on the fair market value of our U.S. real property interests relative to the fair market value of our other trade or business assets and our foreign real property interests. We believe we are not currently and do not anticipate
becoming a USRPHC for U.S. federal income tax purposes. However, there can be no assurance that we will not become a USRPHC in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gain described in the first bullet point above generally will be subject to U.S. federal income tax on a net income basis at the graduated
U.S. federal income tax rates in the same manner as if such holder were a resident of the United States. A <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a foreign corporation also may be subject to an additional branch profits tax
equal to 30% (or such lower rate specified by an applicable income tax treaty) of its effectively connected earnings and profits for the taxable year, as adjusted for certain items. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should
consult their tax advisors regarding any applicable income tax treaties that may provide for different rules. Gain described in the second bullet point above will be subject to U.S. federal income tax at a flat 30% rate (or such lower rate specified
by an applicable income tax treaty), but may be offset by certain U.S.-source capital losses (even though the individual is not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
has timely filed U.S. federal income tax returns with respect to such losses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Information reporting and backup withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Annual reports are required to be filed with the IRS and provided to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder indicating
the amount of dividends on our common stock paid to such holder and the amount of any tax withheld with respect to those dividends. These information reporting requirements apply even if no withholding was required because the dividends were
effectively connected with the holder&#146;s conduct of a U.S. trade or business, or withholding was reduced or eliminated by an applicable income tax treaty. This information also may be made available under a specific treaty or agreement with the
tax authorities in the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is established. Backup withholding, currently at a 24% rate, generally will not apply to payments to a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of dividends on or the gross proceeds of a disposition of our common stock provided the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder furnishes the required certification as to its <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> status, such as by providing a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or IRS Form <FONT
STYLE="white-space:nowrap">W-8ECI,</FONT> or certain other requirements are met. Notwithstanding the foregoing, backup withholding may apply if the payor has actual knowledge, or reason to know, that the holder is a U.S. person who is not an exempt
recipient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. If any amount is withheld under the backup withholding rules, the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder should consult with a U.S. tax advisor regarding the possibility of and procedure for obtaining a refund or a credit against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S.
federal income tax liability, if any. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Withholding on foreign entities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code (commonly referred to as FATCA) impose a U.S. federal withholding tax of 30% on certain payments made to
a &#147;foreign financial institution&#148; (as specially defined under these rules) unless such institution enters into an agreement with the U.S. government to withhold on certain payments and to collect and provide to the U.S. tax authorities
substantial information regarding U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or an exemption applies.
FATCA also generally will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
impose a U.S. federal withholding tax of 30% on certain payments made to a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity unless such entity provides the withholding agent a
certification identifying the direct and indirect U.S. owners of the entity or an exemption applies. An intergovernmental agreement between the United States and an applicable foreign country may modify these requirements. Under certain
circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder might be eligible for refunds or credits of such taxes. FATCA currently applies to dividends paid on our common stock. FATCA will also apply to gross proceeds from sales or
other dispositions of our common stock after December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prospective investors are encouraged to consult with their own tax
advisors regarding the possible implications of FATCA withholding on their investment in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_12"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. and RBC Capital Markets, LLC are acting as joint book-running managers of this offering and representatives of the
underwriters named below. Under the terms of an underwriting agreement, which we will file as an exhibit to our current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> and incorporate by reference in this prospectus supplement and the
accompanying prospectus, each of the underwriters named below has severally agreed to purchase from us and the selling stockholders the respective number of shares of common stock shown opposite its name below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:46.20pt; font-size:8pt; font-family:Times New Roman"><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stifel, Nicolaus&nbsp;&amp; Company, Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cowen and Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond James&nbsp;&amp; Associates, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Blair &amp; Company, L.L.C.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BTIG, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,180,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriting agreement provides that the underwriters&#146; obligation to purchase shares of common stock
depends on the satisfaction of the conditions contained in the underwriting agreement including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the obligation to purchase all of the shares of common stock offered hereby (other than those shares of common stock covered by their option to purchase additional shares as described below), if any of the shares are
purchased; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the representations and warranties made by us and the selling stockholders to the underwriters are true; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">there is no material change in our business or the financial markets; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we and the selling stockholders deliver customary closing documents to the underwriters. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and
Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the underwriting discounts and commissions we and the selling stockholders will pay to the
underwriters. These amounts are shown assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares from certain of the selling stockholders. The underwriting fee is the difference between the initial
price to the public and the amount the underwriters pay to us and the selling stockholders for the shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Us</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Selling Stockholders</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representatives have advised us that the underwriters propose to offer the shares of common stock directly
to the public at the public offering price on the cover of this prospectus supplement and to selected dealers, which may include the underwriters, at such offering price less a selling concession not in excess of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After the offering, the representatives may change the offering price and other selling terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expenses of the offering to be incurred by us and the selling stockholders are estimated to be approximately $0.6&nbsp;million (excluding
underwriting discounts and commissions). We have agreed to pay </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expenses incurred by the selling stockholders in connection with the offering, other than the underwriting discounts and commissions. We have also agreed to reimburse the underwriters for certain
of their expenses relating to clearance of this offering as set forth in the underwriting agreement, which are not expected to exceed $25,000. The underwriters have agreed to reimburse us for certain expenses in connection with this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Purchase Additional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of the selling stockholders have granted the underwriters an option exercisable for 30 days after the date of this prospectus
supplement to purchase, from time to time, in whole or in part, up to an aggregate of 770,000 shares at the public offering price less underwriting discounts and commissions. To the extent that this option is exercised, each underwriter will be
obligated, subject to certain conditions, to purchase its pro rata portion of these additional shares based on the underwriter&#146;s percentage underwriting commitment in the offering as indicated in the table at the beginning of this Underwriting
section. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed that, without the prior written consent of Barclays Capital Inc. on behalf of the underwriters, we will not, during the period
ending 75 days after the date of this prospectus supplement, or the restricted period: (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or
warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock; or (2)&nbsp;enter into any swap
or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of our common stock; whether any such transaction described above is to be settled by delivery of our common stock or such other
securities, in cash or otherwise. In addition, we have agreed that, without the prior written consent of Barclays Capital Inc. on behalf of the underwriters, we will not, during the restricted period, file any registration statement with the SEC
relating to the offering of any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described in the immediately preceding paragraph do not apply to: (1)&nbsp;the sale of shares of our common stock to the
underwriters; (2)&nbsp;the issuance of shares of our common stock upon the exercise or conversion of a security outstanding on the date of this prospectus supplement and described herein or of which the underwriters have been advised in writing;
(3)&nbsp;the issuance of shares of common stock, options to purchase shares of common stock, or other equity awards pursuant to our employee benefit plans disclosed herein; (4)&nbsp;the filing of a registration statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> or a successor form thereto; or (5)&nbsp;the sale or issuance or entry into an agreement to sell or issue shares of common stock in connection with our acquisition of one or more businesses, products or
technologies (whether by means of merger, stock purchase, asset purchase or otherwise) or in connection with joint ventures, commercial relationships or other strategic transactions, provided that the aggregate number of shares of common stock that
we may sell or issue or agree to sell or issue pursuant to this clause shall not exceed 5% of the total number of shares of common stock issued and outstanding immediately following the completion of this offering, and provided further that the
recipient of such shares of common stock agrees to be bound in writing by an agreement of the same duration and terms as agreed to by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, all of our directors and executive officers and the selling stockholders have agreed that, without the prior written consent of
Barclays Capital Inc. on behalf of the underwriters, they will not, during the restricted period: (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for shares of our common stock; or (2)&nbsp;enter into
any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of our common stock; whether any such transaction described above is to be settled by delivery of our common stock or such
other securities, in cash or otherwise. In addition, each such person has agreed that, without the prior written consent of Barclays </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Capital Inc. on behalf of the underwriters, such person will not, during the restricted period, make any demand for, or exercise any right with respect to, the registration of any shares of our
common stock or any security convertible into or exercisable or exchangeable for our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described in the
immediately preceding paragraph do not apply to: (1)&nbsp;the sale of shares of our common stock to the underwriters pursuant to the terms of the underwriting agreement; (2)&nbsp;transactions relating to shares of our common stock or other
securities acquired in open market transactions after the completion of this offering, provided that no filing or public announcement under Section&nbsp;16(a) of the Exchange Act or otherwise shall be required or shall be voluntarily made in
connection with subsequent sales of common stock or other securities acquired in such open market transactions; (3)&nbsp;transfers of shares of our common stock or any security convertible into our common stock as a bona fide gift or charitable
contribution; (4)&nbsp;distributions by any holder of our common stock to limited partners, members or stockholders of such holder or to any corporation, partnership or other business entity that controls, is controlled by or managed by or is under
common control with such holder; (5)&nbsp;any transfer by will or pursuant to the laws of descent and distribution; (6)&nbsp;any transfer to or from certain trusts or to a stockholder&#146;s family; (7)&nbsp;the receipt of our common stock upon the
exercise of options or any transfer of common stock or securities convertible into common stock upon the exercise of options to purchase our securities on a &#147;cashless&#148; or &#147;net exercise&#148; basis to the extent permitted by the
instruments representing such options so long as such exercise is effected solely by the surrender and cancellation of outstanding options; (8)&nbsp;any transfer by operation of law pursuant to a qualified domestic order or in connection with a
divorce settlement; (9)&nbsp;any transfer of shares of common stock or any security convertible into or exercisable or exchangeable for common stock pledged in a bona fide transaction to third parties as collateral to secure obligations pursuant to
lending or other arrangements; (10)&nbsp;any transfer of shares of common stock or any security convertible into or exercisable or exchangeable for common stock pursuant to a bona fide third-party tender offer, merger, consolidation or similar
transaction made to all holders of common stock involving a change of control, provided that until such tender offer, merger, consolidation or other such transaction is completed, the common stock shall remain subject to the restrictions contained
in the applicable agreement; or (11)&nbsp;the establishment of a trading plan pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of common stock, provided that (i)&nbsp;such plan does
not provide for the transfer of common stock during the restricted period and (ii)&nbsp;to the extent a public announcement or filing under the Exchange Act or otherwise, if any, is required or voluntarily made regarding the establishment of such
plan, such announcement or filing shall include a statement to the effect that no transfer of common stock may be made under such plan during the restricted period; provided that in the case of any receipt, transfer or distribution pursuant to
clauses (3)&nbsp;through (9), (i) each recipient, transferee, donee (subject to certain exceptions) or distributee shall sign and deliver, to the extent not previously signed and delivered, a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement
prior to any transfer or distribution and (ii)&nbsp;no filing or public announcement under Section&nbsp;16(a) of the Exchange Act or otherwise shall be required or shall be voluntarily made during the restricted period (other than a filing on Form 5
made after the expiration of the restricted period). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions described above do not apply to sales of common stock by certain of
our executive officers and directors under trading plans established prior to the date of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc., in its sole discretion, may release the common stock and other securities subject to the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above in whole or in part at any time. When determining whether or not to release common stock and other securities from <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements,
Barclays Capital Inc. will consider, among other factors, the holder&#146;s reasons for requesting the release, the number of shares of common stock and other securities for which the release is being requested and market conditions at the time.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We and the selling
stockholders have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make for these liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stabilization, Short Positions and Penalty Bids </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representatives may engage in stabilizing transactions, short sales and purchases to cover positions created by short sales, and penalty
bids or purchases for the purpose of pegging, fixing or maintaining the price of the common stock, in accordance with Regulation M under the Exchange Act: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A short position involves a sale by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase in the offering, which creates the syndicate short position. This short
position may be either a covered short position or a naked short position. In a covered short position, the number of shares involved in the sales made by the underwriters in excess of the number of shares they are obligated to purchase is not
greater than the number of shares that they may purchase by exercising their option to purchase additional shares. In a naked short position, the number of shares involved is greater than the number of shares in their option to purchase additional
shares. The underwriters may close out any short position by either exercising their option to purchase additional shares and/or purchasing shares in the open market. In determining the source of shares to close out the short position, the
underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through their option to purchase additional shares. A naked short position is
more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Syndicate covering transactions involve purchases of the common stock in the open market after the distribution has been completed in order to cover syndicate short positions. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Penalty bids permit the representatives to reclaim a selling concession from a syndicate member when the common stock originally sold by the syndicate member is purchased in a stabilizing or syndicate covering
transaction to cover syndicate short positions. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These stabilizing transactions, syndicate covering transactions and penalty
bids may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of the common stock. As a result, the price of the common stock may be higher than the price that might
otherwise exist in the open market. These transactions may be effected on the Nasdaq Global Market or otherwise and, if commenced, may be discontinued at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the
transactions described above may have on the price of the common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these stabilizing transactions or that any transaction, once
commenced, will not be discontinued without notice. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Passive Market Making </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, underwriters and selling group members may engage in passive market making transactions in the common stock on
the Nasdaq Global Market in accordance with Rule 103 of Regulation M under the Exchange Act during the period before the commencement of offers or sales of common stock and extending through the completion of distribution. A passive market maker
must display its bids at a price not in excess of the highest independent bid of the security. However, if all independent bids are lowered below the passive market maker&#146;s bid that bid must be lowered when specified purchase limits are
exceeded. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A
prospectus in electronic format may be made available on the Internet sites or through other online services maintained by one or more of the underwriters and/or selling group members participating in this
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
offering, or by their affiliates. In those cases, prospective investors may view offering terms online and, depending upon the particular underwriter or selling group member, prospective
investors may be allowed to place orders online. The underwriters may agree with us to allocate a specific number of shares for sale to online brokerage account holders. Any such allocation for online distributions will be made by the
representatives on the same basis as other allocations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other than the prospectus in electronic format, the information on any
underwriter&#146;s or selling group member&#146;s web site and any information contained in any other web site maintained by an underwriter or selling group member is not part of the prospectus or the registration statement of which this prospectus
forms a part, has not been approved and/or endorsed by us or any underwriter or selling group member in its capacity as underwriter or selling group member and should not be relied upon by investors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing on the Nasdaq Global Market </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
common stock is on the Nasdaq Global Market under the symbol &#147;RPD.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stamp Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you purchase shares of common stock offered in this prospectus supplement, you may be required to pay stamp taxes and other charges under
the laws and practices of the country of purchase, in addition to the offering price listed on the cover page of this prospectus supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other
Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters and certain of their affiliates are full service financial institutions engaged in various activities,
which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. The underwriters and certain of their
affiliates have, from time to time, performed, and may in the future perform, various commercial and investment banking and financial advisory services for the issuer and its affiliates, for which they received or may in the future receive customary
fees and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the underwriters and certain of their affiliates may make
or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment
and securities activities may involve securities and/or instruments of the issuer or its affiliates. The underwriters and certain of their affiliates may also communicate independent investment recommendations, market color or trading ideas and/or
publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus
supplement does not constitute an offer to sell to, or a solicitation of an offer to buy from, anyone in any country or jurisdiction (i)&nbsp;in which such an offer or solicitation is not authorized, (ii)&nbsp;in which any person making such offer
or solicitation is not qualified to do so or (iii)&nbsp;in which any such offer or solicitation would otherwise be unlawful. No action has been taken that would, or is intended to, permit a public offer of the shares of common stock or possession or
distribution of this prospectus supplement or any other offering or publicity material relating to the shares of common stock in any country or jurisdiction (other than the United States) where any such action for that purpose is required.
Accordingly, each underwriter has undertaken that it will not, directly or indirectly, offer or sell any shares of common stock or have in its possession, distribute or publish any prospectus, form of application, advertisement or other document or
information in any country or jurisdiction except under circumstances that will, to the best of its knowledge and belief, result in compliance with any applicable laws and regulations and all offers and sales of shares of common stock by it will be
made on the same terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>European Economic Area </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a &#147;Relevant Member
State&#148;), an offer to the public of any common stock which are the subject of the offering contemplated herein may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any common stock
may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to legal entities which are qualified investors as defined under the Prospectus Directive; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">by the underwriters to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent
of the representatives of the underwriters for any such offer; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in any other circumstances falling within Article 3(2) of the Prospectus Directive; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such
offer of common stock shall result in a requirement for us, the selling stockholders or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus
Directive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person in a Relevant Member State who receives any communication in respect of, or who acquires any common stock under,
the offers contemplated here in this prospectus supplement will be deemed to have represented, warranted and agreed to and with each underwriter, the selling stockholders and us that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">it is a qualified investor as defined under the Prospectus Directive; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in the case of any common stock acquired by it as a financial intermediary, as that term is used in Article 3(2) of the Prospectus Directive, (i)&nbsp;the common stock acquired by it in the offering have not been
acquired on behalf of, nor have they been acquired with a view to their offer or resale to, persons in any Relevant Member State other than qualified investors, as that term is defined in the Prospectus Directive, or in the circumstances in which
the prior consent of the representatives of the underwriters has been given to the offer or resale or (ii)&nbsp;where common stock have been acquired by it on behalf of persons in any Relevant Member State other than qualified investors, the offer
of such common stock to it is not treated under the Prospectus Directive as having been made to such persons. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
purposes of this representation and the provision above, the expression an &#147;offer of common stock to the public&#148; in relation to any common stock in any Relevant Member State means the communication in any form and by any means of
sufficient information on the terms of the offer and any common stock to be offered so as to enable an investor to decide to purchase or subscribe for the common stock, as the same may be varied in that Relevant Member State by any measure
implementing the Prospectus Directive in that Relevant Member State, the expression &#147;Prospectus Directive&#148; means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the
Relevant Member State) and includes any relevant implementing measure in each Relevant Member State, and the expression &#147;2010 PD Amending Directive&#148; means Directive 2010/73/EU. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement has only been communicated or caused to have been communicated and will only be communicated or caused to be
communicated as an invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act of 2000 (the &#147;FSMA&#148;)) as received in connection with the issue or sale of the
common stock in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to us. All applicable provisions of the FSMA will be complied with in respect to anything done in relation to the common stock in, from or otherwise involving the
United Kingdom. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The common stock may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined
in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions</I> or subsection 73.3(1) of the <I>Securities Act</I> (Ontario), and are permitted clients, as defined in National Instrument <FONT
STYLE="white-space:nowrap">31-103</FONT> <I>Registration Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the common stock must be made in accordance with an exemption from, or in a transaction not subject to, the
prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a
purchaser with remedies for rescission or damages if this prospectus supplement or the accompanying prospectus (including any amendments thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the
purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or
territory for particulars of these rights or consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National Instrument <FONT
STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts</I> (&#147;NI <FONT STYLE="white-space:nowrap">33-105&#148;),</FONT> the underwriters are not required to comply with the disclosure requirements of NI
<FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_13"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered by this prospectus supplement and the accompanying prospectus will be passed upon for us by
Cooley LLP, Boston, Massachusetts. Orrick, Herrington&nbsp;&amp; Sutcliffe LLP, New York, New York, is representing the underwriters in connection with this offering. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_14"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Rapid7, Inc. and subsidiaries as of December&nbsp;31, 2016 and 2015, and for each of the years in the
three-year period ended December&nbsp;31, 2016, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein,
and upon the authority of said firm as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_15"></A>WHERE YOU CAN FIND MORE
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to the information requirements of the Exchange Act and, in accordance therewith, file annual, quarterly
and special reports, proxy statements and other information with the SEC. You may read and copy any document we file at the SEC&#146;s Public Reference Room at 100&nbsp;F Street, N.E., Washington, D.C. 20549. You may call the SEC at <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for further information on the operation of the Public Reference Room. These documents also may be accessed through the
SEC&#146;s electronic data gathering, analysis and retrieval system, or EDGAR, via electronic means, including the SEC&#146;s home page on the Internet (www.sec.gov). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus supplement and the accompanying prospectus are part of a registration statement on Form
<FONT STYLE="white-space:nowrap">S-3</FONT> we filed with the SEC under the Securities Act and do not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus supplement or the accompanying
prospectus to any of our contracts, agreements or other documents, the reference may not be complete and you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by
reference into this prospectus supplement or the accompanying prospectus for a copy of such contract, agreement or other document. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="suprom529415_16">
</A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The SEC allows us to &#147;incorporate by reference&#148; the information and
reports we file with it, which means that we can disclose important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus supplement and the accompanying prospectus,
and information that we file later with the SEC will automatically update and supersede the information already incorporated by reference. We are incorporating by reference the documents listed below, which we have already filed with the SEC, and
any future filings we make with the SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act (other than Current Reports or portions furnished under Items 2.02 or 7.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> or related
exhibits furnished pursuant to Item 9.01 of Form <FONT STYLE="white-space:nowrap">8-K),</FONT> including all filings made after the date of this prospectus supplement and prior to the termination of the offering of the common stock covered by this
prospectus supplement: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2016, which was filed with the SEC on March&nbsp;9, 2017; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the information specifically incorporated by reference into our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> for the year ended December&nbsp;31, 2016 from our definitive proxy statement on
Schedule&nbsp;14A related to our 2017 annual meeting of stockholders, which was filed with the SEC on April&nbsp;27, 2017; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarters ended March&nbsp;31, 2017, June&nbsp;30, 2017 and September&nbsp;30, 2017, which were filed with the SEC on May&nbsp;10, 2017,
August&nbsp;8, 2017 and November&nbsp;8, 2017, respectively; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our Current Reports on Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed with the SEC on February&nbsp;2, 2017, June&nbsp;14, 2017, November&nbsp;16, 2017, December&nbsp;12, 2017 and January&nbsp;23, 2018; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the description of our common stock contained in our registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;8-A,</FONT> which was filed with the SEC on July&nbsp;13, 2015, including any amendment or report
filed for the purpose of updating such description. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon request, we will provide, without charge, to each person,
including any beneficial owner, to whom a copy of this prospectus supplement and the accompanying prospectus is delivered, a copy of the documents incorporated by reference into this prospectus supplement and accompanying prospectus. You may request
a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in this prospectus supplement or the accompanying prospectus, at no cost by writing or telephoning us at the following address: Rapid7,&nbsp;Inc.,
100 Summer Street, Boston, Massachusetts 02110, Attention: General Counsel, or by telephone request to <FONT STYLE="white-space:nowrap">(617)&nbsp;247-1717.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g529415g25q05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>$50,000,000 of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>and
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>18,419,274 Shares of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Offered by
Selling Stockholders </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From time to time, we may offer and sell up to an aggregate amount of $50,000,000 of shares of our common stock. In addition, selling
stockholders to be named in the applicable prospectus supplement may offer and sell up to an aggregate of 18,419,274 shares of our common stock, from time to time, on the terms described in this prospectus or in an applicable prospectus supplement.
We will not receive any of the proceeds from the sale of the shares offered by the selling stockholders hereunder. To the extent that any selling stockholder resells any securities, the selling stockholder may be required to provide you with this
prospectus and a prospectus supplement identifying and containing specific information about the selling stockholder and the terms of the securities being offered. We and the selling stockholders may sell the shares to or through underwriters and
also to other purchasers or through agents. The names of any underwriters or agents, and any fees, conversions, or discount arrangements will be set forth in the applicable prospectus supplement accompanying this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will provide the specific terms of these offerings in one or more supplements to this prospectus. We may also authorize one or more free
writing prospectuses to be provided to you in connection with these offerings. The prospectus supplement and any related free writing prospectus may also add, update or change information contained in this prospectus. You should carefully read this
prospectus, the applicable prospectus supplement and any related free writing prospectus, as well as any documents incorporated by reference, before buying any of the shares of common stock being offered. <B>This prospectus may not be used to
consummate a sale of securities unless it is accompanied by the applicable prospectus supplement.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should read this document and
any applicable prospectus supplement or amendment carefully before you invest in our securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed on the NASDAQ
Global Market under the symbol &#147;RPD.&#148; On May&nbsp;22, 2017, the closing price for our common stock, as reported on the NASDAQ Global Market, was $18.04 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>We are an &#147;emerging growth company&#148; as defined under the federal securities laws and, as such, have elected to comply with
certain reduced public company reporting requirements. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Investing in our securities involves a high degree of risk. You should
review carefully the risks and uncertainties described under the heading &#147;<A HREF="#tx529415_3">Risk Factors</A>&#148; contained in this prospectus beginning on page&nbsp;5 and any applicable prospectus supplement and in any free writing
prospectuses we have authorized for use in connection with a specific offering, and under similar headings in the other documents that are incorporated by reference into this prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this
prospectus is June&nbsp;2, 2017. </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_1">About this prospectus</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_2">Prospectus summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_3">Risk factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_4">Special note regarding forward-looking statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_5">Use of proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_6">Description of capital stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_7">Selling stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_8">Plan of distribution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_9">Legal matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_10">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_11">Where you can find more information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#tx529415_12">Incorporation of certain information by reference</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_1"></A>ABOUT THIS PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a
&#147;shelf&#148; registration process. Under this shelf registration process, we may, from time to time, offer and sell, either individually or in combination, in one or more offerings, up to a total dollar amount of $50,000,000 of shares of our
common stock as described in this prospectus.&nbsp;In addition, under this shelf process, the selling stockholders to be named in a supplement to this prospectus may, from time to time, offer and sell up to 18,419,274 shares of our common stock, as
described in this prospectus, in one or more offerings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus provides you with a general description of the securities we or
the selling stockholders may offer. Each time we or the selling stockholders offer securities under this prospectus, we will provide a prospectus supplement that will contain more specific information about the terms of that offering. We may also
authorize one or more free writing prospectuses to be provided to you that may contain material information relating to these offerings. The prospectus supplement and any related free writing prospectus that we may authorize to be provided to you
may also add, update or change any of the information contained in this prospectus or in the documents that we have incorporated by reference into this prospectus. We urge you to read carefully this prospectus, any applicable prospectus supplement
and any related free writing prospectuses we have authorized for use in connection with a specific offering, together with the information incorporated herein by reference as described under the heading &#147;Incorporation of Certain Information By
Reference,&#148; before buying any of the securities being offered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>This prospectus may not be used to consummate a sale of shares of
our common stock unless it is accompanied by a prospectus supplement. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should rely only on the information contained in, or
incorporated by reference into, this prospectus and any applicable prospectus supplement, along with the information contained in any free writing prospectuses we have authorized for use in connection with a specific offering. Neither we nor any
selling stockholder have authorized anyone to provide you with information in addition to or different from that contained in this prospectus, any applicable prospectus supplement and any related free writing prospectus. We take no responsibility
for, and can provide no assurances as to the reliability of, any information not contained in this prospectus, any applicable prospectus supplement or any related free writing prospectus that we or a selling stockholder may authorize to be provided
to you. This prospectus is an offer to sell only the securities offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. You should assume that the information in this prospectus, any applicable prospectus
supplement or any related free writing prospectus is accurate only as of the date on the front of the document and that any information incorporated by reference is accurate only as of the date of the document incorporated by reference, regardless
of the time of delivery of this prospectus, any applicable prospectus supplement or any related free writing prospectus, or any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those
dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless the context otherwise indicates, references in this prospectus to &#147;Rapid7,&#148; &#147;we,&#148; &#147;our,&#148;
&#147;us&#148; and &#147;the Company&#148; refer, collectively, to Rapid7,&nbsp;Inc., a Delaware corporation. Our principal executive offices are located at 100 Summer Street, Boston, Massachusetts 02110 and our telephone number is
(617)&nbsp;247-1717. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_2"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>The following summary highlights selected information contained or incorporated by reference elsewhere in this prospectus
and does not contain all of the information that you should consider in making your investment decision.&nbsp;Before investing in our common stock, you should carefully read this entire prospectus, the applicable prospectus supplement and any
related free writing prospectus, including the information under the caption &#147;Risk Factors&#148; herein and the applicable prospectus supplement and under similar headings in the other documents that are incorporated by reference into this
prospectus. You should also carefully read the other information incorporated by reference into this prospectus, including our financial statements and the related notes, and the exhibits to the registration statement of which this prospectus is a
part. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rapid7, Inc. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business
Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Rapid7 is a leading provider of analytics for security and IT operations that enable organizations to implement an active,
analytics-driven approach to cyber security and IT operations. Our data and analytics platform was purpose-built for today&#146;s increasingly complex and chaotic IT environment. We make it simple to collect and unify operational data from across
the entire IT infrastructure, and our advanced analytics unlock the information required to securely operate, manage and develop today&#146;s sophisticated applications and services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We combine our extensive experience in collecting disparate data, deep insight into attacker behaviors and techniques and our purpose-driven
analytics to make sense of the wealth of data available to organizations about their IT environments and users. Our powerful and proprietary analytics enable organizations to contextualize and prioritize the threats facing their physical, virtual
and cloud assets, including those posed by the behaviors of their users. Leveraging our IT data and analytics platform, our solutions enable organizations to strategically and dynamically manage their cyber security exposure and manage IT
operations. Our solutions empower organizations to prevent attacks by providing visibility into vulnerabilities, and allow them to rapidly detect compromises, respond to breaches and correct the underlying causes of attacks. By providing a unified
IT and security platform, with automated workflow, we enable IT and security to work together more effectively to develop, operate and secure their environment. For example, our platform and proprietary technologies were developed to help customers
identify the weaknesses and exposures in their environment and are designed to enable them to detect and respond to breaches immediately. We help them troubleshoot performance issues across their infrastructure, applications and endpoints. Our
platform approach enables organizations to collect data once and use it for ongoing unlimited use and access to solve the specific problems their organization faces, reducing the costs and overhead associated with relying on point solutions, and
enabling workflow between organizations that must work together to resolve issues, reduce risk and increase resiliency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have three
offerings: (1)&nbsp;threat exposure management, which includes our Nexpose, InsightVM, Metasploit, AppSpider and InsightAppSec products, (2)&nbsp;incident detection and response, which includes our InsightIDR, Managed Detection and Response
(formerly known as &#147;Analytic Response&#148;), InsightOps and Logentries products, as well as our incident response services and (3)&nbsp;security advisory services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also offer various professional services across all of our offerings, including deployment and training services related to our Nexpose,
Metasploit, AppSpider and InsightIDR software products, incident response services and security advisory services. Customers can purchase our professional services together with our product offerings or on a stand-alone basis pursuant to fixed fee
or time-and-materials agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were initially incorporated in July 2000 in Delaware. Rapid7 LLC, a limited liability company organized under the laws of the Commonwealth
of Massachusetts, was formed in January 2004. In August 2004, pursuant </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to an exchange agreement among Rapid7 LLC and the stockholders of Rapid7, Inc., the stockholders exchanged their shares in Rapid7, Inc. for equity interests in Rapid7 LLC, after which Rapid7,
Inc. was dissolved. In August 2008, Rapid7 LLC was merged with and into Rapid7 LLC, a newly-formed Delaware limited liability company. Rapid7, Inc. was reincorporated in Delaware in October 2011. In a series of transactions in November 2011, equity
holders of Rapid7 LLC exchanged their equity interests in Rapid7 LLC for capital stock in Rapid7, Inc. and Rapid7 LLC became a wholly-owned subsidiary of Rapid7, Inc., which is the registrant and issuer of the shares of common stock in this
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our principal executive offices are located at 100 Summer Street, Boston, Massachusetts. Our telephone number
is&nbsp;(617)&nbsp;247-1717.&nbsp;Our website address is&nbsp;www.rapid7.com.&nbsp;The information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus, and you should not consider any
information contained on, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;Rapid7,&#148; the Rapid7 logo, and other trademarks or service marks of Rapid7, Inc. appearing in this prospectus are the property of
Rapid7, Inc. This prospectus contains additional trade names, trademarks and service marks of others, which are the property of their respective owners. Solely for convenience, trademarks and trade names referred to in this prospectus may appear
without the&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>&nbsp;or TM symbols. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We qualify as an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act.
An emerging growth company may take advantage of relief from certain reporting requirements and other burdens that are otherwise applicable generally to public companies. As an emerging growth company: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have availed ourselves of the exemption from the requirement to obtain an attestation and report from our
auditors on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will provide less extensive disclosure about our executive compensation arrangements; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will not require stockholder non-binding advisory votes on executive compensation or golden parachute
arrangements. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may use these provisions until the last day of our fiscal year following the fifth anniversary of our
initial public offering. However, if certain events occur prior to the end of such five-year period, including if we become a &#147;large accelerated filer,&#148; our annual gross revenues exceed $1.0 billion or we issue more than $1.0&nbsp;billion
of non-convertible debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period. We may choose to take advantage of some but not all of these reduced burdens. To the extent that we continue
to take advantage of these reduced burdens, the information that we provide stockholders may be different than you might obtain from other public companies in which you hold equity interests. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Shares of Common Stock We May Offer</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may offer shares of our common stock up to a total dollar amount of $50,000,000, from time to time under this prospectus, together with any
applicable prospectus supplement and any related free writing prospectuses, at prices and on terms to be determined by market conditions at the time of any offering. In addition, the selling stockholders to be named in a supplement to this
prospectus may offer or sell, from time to time, up to 18,419,274 shares of our common stock. This prospectus provides you with a general description of the common stock we or the selling stockholders may offer. Each time we or the selling
stockholders offer common stock under this prospectus, we will provide a prospectus supplement that will describe the specific amounts, prices and other important terms of the offering.</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any applicable prospectus supplement and any related free writing prospectus that we may
authorize to be provided to you may also add, update or change any of the information contained in this prospectus or in the documents we have incorporated by reference. However, no prospectus supplement or free writing prospectus will offer a
security that is not registered and described in this prospectus at the time of the effectiveness of the registration statement of which this prospectus is a part.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>THIS PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SHARES OF OUR COMMON STOCK UNLESS IT IS ACCOMPANIED BY A PROSPECTUS
SUPPLEMENT.</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or the selling stockholders may sell the common stock directly to investors or to or through agents, underwriters or
dealers. We and the selling stockholders, and our or their agents or underwriters, reserve the right to accept or reject all or part of any proposed purchase of common stock. If we or the selling stockholders do offer common stock to or through
agents or underwriters, we will include in the applicable prospectus supplement:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the names of those agents or underwriters;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">applicable fees, discounts and commissions to be paid to them;</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">details regarding over-allotment or other options, if any; and</P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the net proceeds to us.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may issue shares of our common stock from time to time. The selling stockholders may offer shares of our common stock to the extent such
shares were issued and outstanding, or issuable upon exercise or conversion of securities issued and outstanding, prior to the original date of filing of the registration statement to which this prospectus relates. The holders of our common stock
are entitled to one vote for each share held of record on all matters submitted to a vote of stockholders. Subject to preferences that may be applicable to any outstanding shares of preferred stock, the holders of common stock are entitled to
receive ratably such dividends as may be declared by our board of directors out of legally available funds. Upon our liquidation, dissolution or winding up, holders of our common stock are entitled to share ratably in all assets remaining after
payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and no right to convert their common stock into any other securities. There are no redemption or
sinking fund provisions applicable to our common stock. In this prospectus, we have summarized certain general features of the common stock under &#147;Description of Capital Stock&#151;Common Stock.&#148; We urge you, however, to read the
applicable prospectus supplement (and any related free writing prospectus that we may authorize to be provided to you) related to any common stock being offered.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Proceeds</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as described in
any applicable prospectus supplement or in any related free writing prospectuses we have authorized for use in connection with a specific offering, we currently intend to use the net proceeds from the sale of the common stock offered by us
hereunder, if any, for working capital, capital expenditures and other general corporate purposes, funding future acquisition, or for any other purpose we describe in the applicable prospectus supplement. We will not receive any proceeds from the
sale of shares of our common stock by any selling stockholder. See &#147;Use of Proceeds&#148; in this prospectus.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange Listing</B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is listed on the NASDAQ Global Market under the symbol &#147;RPD.&#148;&nbsp;The applicable prospectus supplement will contain
information, where applicable, as to other listings, if any, of the shares of our common stock covered by the applicable prospectus supplement.</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_3"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Investing in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should carefully consider
the risks described in the documents incorporated by reference in this prospectus and any applicable prospectus supplement and any related free writing prospectus, as well as other information we include or incorporate by reference into this
prospectus and any applicable prospectus supplement, before making an investment decision. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our securities
could decline due to the occurrence of any of these risks, and you may lose all or part of your investment. This prospectus and the documents incorporated herein by reference also contain forward-looking statements that involve risks and
uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described above and in the documents incorporated herein by reference, including in
(1)&nbsp;our most recent annual report on Form&nbsp;10-K on file with the SEC, (2)&nbsp;our most recent quarterly report on Form&nbsp;10-Q on file with the SEC and is incorporated herein by reference, and 3)&nbsp;as well as any amendments thereto
reflected in subsequent filings with the SEC, which are incorporated by reference into this prospectus in their entirety, together with other information in this prospectus, the documents incorporated by reference and any free writing prospectus
that we may authorize for use in connection with a specific offering. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_4"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus, including the documents that we incorporate by reference, contains forward-looking statements within the
meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&nbsp;21E of the Securities Exchange Act of 1934, or the Exchange Act. Any statements about our expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as &#147;may,&#148; &#147;could,&#148; &#147;should,&#148;
&#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;projects,&#148; &#147;potential,&#148; &#147;continue,&#148; and similar expressions, or
the negative of these terms, or similar expressions. Accordingly, these statements involve estimates, assumptions and uncertainties which could cause actual results to differ materially from those expressed in them. Any forward-looking statements
are qualified in their entirety by reference to the factors discussed throughout this prospectus, and in particular those factors referenced in the section &#147;Risk factors.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus contains forward-looking statements that are based on our management&#146;s belief and assumptions and on information
currently available to our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity,
performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could
differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_5">
</A>USE OF PROCEEDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Except as described in any applicable prospectus supplement or in any related free writing prospectuses we may
authorize for use in connection with a specific offering, we currently intend to use the net proceeds from the sale of the securities offered by us hereunder, if any, for working capital, capital expenditures and other general corporate purposes. In
addition, we may use a portion of the proceeds for the acquisition of, or investment in, technologies, solutions or businesses that complement our business, although we have no present commitments or agreements to enter into any such acquisitions or
investments. As of the date of this prospectus, we cannot </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
specify with certainty all of the particular uses for the net proceeds to us from the sale of the securities offered by us hereunder.&nbsp;We will set forth in the applicable prospectus
supplement or free writing prospectus our intended use for the net proceeds received from the sale of any securities sold pursuant to the prospectus supplement or free writing prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will not receive any proceeds from the sale of shares of our common stock by any selling stockholder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_6"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following description of our capital stock, of certain provisions of our amended and restated certificate of incorporation and amended and
restated by-laws, and of certain provisions of Delaware law, together with the additional information we include in any applicable prospectus supplement and in any related free writing prospectus, summarizes the material terms and provisions of our
capital stock. The following description of our capital stock is a summary and does not purport to be complete and is subject to, and qualified in its entirety by reference to our amended and restated certificate of incorporation and our amended and
restated by-laws, which are filed as exhibits to the registration statement of which this prospectus forms&nbsp;a part. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Authorized Capital Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of
preferred stock, par value $0.01 per share, all of which are undesignated. As of May&nbsp;19, 2017, we had 43,154,999 shares of common stock outstanding and no shares of preferred stock outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The holders of our common
stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Because of this, the holders of a majority of the shares of common
stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose. Holders of our common stock are entitled to receive ratably any dividends declared by the board of directors out of
funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund
provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in
all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock. All of our outstanding shares of common stock are, and the shares of common stock to be sold in this offering
are, fully paid and nonassessable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The rights, preferences and privileges of the holders of common stock are subject to, and may be
adversely affected by, the rights of the holders of shares of any series of preferred stock that we may designate in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred
stock in one or more series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation
preferences, sinking fund terms and the number of shares constituting, or the designation of, such series, any or all of which may be more favorable than the rights of our common stock. The issuance of our preferred stock could adversely affect the
voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a
change in control of our company or other corporate action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have no present plans to issue any shares of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Provisions of Our Certificate of Incorporation and By-laws and Delaware Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of incorporation and by-laws, as well as Section&nbsp;203 of the Delaware General Corporation Law, include a number of
provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of
directors rather than pursue non-negotiated takeover attempts. These provisions include the items described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board composition and filling
vacancies </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of incorporation provides for the division of our board of directors into three classes serving
staggered three-year terms, with one class being elected each year. Our certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of the holders of
66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% or more of the shares then entitled to vote at an election of directors. Furthermore, the authorized number of directors number of directors may be
changed only by resolution of the board of directors, and any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of our board, may only be filled by the affirmative vote of a majority of
our directors then in office, even if less than a quorum. The classification of directors, together with the limitations on removal of directors and treatment of vacancies, has the effect of making it more difficult for stockholders to change the
composition of our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>No written consent of stockholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of incorporation provides that all stockholder actions are required to be taken by a vote of the stockholders at an annual or
special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our by-laws or removal of
directors by our stockholders without holding a meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Meetings of stockholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of incorporation and by-laws provide that only our chairman of the board, chief executive officer or&nbsp;a majority of the
members of our board of directors then in office may call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our by-laws limit
the business that may be conducted at an annual meeting of stockholders to those matters properly brought before the meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Advance notice
requirements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our by-laws establish advance notice procedures with regard to stockholder proposals relating to the nomination of
candidates for election as directors or new business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at
which the action is to be taken. Generally, to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our
by-laws specify the requirements as to form and content of all stockholders&#146; notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment to certificate of incorporation and by-laws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any amendment of our certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our
certificate of incorporation, must thereafter be approved by a majority of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the provisions
relating to stockholder action, board composition, limitation of liability, forum selection and the amendment of our by-laws or our certificate of incorporation must be approved by not less than 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB
STYLE="vertical-align:bottom">3</SUB>% of the outstanding shares entitled to vote on the amendment. Our by-laws may be amended by the affirmative vote of a majority of the directors then in office, subject to any limitations set forth in the
by-laws; and may also be amended by the affirmative vote of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the outstanding shares entitled to vote on the amendment, voting together as a
single class. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Undesignated preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of incorporation provides for 10,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares
of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of
directors were to determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other
transactions that might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation grants our board of directors broad power to establish the rights and
preferences of authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also
adversely affect the rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Section&nbsp;203 of the Delaware general corporation law </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are subject to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. In general, Section&nbsp;203 prohibits a publicly
held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business
combination is approved in a prescribed manner. Under Section&nbsp;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">before the stockholder became interested, our board of directors approved either the business combination or
the transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and
also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or after the time the stockholder became interested, the business combination was approved by our board of
directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the outstanding voting stock which
is not owned by the interested stockholder. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;203 defines a business combination to include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of
the assets of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any
stock of the corporation to the interested stockholder; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In general, Section&nbsp;203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Choice of Forum </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our certificate of
incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty owed by and of our directors, officers
or employees to us or our stockholders; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our certificate of incorporation or our by-laws; or any action asserting a claim against us that is governed by
the internal affairs doctrine. Several lawsuits have been filed in Delaware challenging the enforceability of similar choice of forum provisions and it is possible that a court determines such provisions are not enforceable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain holders of
shares of our common stock are entitled to certain rights with respect to registration of such shares under the Securities Act pursuant to the terms of an investors&#146; rights agreement. These shares are collectively referred to herein as
registrable securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The investors&#146; rights agreement provides the holders of registrable securities with demand, piggyback and
S-3&nbsp;registration rights as described more fully below. As of May&nbsp;19, 2017, an aggregate of 21,895,075 registrable securities were entitled to these demand, piggyback and S-3 registration rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
holders of 20% of the registrable securities held by (1)&nbsp;affiliates of Bain Capital Venture Partners, LLC and (2)&nbsp;affiliates of Technology Crossover Ventures each respectively have the right to make up to two demands that we file a
registration statement under the Securities Act covering at least 40% of the registrable securities then outstanding (or lesser percentage if the proposed aggregate offering price would exceed $15.0 million, net of underwriting discounts and
commissions), subject to specified exceptions. We are not obligated to effect any such registration during the period that is sixty days prior to our good faith estimate of the date of filing of, and ending on a date that is one hundred eighty days
after the effective date of, a registration initiated by us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we register any securities for public sale, the holders of our registrable securities then outstanding are each entitled to notice of the
registration and have the right to include their shares in the registration statement. The underwriters of any underwritten offering will have the right to limit the number of shares having registration rights to be included in the registration
statement, but not below 30% of the total number of securities included in such registration. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Registration on Form S-3 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As long as we are eligible to file a registration statement on Form S-3, the holders of at least 15% of our registrable securities held by
(i)&nbsp;affiliates of Bain Capital Venture Partners, LLC and (ii)&nbsp;affiliates of Technology </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Crossover Ventures each respectively have the right to demand that we file a registration statement on Form S-3 provided that the aggregate amount of securities to be sold under the registration
statement is at least $5.0 million, net of underwriting discounts and commissions. Affiliates of Bain Capital Venture Partners, LLC, on the one hand, and affiliates of Technology Crossover Ventures, on the other hand, each respectively may only
demand a registration on Form S-3 once during each 12-month period. The right to have such shares registered on Form S-3 is further subject to other specified conditions and limitations. We are not obligated to effect any such registration during
the period that is thirty days prior to our good faith estimate of the date of filing of, and ending on a date that is ninety days after the effective date of, a registration initiated by us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expenses of Registration </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will
pay all expenses relating to any demand, piggyback or Form S-3 registration, other than underwriting discounts and commissions, subject to specified conditions and limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Termination of Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These registration rights will terminate on July&nbsp;22, 2022, or, with respect to any particular stockholder, when such stockholder is able
to sell all of its shares pursuant to Rule 144 under the Securities Act or a similar exemption during any three-month period without volume limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock is
listed on the NASDAQ Global Market under the symbol &#147;RPD.&#148; On May&nbsp;22, 2017, the closing price for our common stock was $18.04 per share. As of May&nbsp;19, 2017, we had approximately 153 stockholders of record. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
transfer agent and registrar for our common stock is Computershare Trust Company, N.A. The transfer agent&#146;s address is 250 Royall Street, Canton, Massachusetts 02021. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_7"></A>SELLING STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus also relates to the possible resale by certain of our stockholders, who we refer to in this prospectus as the selling
stockholders, of up to 18,419,274 shares of our common stock that were issued and outstanding prior to the date of the registration statement of which this prospectus forms a part. The selling stockholders are former holders of our preferred stock
and common stock originally acquired through several private placements prior to or concurrently with our initial public offering. All of such shares of preferred stock were converted into shares of our common stock in connection with our initial
public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The applicable prospectus supplement will set forth the name of each of the selling stockholders and the number of
securities beneficially owned by such selling stockholder that are covered by such applicable prospectus supplement. The applicable prospectus supplement will also disclose whether any of the selling stockholders has held any position or office
with, has been employed by, or otherwise has had a material relationship with us during the three years prior to the date of the applicable prospectus supplement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The selling stockholders shall not sell any shares of our common stock pursuant to this prospectus until we have identified such selling
stockholders and the shares being offered for resale by such selling stockholders in a subsequent prospectus supplement. However, the selling stockholders may sell or transfer all or a portion of their shares of our common stock pursuant to any
available exemption from the registration requirements of the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_8"></A>PLAN OF DISTRIBUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or the selling stockholders may sell our common stock from time to time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to or through underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through dealers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through agents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">directly to one or more purchasers; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">through a combination of any of these methods or any other method permitted by law. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or the selling stockholders may directly solicit offers to purchase securities, or agents may be designated to solicit such offers. In any
applicable prospectus supplement relating to such offering, we will name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions that we or the selling stockholders must pay to any such agent. Any such
agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities
through any of these methods or other methods described in the applicable prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The distribution of the shares of our
common stock may be effected from time to time in one or more transactions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at a fixed price, or prices, which may be changed from time to time; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at market prices prevailing at the time of sale; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at prices related to such prevailing market prices; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at negotiated prices. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each prospectus supplement will describe the method of distribution of the shares of our common stock and any applicable restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A prospectus supplement or supplements (and any related free writing prospectus that we may authorize to be provided to you with respect to a
particular offering) will describe the terms of the offering of the shares of our common stock, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the name or names of the agent or any underwriters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the public offering or purchase price of the shares of our common stock or other consideration therefor, and
the proceeds, if any, we will receive from the sale; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any over-allotment options under which underwriters may purchase additional shares of our common stock from
us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any agency fees or underwriting discounts and commissions to be allowed or paid to the agent or underwriters;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all other items constituting underwriting compensation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any discounts and commissions to be allowed or paid to dealers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any securities exchange or market on which the shares of our common stock will be listed.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any underwriters or agents are used in the sale of the shares of our common stock in respect of which this
prospectus is delivered, we or the selling stockholders will enter into an underwriting agreement, sales agreement or other agreement with them at the time of sale to them, and we will set forth in the applicable prospectus supplement relating to
such offering the names of the underwriters or agents and the terms of the related agreement with them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the offering of securities, we or the selling stockholders may grant to the
underwriters an option to purchase additional securities with an additional underwriting commission, as may be set forth in the applicable prospectus supplement. If the selling stockholders grant any such option, the terms of such option will be set
forth in the applicable prospectus supplement for such securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a dealer is used in the sale of the securities in respect of which
the prospectus is delivered, we or the selling stockholders will sell such securities to the dealer, as principal. The dealer, who may be deemed to be an &#147;underwriter&#148; as that term is defined in the Securities Act, may then resell such
securities to the public at varying prices to be determined by such dealer at the time of resale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or the selling stockholders may
provide agents and underwriters with indemnification against civil liabilities, including liabilities under the Securities Act, or contribution with respect to payments that the agents or underwriters may make with respect to those liabilities. In
addition, we will indemnify the selling stockholders against certain civil liabilities, including certain liabilities under the Securities Act, and the selling stockholders will be entitled to contribution from us with respect to those liabilities.
The selling stockholders will indemnify us against certain civil liabilities, including liabilities under the Securities Act, and we will be entitled to contribution from the selling stockholders with respect to those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If so indicated in the applicable prospectus supplement, we or the selling stockholders will authorize underwriters or other persons acting as
agents to solicit offers by certain institutions to purchase securities from us or the selling stockholders pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the applicable prospectus supplement. Each
contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the applicable prospectus supplement. Institutions with whom the
contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions. Delayed delivery contracts will not be subject to
any conditions except that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the purchase by an institution of the securities covered under that contract shall not at the time of delivery
be prohibited under the laws of the jurisdiction to which that institution is subject; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if the securities are also being sold to underwriters acting as principals for their own account, the
underwriters shall have purchased such securities not sold for delayed delivery. The underwriters and other persons acting as the selling stockholders&#146; agents will not have any responsibility in respect of the validity or performance of delayed
delivery contracts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Offered securities may also be offered and sold, if so indicated in the applicable prospectus
supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or as agents for us
or the selling stockholders. Any remarketing firm will be identified and the terms of its agreement, if any, with us or the selling stockholders and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be
deemed to be underwriters in connection with their remarketing of offered securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain agents, underwriters and dealers, and their
associates and affiliates, may be customers of, have borrowing relationships with, engage in other transactions with, or perform services, including investment banking services, for us or one or more of our respective affiliates and/or the selling
stockholders or one or more of its respective affiliates in the ordinary course of business for which they receive compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order
to facilitate the offering of the shares of our common stock, any underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the securities or any other securities the prices of which may be used to determine
payments on such securities. Specifically, any underwriters may overallot in connection with the offering, creating a short position for their own accounts. In addition, to cover </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
overallotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase, the securities or any such other securities in the open
market. Finally, in any offering of the shares of our common stock through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the offering
if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above
independent market levels. Any such underwriters are not required to engage in these activities and may end any of these activities at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or the selling stockholders may engage in at the market offerings into an existing trading market in accordance with Rule&nbsp;415(a)(4)
under the Securities Act. In addition, we or the selling stockholders may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the
applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third
party may use securities pledged by us or the selling stockholders or borrowed from us or the selling stockholders or others to settle those sales or to close out any related open borrowings of stock, and may use securities received in settlement of
those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a
post-effective amendment). In addition, we or the selling stockholders may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable
prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Rule&nbsp;15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in three business days, unless the
parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities may be more than three scheduled business days after the trade date for your securities.
Accordingly, in such a case, if you wish to trade securities on any date prior to the third business day before the original issue date for your securities, you will be required, by virtue of the fact that your securities initially are expected to
settle in more than three scheduled business days after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In compliance with the guidelines of the Financial Industry Regulatory Authority,&nbsp;Inc., or FINRA, the aggregate maximum discount,
commission or agency fees or other items constituting underwriting compensation to be received by any FINRA member or independent broker-dealer will not exceed 8% of the proceeds from any offering pursuant to this prospectus and any applicable
prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable
prospectus supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The anticipated date of delivery of offered securities will be set forth in the applicable prospectus supplement
relating to each offer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_9"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Cooley&nbsp;LLP, Boston, Massachusetts will pass upon the validity of the shares of common stock offered hereby unless otherwise indicated in
the applicable prospectus supplement. Any underwriters will also be advised about the validity of the securities and other legal matters by their own counsel, which will be named in the applicable prospectus supplement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_10"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consolidated financial statements of Rapid7, Inc. and subsidiaries as of December&nbsp;31, 2016 and 2015, and for each of the years in the
three-year period ended December&nbsp;31, 2016, have been incorporated by reference herein and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein,
and upon the authority of said firm as experts in accounting and auditing. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_11"></A>WHERE YOU CAN FIND MORE
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are subject to the information requirements of the Exchange Act and, in accordance therewith, file annual, quarterly
and special reports, proxy statements and other information with the SEC. You may read and copy any document we file at the SEC&#146;s Public Reference Room at 100&nbsp;F Street, N.E., Washington, D.C. 20549. You may call the SEC at 1-800-SEC-0330
for further information on the operation of the Public Reference Room. These documents also may be accessed through the SEC&#146;s electronic data gathering, analysis and retrieval system, or EDGAR, via electronic means, including the SEC&#146;s
home page on the Internet (<I>www.sec.gov</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus is part of the registration statement on Form S-3 we filed with the SEC
under the Securities Act and does not contain all the information set forth in the registration statement. Whenever a reference is made in this prospectus to any of our contracts, agreements or other documents, the reference may not be complete and
you should refer to the exhibits that are a part of the registration statement or the exhibits to the reports or other documents incorporated by reference into this prospectus for a copy of such contract, agreement or other document. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="tx529415_12"></A>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The SEC allows us to &#147;incorporate by reference&#148; the information and reports we file with it, which means that we can disclose
important information to you by referring you to these documents. The information incorporated by reference is an important part of this prospectus, and information that we file later with the SEC will automatically update and supersede the
information already incorporated by reference. We are incorporating by reference the documents listed below, which we have already filed with the SEC, and any future filings we make with the SEC under Sections&nbsp;13(a), 13(c), 14 or 15(d) of the
Exchange Act (other than Current Reports or portions furnished under Items 2.02 or 7.01 of Form 8-K), including all filings made after the date of the filing of this registration statement of which this prospectus is a part and prior to the
effectiveness of this registration statement until we file a post-effective amendment that indicates the termination of the offering of the securities covered by this prospectus </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, which was filed with the SEC on
March&nbsp;9, 2017; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information specifically incorporated by reference into our Annual Report on Form&nbsp;10-K for the year
ended December&nbsp;31, 2016 from our definitive proxy statement on Schedule&nbsp;14A related to our 2017 annual meeting of stockholders, which was filed with the SEC on April&nbsp;27, 2017; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Quarterly Report on Form&nbsp;10-Q for the quarter ended March&nbsp;31, 2017, which was filed with the SEC
on May&nbsp;10, 2017; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our Current Report on Form&nbsp;8-K filed with the SEC on February&nbsp;2, 2017; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the description of our common stock contained in our registration statement on Form&nbsp;8-A, which was filed
with the SEC on July&nbsp;13, 2015, including any amendment or report filed for the purpose of updating such description. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon request, we will provide, without charge, to each person, including any beneficial owner, to whom a copy of this prospectus is delivered,
a copy of the documents incorporated by reference into this prospectus but not delivered with the prospectus. You may request a copy of these filings, and any exhibits we have specifically incorporated by reference as an exhibit in this prospectus,
at no cost by writing or telephoning us at the following address: Rapid7,&nbsp;Inc., 100 Summer Street, Boston, Massachusetts 02110, Attention: General Counsel, or by telephone request to (617)&nbsp;247-1717. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither we nor any selling stockholder have authorized anyone to provide you with information other than what is incorporated by reference or
provided in this prospectus or any applicable prospectus supplement. Neither we nor any selling stockholder are making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this
prospectus or in the documents incorporated by reference is accurate as of any date other than the date on the front of this prospectus or those documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="5"><B>5,180,000 Shares </B></FONT></P>
<P STYLE="font-size:30px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:0px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g529415g25q05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="5"><B>Common Stock </B></FONT></P> <P STYLE="font-size:100px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:23%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3">Prospectus Supplement
</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018
</FONT></P><center> <P STYLE="line-height:13px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:23%">&nbsp;</P></center>
<P STYLE="margin-top:100px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="5"><B>Barclays </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="5"><B>RBC Capital
Markets </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:10px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="4"><B>KeyBanc Capital Markets </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="4"><B>Stifel </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3"><B>Cowen
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3"><B>Raymond James </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3"><B>William Blair </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:arial" SIZE="3"><B>BTIG
</B></FONT></P> <P STYLE="font-size:30px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g529415g25q05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g529415g25q05.jpg
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M  4%      $" P0%!@<("1$2"A,4 !47%A@A(AHC)Y?5)"4Q5EC_Q  = 0$
M @(# 0$             ! D" P$'" 8%_\0 /Q$  @$# @,#"08$! <
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M5BR<_I;CYC^CVJQ2X)G^ C*7V&6R^MP:JX!X!(2R5JGI5BV.("NSK,LN3O\
M#-]*SF.R;>LGY=?TK0/4Z[?^7>JUHU5;//EQ/'_-,NQN/,FIY-@=#"*ZA8"I
ME >P.&EBTN3B7IC%!3Y$69$PF302[*YA&R;^))^'3Z&BR_3/Y"QPKI)46_3I
M4853:KYK>[6)V\ $1:Q#.5#.XE\[6,']62E2S",FVX^0IE:2'O@!3JJA]*T2
MG=S[-A^_C2YOD#I<[R:Y-;-KA&SQ_8=XVZ^WQI'@45'BK_1[O*34?%()=Q[&
M3/+MX]JW(($2*1)!,"D(4 5*4<J@=VP_O^Q3A7C=D3# ./.%87& B#'',@S?
M,6YT #VURT:H0]:.Z\NP"H=VI&G=*K&#W%U5CK*"*AS"*H1.Y)/>3O\ &A9_
M5ZX+G[_C#QOY-!$1S74JMNK7$AGT4$4)29H5ZH6A78\/(NB%*O)-H"P9\@]@
MV[DRJ<2:?L2C($!EGWR%;8#Z1'J(W_$$57+Z0.[S[#FCR>S=NX7+5[7Q@"[2
M[4IS V5GL_U:A05<<+)]_ R[:/TJTI-SB'D0CMR4O\'/]*SG[E]YJ[+K P#*
M)Y1P,JU(0BUIR.KRTD)0 #JOV5@MU?*L?L']O^V0\:@4P]Q\4/'OV* !X#\I
MVRBMN(5E<Q* ^1TSC[FXV&Q::&]R=D')]?\ E[6W0$]=DV[@*M+\BO(SWG"7
M(VDS,R8G6>6L[4$[A+:?&X7(E%\/\W>W4A Z;R;]Y-6#<?\ J \,<GQ#*<X<
MZ5((R%/H=:AY@B- OBB0SZ,8W/8%4U$:X9)0J\VH_7!1,YR'!3R*<X#Y#W7H
MOC3PKTWI+3F"DS\R38S#V%K=!<+F67SQ+=#>LK+8%6#W;3."I(/-N"1UKS=Q
M&\G+CEK#7NK]3Q:6MI+;-:ARE]9,^H].JXQTEW(,<C*^4#J8[%;>,JP5EY=B
MJD;"SZF6Z$OU3KEVK2KIQ7K7#L)^#<O6#V+<.XF4;D=Q[L\?(H-GS8KMJJDX
M2(Y;I*BBJF<2 !@^O06*R=IF<;8Y:P:1[')6L-[:22PRV[R6UP@E@E,,Z1S1
MB2-E=1(BMRLI(&]>4<YAK_3N8R>!RB119+#WUSCLA%!<P7<4-Y:2M#<PK<VL
MDMO*89D>)VBD= Z,H8[&A5.H[L_YCY2W86+OY-:SCV\TKO@?R0,%;7<_J%VG
MXB*2GR[4ZFQ1=)]_D1R4?_<Y$D^U=''757\4<0\MV,G:6&"Y<!8\IW0^8/)Y
M](-O1;M,C)=\LB[\\"0=2%6K=_)BT-_!'"3!><0]EE-3\VJ<GNNT@^U(XOLR
M%MQSKV.(BL.>%MNRN7N?1#.V^)P[YA6/B\SO\?%F!PQN#FMO/B."%7;MG<.E
M-H+N$$E0,1)9VC(-4G*A  RQ&34J@F!!,"X\+>)U[P^BS4$+*\.3DL)1%)Z2
M)):K=H\B*00K2K-$LC#8L(HP=^4;;>-W!7&<69M.7-UO#<82+*0=M$>226&]
M>PDCBD=2K.D+VTSQ*20C3RE0#(V]%/JG=O\ RAU0I#.VCSWHWCQBN9YNHV2/
MYMD[!9FTCKLPZ#L(E^8HPT2!C7@E'^GV=!NH4JK=0/JRBJ>(1LF_K)^73]:X
M9Q+]/5SNYG<4JSR\R*>P1I0[I&7F4J--N-ROL1I=A3HEAL56=-V$/&9=.5LC
MF?FZS(-:U\VVM&[TBK)R]<1K9Q[I%<M*JD@ANG@!^HJGK(Z+7;WL&=YMH%W1
MR.M6Z_5NEVK0YB$6F&>=,)N<:PLC:9N"^X0SEU'UH')Y&8:%D&;DC-HZ\#"L
M0J1E;"=@2!OL-]O&F;O2^Z"O$_IKSR&M-9F;W[D86-=1S+7[O%1\-&TYI)M3
MLY8N8T5@YE&E27F6*JC&0FY*>M5F&.</HMA/1\/*RD<]5$>1GZ'H/ ?6NZ=9
M+J'173@X57K5XUZR-M%X!;-./\&X!%P=WI$\P="2SN6"H'^3!Y[$IO;?+ LD
M+%XXCXJN.%V[BQ,C&5BBEVV]7K/@*534^X0 :O7;]LD!.ZW7!O;"VZ76@N*U
M8L.D1YIM.7M,0O>UXBSNX61MA!>-G=E-#3#UJJ^6?E;.')2]U32#MLO3IL/9
M_:B\+SZLZCWC&[CAB_33;Q5 N&9V')UH2,Y4M&\;&T^P59W3U(N/CD>,J+5!
MBSA78M&C)(J3=)NFF@0")E  5H$!!!YA\#0A&3Z)-9#J>::Q6S"2Q9A?Z;HD
M"<J@I"2:I5BCK+%F!4H"9,2OHQ 04* B00\@ 1#Z5O(W!'B"/C3I6FVN%OE0
MJEYK;D'M=N=;@[7 O [=G<+8HMK,1;D/$3%[+L7B"H=C&#L?^!$/Y^E0*3[=
M1';_ -R'.OEMMJ+SYT7?]\TJ2K+GS]SO2F-E?0M&2!3N('!M3HR#; <O8A@1
M 2%*02E!4Y!LBCV?/K5U58])SU*+/6Z]9"Z3Q!A"V&#B9PL-.Z+L+:;B"RS!
MN_",F6S+ Y!HWE6 ./BR*#1\];I.TEDT';E(I%CJU]NG@WP'ZUVO+_2"\RI2
MRLT-FY-<9Z/3Q72^X2F:#J&GV8K?R 5OAU^ST/)8E142=RI&7M"10./D<@E+
MXG5P9U]2D^_8?K1C_3YZ=G'#IG8>MDN$QSXQI9TC8].TZW.&CFZZ+863,S<D
MQ99%NW9,6,5$-3.&]?KL8V9PE?9K/%4D5I63FY>55H9BYW/]!2I3E[L;ODOR
MUY&;BD9P_'9=TTJ\PR)2**+%B+5<Y5_6HMLEV%44V,,YC8QDAV,H"+=%+^Q@
M_E4Q1RJ!X ?UIEAS&71Z=?0:T2HM5DXF7Q_A#5L!CWB)RIK%T"[5*NXBC-(&
M(( I)*72W&GC'( E.[%5<Q?;\P!40>FXWZ[MN?=WGQ]5+YNCMB'[ANIWPLS5
M9G\^-#;ZY?Y]H8GN(.:WD";S6K"T=@("4&CZ(I+Q@OY"7R*Z]LA@54)]*E2'
M9&]VWQZ4W,,8I2B8P@4I0$QC&$ *4H!W$1$?X  #^1$?X /Y'Z5"I>1ZH/J:
MYIRHT_,^(N!6V,O.<<>IJ=M>FW6O/49.KV/8Y)F-?8P-?DVIU6,NUSFOGFF;
M^:CUG#)U.6V6B45/*OJJN%284(](^L=/=W_GTVJ</I">*UAA:YR<YE6*,<,8
M6Z# 8/F#MPB=$9EG7GPV[3Y%K[H%%S%IRXT2(:/6_FV4EHBQ,#*"YC%TTE8S
MG<A?#??\=MOW[:E-U0])8Z)RVM32,<$=L<X@8+.".$C 9,[Z(%],SJ(=A'LI
M'V"PRL4X 0 0<,%0_DH%$:YO*%SL.;XEY&*!UDAP5E9X(.IW4S6W;7=XOL:"
M]OKBV<=X>%JMS\DS2]QIK@WB)KJ-H;C4^1R&IS&X(86]X+>QQ\AW[UN<=C;2
M\B(W!BN$/>2!&;C/CKO>MTSC+4"+?"L=@;FL+A 1*=E58LAY:SO"J@'BDLE"
M,GI69CB4JC\[5 #>:Q 'X#0.EY-9:OP6G4#]C?7J&^=-P8<;;@W.0E#=RLMI
M%*(B2 TS1IONPKM7BIK:'AWP_P!3ZMD*=OC,;(N,CDV*SYB[*V>)@*][1M?S
MP&<*"5MUFD(Y4-%@\E]4CN.O';0;['D:QZM3J8Q--8IIID;$L,@1&OU!D@U
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(Q)(L,?\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g529415g72e01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g529415g72e01.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X7H+:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,3@M,#$M,C-4,3,Z,C(Z-3(K,#4Z,S \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3@M,#$M,C-4,3,Z,C(Z-3,K,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$X+3 Q+3(S5#$S.C(R.C4S*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,3 X/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06)!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03<Q<#)N865D4'138E=%:W=X
M,5!P)B-X03MR+TM08D-Q22]2=6YF.'-S4"])=&8V67%X3%AF3VYL<E).8FTP
M=3DP<W8V54,S2')W4GA/3TQ(:653<U5)*TIK030Q<EAS0EA*0TI+)B-X03M#
M57%8.# O2WIX<3!/:71+>FQ(4D9&=%@P;FM%6DIQ,SDT=3E6*WI55359945O
M-&Q#-2].4%-R945Y=C5C04-%<SE7:DE%4'%,1TAQ)B-X03MQ34-3,W%F1"]K
M9&0Y;FA8:5IP-5=U.4\Q-U%,5%9V,&)&8F979WA-0E9(2VQ86DMC=4LQ*WHT
M6D4W2D-A+V\S5'8X06QL:"\U1G(O)B-X03M!17=*57)A>'-*27EZ5W-&43AI
M-U)R,%)Y;S=E07A65B]2=6YF.'-S4"])=&8V67$X-5 U="M513!Z-C%*;W-Q
M6$A";5=(,#1$1U-0)B-X03M502]E03$T;#1'5W9#=CA!:S509TQ(:5AN.#$O
M2TIL9FAO-R]!1F1487(V-W)B<4LS36I+47=$3G@T>')Z2'E+='=05C1#=D4S
M8B]M)B-X03MT-4].<D9*96%22D)C=5-*3&19-%=+2&M19UEU66HX4S!9+T11
M5C-09DAH2SA4;2].5'EN2'%$=WIA3W=T4%1H94=A3DDU2E0V>7$S)B-X03MX
M>$%!24)Y-CAZ5VTS559E17)X374X=3,K9V$O64YE,E9K<5),25EY2EDT9S%1
M;V)O:&5M>D19-VIO441K4TM313 O4G5N9CAS<U O)B-X03M!0TQ8*VU"2VQB
M5TYH2D=783%G<4AK6&%.96E/5DAB=T=+<F11=#E/=$Q#-74O<55,+U8T;FPT
M8T9(3&=P86QA1VQA67%W:50X>B]+)B-X03M5671),C!I4F)M-VY&=7%'2T5O
M1T1Q:DYZ57-X5W)(:CA.5%1C1')K=45S94I#6&8U=&57-&\O5F@P17E2=4A.
M=7IM,U5.-E-U6D%X)B-X03M1>4)31U%5<%=O4&IT:#1#=D4U4'I1,#5R=4LS
M2&PV0FA*3TE7:U-A3FQ21$HV9DII66=&8TAC<7A!04E03&9(:%AI96LO;S-4
M=CA!)B-X03ML;&@O-49R+T%%>41*4VUS8D)*249&<D)34GER5FI8;T5:='1V
M1F-64VYZ5G%U:V588E,P=7!T35<V4S9U;S=14GA*14A$4VAU2DA0)B-X03MI
M<"M*44XR2'IW9U=G;6U-2#@R+TEX=6\T:S!U5F\S:DUN<4='0E0Y;4XQ;T=C
M0VA6>C%)3E)10FEC;'=&2$5%4"]Y=&91,E-0,#E!)B-X03M26E1B4EA-<51Y
M47A!96]J>4=/3F=R*V\U5D8Y36)&-C!016EM4$%V16Y6:"M92&MY.3%/,C V
M3%0U0E!D5'1B>',P35!!379D:4A.)B-X03M!9D1R-UE/17!T;&1Z63)%8UE:
M8E=#<&5.9#0Q-D\T53EV035&2W(K:F1/+S5:668K4F$O,'A69T(O33-Y=F)R
M9%!Q1VME9W1V2DMI)B-X03MR1W-5:VI,0R]!>6-(.4PT5UIL0SA3>"LQ54)5
M3%I0:$Q(:5AF.')4.&QF5UDW53908VDV;&LY2EEF4G1A."M+<T%4-C-(-&<T
M;V$P)B-X03MW8TI8:51N>6@U;#AV96%8=3)S3D]73S)T;&A:2EI5:D10-G9/
M=G=,>4LP.5!U86YR4VQ#45)346)4>E5D3S X869D15=S24EH:V]F)B-X03M4
M6"M5*S)"2UE7=6LV=D)B47=L3&1J16EP>3E6>%AI2U8O=7-65F8P9G$O*RLW
M9B]!2DA0+W="57-65TYP5W!-871"8D4P<%5Y=511)B-X03M'=CA!=G)X>%9#
M:GEQ0F9,9FI4<D58<5(K:71X>5!-4F<Q-$$K:C!R:F$P:6AP3V]H4V]T-U5+
M96\Y4G%(8VXO04@Q-&Y&5G<P-U9H)B-X03LP:70O*U)R+T%05DQ&5R\P9G$O
M*RLW9B]!2DA0+W="57-65W)P=7%Q2TQ&8F=62B]V;C9K,5 X075R>'A69"MJ
M.5@O,S-B+SAJ;B\V)B-X03MP67%P2%(W.&=!,C%R461"-FIB9&8K2W8X;S1Q
M:#=(>7(Y471J83)7;E=.=F)L:35I:EEQ<%II4U1142LK3G%U=5!,5#--:GE8
M1FA9)B-X03MZ4U-+<4\X:D9I>6\S3E9*35!13G9J86]J.49A;%5N,$QA<'!5
M*W$S-TIQ=BLV=3-B1E9Y-F)Q<6EI>%<T1E-A0U9X=515+S=Q>%9V)B-X03LY
M2#9V+W9U,R]W0U)Z+SA!5DQ&5G$V8G%Q:6EX5S1&4V8W-2MP3E0O04QQ.&-6
M8D]N87-247A7-4(V:C%8+S9P67%P4V%*95-+5FMT)B-X03M,4C%.87%Z<U)V
M,39W.3A656)(>7<Q:F%P85=D:%I7.71(6&A$1S564E4Q3W=H-VY',5)+-E9Q
M4S$T=U=W-45L<5-V=50Q<BLV-S1Q)B-X03MV+U(K<B\W-W0O.$%K8R\O0493
M>%9A9$XQ56Q367)C;%169C-Z-T=H2"LK=D$T<35T33%2<6-O8EDP3E)75GI1
M:G8X03-72V]3*SAQ)B-X03LO6#!33SDP-GAU16IK5U9&:UES039B2S(X4%5!
M52M73G%I9C!2<49A+U8W5W4R+W%.*WHP+W=",61S5E=7*V<S5G1'<V1V85=C
M36%&)B-X03MM4DDS6E%'87!99T-(871C8E968E1D5EE584LS27%$+T%(>CE1
M86HO04A6-#1Q=2]2*W(O04\K-V8O:V,O=T0Q4WA65$]K86=453(Y)B-X03MQ
M5#1M4G4Y9BM+=CAO+V9I<E@V1W8K668V=&$X,39.-FI62%1V-EAT:7$U3DLQ
M2T]P4T,R5&Q3=D=6:%=M=S9267%T=71*,65E,FUH)B-X03M#5S9M5D=4;#9R
M;6Y)57(O04A72W-,+U1/<B\X=#%X+WE.9BMU6#A)86),=C!Z<2\O3&1C9CAJ
M6"]R:G=H8DQV,'IQ+R],9&-F.&I8)B-X03LO<FIW:&),=C!Z<2\O3&1C9CAJ
M6"]R:G=H8DQV,'IQ+R],9&-F.&I8+W)J=VAB3'8P>G$O+TQD8V8X:E@O<FIW
M:&),=C!Z<2\O3&1C)B-X03MF.&I8+W)J=VAB3'8P>G$O+TQD8V8X:E@O<FIW
M:&),=C!Z<2\O3&1C9CAJ6"]R:G=H8DQV,'IQ+R],9&-F.&I8+W)J=VAB3'8P
M>G$O)B-X03LO3&1C9CAJ6"]R:G=H8DQV,'IQ+R],9&-F.&I8+W)J=VAB3'8P
M>G$O+TQD8V8X:E@O<FIW:&)+<&)A:G)L>F-2,CA6-V-'4U9G<2]V)B-X03M:
M3W!0>GA)0S)587-F;4@Q5VEK,4M327)S4S P>$9E5')4-%$S*RMZ9S(W:S=R
M-#=B>DY+:G1$<45K:&I#;#%785=O-3 T:F5N5E1Y)B-X03LK6%AF8D)95VDS
M3&$K6DE66G!T4VMJ0RMP>'),3658<'8V8E5O1#-P4W9J:EDW:S!80WHX>FMY
M<75O4TTX4$5Y;THU2W)Z231D979))B-X03M';W K=F)'=W1&3$I.5S%L2D=1
M,S%X5E-63DI8-T=N:FMQ1$=Y="]43W(O.'0Q>"]Y3F8K=5!#1G-U+U1/<B\X
M=#%X+WE.9BMU4$-&)B-X03MS=2]43W(O.'0Q>"]Y3F8K=5!#1G-U+U1/<B\X
M=#%X+WE.9BMU4$-&<W4O5$]R+SAT,7@O>4YF*W500T9S=2]43W(O.'0Q>"]Y
M3F8K)B-X03MU4$-&<W4O5$]R+SAT,7@O>4YF*W500T9S=2]43W(O.'0Q>"]Y
M3F8K=5!#1G-U+U1/<B\X=#%X+WE.9BMU4$-&<W4O5$]R+SAT,7@O)B-X03MY
M3F8K=5!#1G-U+U1/<B\X=#%X+WE.9BMU4$-&<W4O5$]R+SAT,7@O>4YF*W50
M0T9S=2]43W(O.'0Q>"]Y3F8K=5!#1G-P>"]G4%8O)B-X03LY+U<O+T)0+T%-
M,%I(>$%Y-$,W+T%!2'$O=T1V-C,O-$HO.$%M:DAX079!6&8T1#%F+V8Q=B]W
M5"]W1$Y'4&E"94%U+W=(<2\K+W)F)B-X03LO9VXO04]A369%0SA"9"]G4%8O
M.2]7+R]!050O05!.1U!I0F5!=2]W2'$O*R]R9B]!24HO*V%-9D5#.$)D+V=0
M5B\X068Q=B]!344O)B-X03LO3D=0:4)E074O=TAQ+SA!=C8S+T%/0V8O;6I(
M>$%V05AF-$0Q9CA!,SEB+T%00E O=T$P62M)1C1#-R]!04AQ+W=$=C8S+S1*
M+SA!)B-X03MM:DAX079!6&8T1#%F+V8Q=B]W5"]W1$Y'4&E"94%U+W=(<2\K
M+W)F+V=N+T%/84UF14,X0F0O9U!6+SDO5R\O04%4+T%03D=0:4)E)B-X03M!
M=' U1S%P1'E394)446EO95%B34M%9EDW9S0K248T0W).-5(X>4UQ;V(R27%H
M<6]-:VQ!854O:W=C65AH3&PX<"M:5E)55SEJ0TM#)B-X03MQ<4I*2T%(=#EJ
M2&I#.$IA9GEJ-6MK3&PW,DYJ2E0Q0UI*0U=P,'(X2'1J>&AE17)J-54X>D5!
M1RMJ;T151#%:979)4"],+TU!8V5-)B-X03M,=VQ$;GE,<DQ%<UHW8VLW:VQN
M-B]W1$%99D5#.$)D+V=05B\Y+U<O+T)0+T%-,%DK248T0S<O065R+S<K="\K
M0V8X035O>#A13'=&)B-X03LS*T$Y6"\S.6(O.$%"4#A!.#!9*TE&-$,W+T%E
M<B\W*W0O.$%G;B\U;W@X44QW1C,K03E8+W="+U<O.$%W5"\X,%DK248T0S<O
M065R)B-X03LO=T,O<F8X031*+RMA369%0SA"9"]G4%8O=T1F,78X03A%+R]!
M1%)J-&=89TQV.$%!97(O04\O<F8O9VXO=T-A369%0SA"9"]G4%8O)B-X03LY
M+U<O+T)0+T%-,%DK248T0S<O065R+S<K="\K0V8X035O>#A13'=&,RM!.5@O
M,SEB+SA!0E X03@P62M)1C1#-R]!97(O-RMT+SA!)B-X03MG;B\U;W@X44QW
M1C,K03E8+W="+U<O.$%W5"\X,%DK248T0W(O=T1+-%!)=B],6DHO=T%I2E X
M06UN36HK5',S9#ER9R]W07)A9CA!)B-X03MN9EE89CAR9SAI+SAT:VXO04-)
M:R]W0V%C9C5/>F0S,G(O2S)N+VYF65AF.')G.&DO=T1,6DHO>4EK+S5P>"]K
M-TXS9F%V.$%+,FXO)B-X03M!2C,R1DY03#-N=GDQ-6=U,W1.375':W5),$UR
M239-;G=G9T5J:T)89&AL5V)36DU9=5$R8CE0<G-763%!,E5"9&9M=C5+=&)M
M83)M)B-X03MU-4),03=2>4%1>4=J265*,T$X4FQK97HX<$9G9F$Q5#=5=U)*
M0D\T.&EP9CAR9SAI+SA!3%I*+WE):R\U<'<O>61M-W9T62]Y=' O)B-X03LU
M,S)&,R]+-%!)=B]!0S)39CAI2E K86-F-4]Z9#,R<B]+,FXO;F996&8X04LT
M4$EV+TQ:2B]Y26LO-7!X+VLW3C-F878X<F%F*V0Y)B-X03MH9"]Y=41Y3"]W
M071K;B]):50O;6Y(*U1S,V0Y<2]Y=' O-3,R1E=J+TY4>5I*87I84S-5:&AG
M6D5K4&]Y5D)K-6-D<68U0G=(45I1)B-X03MA<FUZ2&%E07A-<C)(:V5Q:B]Y
M=41Y3"]!371K;B]):50O;6Y$+THR8G4K,6@O2S)N+VYF65AF.')G.&DO=T1,
M6DHO>4EK+S5P>"]K)B-X03LW3C-F878X04LR;B]!2C,R1C,O2S10278O3%I*
M+W=!:4I0.$%M;D@K5',S9#EQ+WET<"\U,S)&:$YX-7=H:V%D22]/33!557I"
M,&M&)B-X03MT9$=73G@V=T1,5U%R+W4U6#15-$5O1DLX0U)H+VLW3#-F878X
M<F%F*V0Y:%$P,VU66# K.&=4>C%D>#-5-4)H=6QT<FUQ9G9%96Y%)B-X03MU
M44%N0F@X3D-W66AJ<W1(*U1S,V0Y<5 U5S O.#<W0S%R;7!84UAC8V)E9G)Y
M2C!H0FQ63&5D03=42S!K8C!J96=#0UEF0T]T0E5J)B-X03MJ:UDV1$Q)5T%Z
M;C)N:&=A2C,Y>&(Q5'I&1&1Y5WI7+VYM.71&:5-*6D5J9W5A35EW-#=S83=U
M<%!,9#9F164K4R]K-TPS9F%W+VQB)B-X03M4+WIV<TMS4$TQ:VMK2EAZ>&5Y
M45)C;#E#4S-U3G=F<VMY2S1K6FQ/+W=!4DYD9V1Q,68U3WID,S)R+TLR;B]N
M9EE5,#AM*V9.1#!5)B-X03LS9C96.'DS3W)*3W-!9U=A2S19>$=*4W-H1%!Y
M<C9H25!19%!U9C5/>F0S,G O;&)4+WIV<TQ*9BM6=V529CA!;'-K+S5%4V8X
M,#10)B-X03LU3WID,S)R+T%#=' O=T-D.6A6<F8X,5!*;'=K-U)856A&=D@V
M,'196D)207ER6' T=4U%=$)L1E=/8D](865#5C!E479K5D@O;&-()B-X03MK
M6"]L<VLO-4539C@P-&8U3WID,S)S4#57,"\X-S=#-R]L8TAK6"]L<VLO-453
M9C@P-"]Y9&TW=G18*U9T4#A!>G9S3'8K5G=E4F8K)B-X03M7>50O04I%4V8X
M,#0O=T%N6G4W-U8O;&)4+WIV<TQV*U9W95)F*U=Y5"]K4DHO>E1J+THR8G4K
M,68U5S O=T1/*W=U+S580C5&+S5B)B-X03M*4#A!:U)*+WI4:B]!0V1M-W9T
M6"M6=% O3RMW<3%X*V%N:WDS4T)P8G%10S1J.6%+:TUH<6A:;'(P.%5/0T]G
M>6TV2$IN4'100D=R)B-X03M035AY2VHO>75$>4PO=T%T:VXO26E4+VUN1"]*
M,F)U*S%H+TLR;B]N9EE89CAR9SAI+SA!3%I*+WE):R\U<'@O:S=.,V9A=CAR
M868K)B-X03MD.6AD+W=!<F<X:2\X=&MN+TEI5"]M;D@K5',S9#EQ+WET<"\U
M,S)&,R]+-%!)=B]!0S)39CAI2E K86-F-4]Z9#,R<B]+,FXO;F99)B-X03M5
M6'!0-6PK5616,4=(5#=+-60W<31*5TI41DEO2D%,9%-+9$)K36UH>5%I6D5B
M0G-X9&\T8VMH1THS4&M8:3)I83,U6F=3,F=V9$-I)B-X03MU-5%N<'902D\X
M82MO6E-W:UE+1'-&64%J,GIE-6-743)22W9G.#-G,4=%04-5050S,S4X,E<S
M3V@K5&Q+<'DP<R]U2&EM-#-*5GE6)B-X03MR4U=-9T9E4F-!9DDO4TU+3UA,
M+T%%=69C-U-71$)Y.4A,=E,W6&)Z>6YP5C%%>C9.63-S9'I#2U%7;'IY.4M1
M53E2:39Q,6%G+T%.)B-X03MX,S-Y,T9(2DUF55)894A(,4]41&E).45:6#-(
M;"M/:40O3#)D-2]Z1W,U9$EG*W%7-W4U3G5736=305)N;7!99V-T=6@X8VYR
M0E=!)B-X03MI4G,O<&%/>C5C5W!"9T]%9#-L5$=V35@O2U%A;B]Z1GHO.$%*
M>'-Y.% P4CEW8T15+S-S=C9X*SE",GAG1GA%6G=79T1Q6E98<55R)B-X03LX
M44A4=&LU6%=Z6$-U25AY6DLQ,2M8+W%&:EHS3D%R.$51<U9,5EER>35303!P
M>$=X.3AX3TA.,V@R2FYP4#5P+TAX44=Q>BM62'1N)B-X03M';E<X.&1W5%=-
M=3%65F%R<S%78FLS,G9I1D(W949U35I,.5)&3D]A5T%X.4%.<$QL-VA*=%IF
M.&\Q<78O1V4P+U9.;$TO-WE0=5 V)B-X03M(2WAF,TTO9D@Y2U4U8S1Q8C9,
M2C584T8O=T),>%A-<WAC1D)">$,X4E19:W-V5W!05'14=E556E)K=C P-5=N
M3T5$.31#5#5)<C%F)B-X03M*9G))5FAU0D9Y4V]K<51X56IM5'AC9F)&96@R
M>4Y:839.,T9P<C5(.&9&3&1::S!L-W14<&-44E<T:E%-<D9I5$E".%(K26LW
M-6)I)B-X03M%<3E83GAT46-:;#9/5DE$3$=H3G9.2"]!0C)'+W=#349R+S%$
M4C54<"]P*THK.'56<F8W=RLV4"LU0U@R6G128W@O5W=X=&EA4SA0)B-X03MT
M:%1T>5=P04I8<4%E=5=3=71U8E)J-&5,,6-M45!C*U%M9V=+,FPP:W=)861!
M,5%25#1L1$8O13=';F)-65)Z5V1W-35N<&%','(O)B-X03M!0C5R-'!F>2]J
M9&DP5GA01U-P5DI!>4U"=U=O-4I*5"LX5G$W9$1T4VU!:DXU9FHT2FED2T]H
M4'HO5WAI56]:2$U9<$=74$%E07)T)B-X03MM5TA7>7%Z6$I.3D,O=T(U=%DO
M-6='+S50=S56;35X+W)F;TQK-F)L4"MP*VM*5&QZ:7!N;U4R9WAZ>69P;4-3
M949K<$=):5%6878R)B-X03MT;5AT;%=55$DY0F-N5%-X06YX05-%,%<Y.&AE
M<4]E;GII3E-X8F<W;FU#5TMQ=%@K1VYW5DHV<GDR1%5/53A/8G9$:SAE;'8V
M5#EV)B-X03LV+W@W,&XQ96936EIK3VU7-U<X241C=WA9:VXQ1S0Y5V8O9&9(
M-F$U9FI%9U!58F-04$Q'5#9"42]B*W!!6EDP<'1R=BLX,FHO=T1-)B-X03M!
M=CA!>69M>6Y$>FPO5R]12$LQ4$M(.50Y2E,K>F$R5S5J3C!P93-"+V5+=E5J
M-WAL:W)R8FTP67I(:4A&>5I"2F0K47E*:$9:6$-J)B-X03LQ13E"<$=9<TEQ
M4C@K6$8V1F=W8T198F4K67=J;3=W-3-(<&0O4V5E,U!L=#4K.74T=2])26M*
M9W-R:VA1;U5/4T99-T9Y=T5N2VQA)B-X03MH84AP4W9U:4]B<5(K4&=M53E,
M93!4*U!I:S)T>6%62G%C-V%413!/;FMJ,$DS2DQ!549A;&E45W58-&A,:$A&
M>F-054=";65$-E4U)B-X03LO3$PO04I4<E-F.$%J22\O04-B8DM.9"]C>6-N
M<W8X07AI4#0V1D%26&5J>E-P1$1O<E-3>4U%:FI3959M6FU.07%G0W!*3U='
M37=,)B-X03M-=G-A>&MX13!-92\Y66\Y9$QL6E9:9DMD-'EU2V]18FMH9V1T
M=F<S>79J+T%.<T@R3C-H+W=#,'DO,E@V:TQE1W=S<$)(92M8-6)A)B-X03M2
M:%95;6QM:DI!3DMG36\W:DIX-'!C<#,X;45Z0T@Q66E095-Z1#AO3E8P365A
M5V=J<U)A,TYZ8G5K17!L85-P56@R5VID2W%P4#!:)B-X03MH9&\T-2M(9#)!
M6%ED:S5S6&DP23A*23<W66IR.3=P;S$S56<R;DEZ0S9M0F(Q6E)5*V\R*WI:
M;5E94S1"=C!$<CE2;'@K2DPP9GA()B-X03MQ93E!9E@Y32]W0W)9;B]),E@O
M;7),3T-8.#<W;6YX8V8X>C=3-S8O<&XO5G-4+VMB3"]Z5FIW4R]N9F-V:30O
M-6XR;$8R8T%V145L)B-X03MR;UIM47EP8FAK95EG>7E!;$4K,3%0135#4C1E
M8W9U8F]217AC8V0W,7I03E5J<UI:141P;T):0S!A.&<X,4]5=&5!*S$K,7A/
M07IR)B-X03LK4#=M47A8+T%*3#=4,5).:D1E>E=5;'1B84-(=#=W>%,Q.5=4
M-'5!:S1C4U@O,38O3$EY24)S>3-$6FIJ27AQ3U!A5F14-3!H-4Y.)B-X03MN
M:FIK:V910T5J-&PR.5-9-TUQ=4-+3G8X36EN8G-2:VA-2"M0-VUS-'%"4&AC
M=DUQ5C%B:3%M149Z;V9P5$Y),$E2<$IG5$EL07DO)B-X03MA-FIK34U467-3
M*S5J3TEI84]/:F1C>6E*9$IU;VA)6E!,>$-X2UAC*W!+4GA&86M%3CA63TIR
M5'!49DEJ240O04)S-5E33'9&>3AY)B-X03MP6%9L2F%2*W!C-D-9:S)Q>E-4
M8D5K0V@K3#=65'5/;W=X;&9+6#-);FHT4EIX+V%62R]33%0U4D9E-DM)2D=(
M2E9E4UE61E-V.#-9)B-X03MG9RLK4V=43&-3*S5H;#191W!9-BM*5S-U=#)6
M-6-'96)427I)5E).<$I12U)O15@Y<BM64FI(15EI:$PW;4]457=M8DU.+V56
M1#8O)B-X03MP;B]6<U0O:V),+WI6:W5#6#@W-VU(:30O=T-:.7!2=6Y(4TQQ
M2RMD.4]65&$R>&Y3:W-U-T-216]F:3959DE4-&A7+TUT,DDT-4-8)B-X03MO
M*VU..'HU24PV+W!N+U9S5"]K8DPO>E9K*T-8.#<W;6YX8V8X>C=3-S8O<&XO
M5G-4+VMB3"]Z5FIW4R]N9F-V:30O-6XR;$9797%1)B-X03M1<$]S1VM+5G5O
M5$A*.&-X<DAZ56MJ-'8U:T%R:TI9>6%U6$PS3G5034)D435J=E!*4TUT<496
M:F\Q1F-";$IE96A"24%),SA4:W%0)B-X03LX-S=M3G@O,5 W6DY#-'-I8413
M0E5I=%!5;39C=5!J+T%$8F901VHO041V=5AI:"]Q9C)L>E17:4YX8E)W<D%K
M1E,X-$Y61E<W.6=A)B-X03MN1VHO041V=55Y:5 X;CEP8D5L<5-O1VI63&EQ
M9U!0=4M!,4<O=4UA4#@W-VQU4"MP+V)*=&UT,6M-5&%+4DE&-49#."],:C0P
M<C!X)B-X03LS+VYF8VTT,UAH-RLK4TEU<G=Z>#(T;3!3:5<P4$-),6Y(-W!7
M3&MN9G-:3W51:D=R<5A-*U1/8RM+<G@X:"]3-4ED<$Q:47!B4G5))B-X03MD
M4S9%=D]+<6]Q4TXY=T)V:S90.#<W;7-M22]Y9C)Y8E%W4T)#;6E&>$E#54MT
M3V512%5I:#-P9TXO>G9U4T]%.'-F*S955W9D3E9I)B-X03MR85=G64=H0FQM
M0D)(*WEY6$),*V0Y>D$U35DO9RLP=&98.4TO=T-R66XO23)8+VUR2&=L+T\K
M-4AI-"\U;C)L:VXU8S-L9R]N6%,P)B-X03MJ<T5I8WE.>&M%:VI%9G4R-TUA
M6FIA,DUV0VQU-79:,E-">GA!:E(Y-3=M2%)3>7=Y<$Y%-6IL:EE02$EP25I7
M53%"0DA19S5M:U=+)B-X03M,<31K9S)/8DMT3#@Y;3(P-%<Q-&PW9%0W3#9Q
M,S@X2RMM1T(T*VUU,S)">"](35!*<$QL66]F-6]D;&DW4C19,4E32B]R14UC
M=CA!)B-X03M5-RLO:U8W>31K=4=J2$=->7582W)7=$)837%%27@U0VY!>35P
M5%!Q2DQ+4'EL,&U455!/;'))2VE+>%9R;59H=#EK8U9&9F1M2#!:)B-X03MI
M9&]:3TA%9E!:>BMY35)N;D(O;3=P1C5H=&)O-B]Q6D5,:T<W;DE)52\W.&(R
M>DEW>4A!3BMG8UA5-#5E3$Q9+U5F=E%(,5,W+S-Z)B-X03M*+W=*+W!L;D5/
M.7 X2UAC6&963'8O9DUN+T%N*VU014\Y9D-L,T909$HX>6$W<&1N2%HR.6]H
M=#0U4%=)84=R=$QZ5G5F<54U:BLW)B-X03M684M12UIJ-4U%2FUY9"]E-75$
M535C8U)%4C(Y,U9'=RME=DUQ36YQ,F-5>69#6C%A16AP5U1G47I33%)W9551
M63A30517;WE",&U0)B-X03MV*S%U:G(X,C%X=C1C,',O5$]Q3#E54T=Z359T
M6E-44U<Q=E-6;%@Q,4-S4&E*4#=.8W0X3T\Y;F,Q,V1(2#AF24MQ3D-.,$XK
M<4E8)B-X03MZ3'%F2S%K;#!Y2V%E>%-'3S!L94]5.$9H:FII*WIY-$YY15%0
M>$1U9F%K4$%J=C9U9DYM3E1K,G5&;4Y6<V4T1#E$5V\K63E5,4=/)B-X03LR
M83<P-4=V3&%14TID26IX:VM"1F]9,$MX1#19;$AW<4U-34U9,U(R2S5.5&MM
M0GA1.554>C,X=6Y,;S5V32MV4V=M-71F<D5Q4$Y*)B-X03M:>4]S;BMJ=&-+
M1FLY3E9+<5%10G-W3RLO:E8X0T$U1W4O>G!F>E=5-VU.;F5U93%R<%!-9#=,
M1$Y$2G!%4FIN9' U5D%N,W5(2W,P)B-X03MV,BLU469$.6XR=T1#06(T=5AU
M-4HO37EO9W<U-SEE9F8K>$$V+W%7<#8Q9'!C>C)H:F1%-&9!<VI&=FE,17-Z
M;#)9,6)U96U765E2)B-X03MG2T)A3E1K;FQL6FI8>E,S-G!D+S<U:R\T12\P
M>3-I2&4T+VA3-VDW-G!D+S<U:R\T12\P>#1H,W(T574T<')O9')C:3(Q97-,
M:71I)B-X03MW2'=N<C8X5U4U6D,T+S%V,$9Y=$YJ;%4Y:CE(-E%L6#%3-R]!
M3CAY9CA#9C9:9'A$=F-8=W!D>&0Y574O=T1F36XO06XK;5!%3SEF)B-X03M#
M;#-&:S)K96%,<E0Y3U=X3VU'4E)B=D(V=D=K;%=U5G5+.'5"8FI286-A.60X
M>&-M05-L9D8Q+U)4<V-'<6QJ:4DX2%-V='1&>2MD)B-X03M:;35.2'!-:&MK
M67E/<W@Y5TY3,'-5:%=+3F\V2V\Y2VDY,3(X37)';$@X-SAB='@Q>"]M2#0W
M.5%D='9,6D,R4&UQ.7191VHO4CAJ)B-X03M33E!),W)!<W)I,FQB,4=H53A4
M46E50U)7-TAT:S4V8T4X*VXR.2]Y,F%S97)N169395HK4C-R-3=Q,&YM94=3
M1WEJ9E1B=&I93DUS)B-X03M-:E-!=3AD>$9(1$HV<D=09'=S6C1N;TYH=E1!
M34)"3S0S+U)V,W-J<7(T8FI,,#,X:4%$93-.2#)F-6A08E<X8T$P5U(Q9U))
M3&52)B-X03MM4$Y956IJ:DE*-%4U3CE8:DIP-S563%(R8C1V>"M#5S=(,F=9
M9T1G3S(S=RM8:T5V="].56M'=EA'<$Q96$1X>GA,1UDV<6I$:31K)B-X03MP
M5EDV045Q3G=!=S8Q>3 V931#3FHX9D9Q1W))>4=F1$QC9FIP*S%:6BMA-WE'
M1S%I;',W<&QS+U)E3# U1UAK.$1Y349E<7173FA,)B-X03M1<C$R-C1:86-%
M;6E.+S Q.7)'3W-K04%9>3E.9EIF4'E2:UAN-C=32E5B4G952TMS2VAI-%@P
M9E1J:FM"-$)73$@P-D)U5D]*24E/)B-X03M6;E-#+W%B4C)H2W9O+W,R='4P
M.#=,0D1*2"MI-V\K<7%Q>$UG8U)I3D%I<D=J4CA!<$,Y0T14=&I,4S)F<4@T
M*TM982MH.45V>#-B)B-X03M-375)3'%795-145,P9&U98VQ.9'I896=!>D]%
M9T)Z9%)/16E384MZ-G!D+S<U:R\T12\P=SA1-S)0:%,W:7EB.'1B8314>GAP
M3$Y%)B-X03LV<4I'<5-P02]U,GI&,7-H-%5N3S=.>'E'94YG+V=+1F@U=#@U
M,VQX-DDQ*V%$-%=B,4HW:&M4-%)7;&0Y>FMP-F9&15AW+UEJ1G$X)B-X03LX
M>EA(6'9+8U184&Y325-F.#=J02]P1TU0=W9:1R]V3U9+14Q2<4)+='AR4V]Y
M9U)X2"]*;C5/551Q4#E6:B]P=C))1%=.9#@W-E@V)B-X03M04'I),3!*9U-$
M85A:;4-L859$,#9(9DQ-5TQ&4"M#=F5':E!N,4=/<GE89F-B5&XX<R]09750
M-7)T-U!63"ME-W1R,$Y!1FUD;D-Y)B-X03M(-&M902LV.&9P>6I885-(:&MX
M04)$:V1M82])8V]J36MI5$5V34=Q86UU=F%K<3-C>7%T,4]!0DDT04%K8C-Z
M3G<T-#A!,DA)3W8Q)B-X03M/95EY4SE2*V\Y9DY'84QO,VUZ5TQ8-GI:,VHK
M;'IL:G$X,&=02T=-4W-.<3E63S-J=FQE6$IJ9V%)*WAU,"M(4&QJ8UIF869E
M;58S)B-X03LU1S@K,C$S1&%.9#@U-3-:1E9,:'I1<D@V=%=R4V=),DAI9'-Q
M:G%S2D8Q.6IF3%$V:T5$:34O,&HW,G)B>58U>G4S2U=M<'!C3TMF)B-X03M#
M;'I+1'514#(Q6#4O4FAL<7-1-7AR-$M.1'%$>6YF*V-7-VYY4#4U=')L<F5E
M+T5B<G=!63--;D9M8VA65E14<E9H5W93=2M#3W%W)B-X03MK5T(Y:7DP3W!"
M;WDO=T)K574Q<E$O3C)J,E18;#5E4#9#>G)B17!/-6(Q2&I-9RM%,$Y/2SEC
M='A:8U5Z44A3*U12<4U/9D9(:6Q,)B-X03MA-C5L1"M79%0Q2CE85E=U-6U8
M,$QK,$UJ:V)7,&A(9DI:.&-E2&M/62LY:&\X,'IK1GE023EF27!B2'%E<GE3
M3$=T-5!Y8VA2*SEF)B-X03MQ5%1X>3 T-&IO2$AJ;7E%,7A(-6QL<VYK3'HW
M2$I%:EAO<DMX4F8Y2F9A:DEN>%9',5=L54-U*RM963%E2'4K>#):,$=P2#A8
M*WE+)B-X03MI,VLS>C!*;V]29$TP:S!R=TMO;FLR84],,5=Q5%%5-&Y9:G%E
M;5,O331A=79S66Y286UW3TQM93@Y,7(W8GE6-7IU,TM7;7!P8T]+)B-X03MF
M0VQZ2T1U45 R,5@U+U)G;'%S435X<C1*1V@Q0C54=B]/3&1Z-4@X.#(Q>3%V
M4&9I3C$T04UB;51I>D]1<7%P<#%Q=W)8<%AF0DA6)B-X03M94TQ!*WA:84A5
M9S!:9C=)<&1R5V@K8G1(<VUV3'DX9C!&;E<R2E-D>3-Q4$=:0CA*;V%C5C8U
M8FEY-'!M9T]L.&UJ55EC*TM01DM7)B-X03LQ,7I+,WDU<65P3EIA*U=U-6U+
M86%746U2:E$O5S=C5D<O9V-C,D].>#)(,69O2TY,;6U23S5(-D\O>D-#,%EE
M64Y8,4=,5#=3.&PK)B-X03MS4V@R6&Y,24)33D=K8G!5+UI1.7-S>3A%23A2
M1WI49T]83$U216I:.'EN13-L5'IT1&)4>E-88D)R94@V>DI"-C<K<#9144UZ
M061$)B-X03MX<GA)<E=O3U5J55EI44LU;754;'DP;7!%4U1,:TPU;$5F-$<X
M.6AO;&$Y0VU9:U(O=T-K=5%31DPP2E=O0DE864AF269M<U!D.6I0)B-X03LX
M:'%F-3,K>4LR*SAJ*V8W2T5Z5%A$1D%X53A,:#))-'562DE'.4YU6'EW>#%7
M1U)O1#=&;F]D5D58>&8W27%J95$O4&E&0DIE*VM:)B-X03M'4D5$>GI+4S!H
M54MU-CE36DMF34AW=V9M.%!D.6=4*U$Q4#@W-U-G3F(X=65C.4<P.#,Y-V1T
M.5=%9VAQ;'=Z2&U19C)A,7!S9"]U)B-X03LR;V-S>%IS535C24<O=6%C*VXQ
M1TM01DM7,SE9=&549%,Q1C=N5D$Y,4UW6%-R.6PU4TUA34QD:4-+;G%-9%1#
M3E(R+VEJ.39.1FUM)B-X03M43WEF;VPQ.&MR,&QT9C%854ER1S%V2G98;#5&
M955R9U520S=D0U0P53=!5D]86D)#16))8V9$3$QK:TEI4G,K6E0U9DHS;EDR
M:5AJ)B-X03LS=VIT,E0Q0S<S3#%695!,9%)6=6YC0VYV;4XK6GA85F(K-7I2
M;W145CA7,SE9<C=R>5(U-71:;FAM=F=(4VTS,6E5,4IA2D%"="].)B-X03MC
M25 Y;S1X,5=%:7=0<SDO-FMY,$]P0F]Y+S)2.'8Q;V4X.'%E94Q.-$)D6$5K
M85A%:V-3>2MT2556<&U:535L83AA.&8K1UAX>55D)B-X03M2:&QD1&PU34HV
M5%5X<35(8S%Z4%@X9F%%5$@U1S@K4T5&3'-L1U9:16M&>$I2:V-%:&A49G0P
M*S$T1')K1'%S239F67I':#%*+VDO)B-X03LR4E<S,VMJ>CE9,DUL-V,S2E='
M2TIP,W!D1FU#;W9):6EK-SAF;SDV:U9-3E9H:V%!*WA'5%)A;45427DR078V
M:6\O;'9Q3V]3*V0Y)B-X03M+:FQU<&YJ85)U4TY)>$(O9'0Q0D]3,7-):D9,
M6G(W3GI43V5)2E!Z.&MF<&8U8F9M6'!6,DQU=W0P:'5&1D))2F]4=%5(;WA)
M-UI8)B-X03MK,75#66]N8C1T,DAS,U99>GA2;T@S:$XQ,$0X-49*25-'<E-*
M360W4VY/3W9%,#9D+T1+4$<P=FXY<FQ$1')F3#=%=C%R>4@K84]T)B-X03M'
M2G11=&]*1V@U8T-J5W-8,C96<C9F0W8R4C%Y,T9Q.5!$-E-F=&%-*V@Q5U=U
M2W1V8VTS-6-F;'!R,FQE6E4Q3%=B9$EO8F%.>D)2)B-X03LP:W)+=S1$6E-E
M:7-X>6Y7-C9%.&9$13@R+W,W<S-*:GDX52MG*S%,3E@O2C-Z9&0V<F4S5517
M=G!4>GEY>#%L64AI-VQH6#10035B)B-X03MJ-U-X:4E'*W=C9DXR4&UL3U5G
M63=K+VIK:&PO2F9Z<V]O<VQQ0C=434\Q4#50035,*U4X6&XX;4$W1WIJ<D@U
M;CE46B]*<GIW>'%:)B-X03MR66YB8WI0,C9F<UDO=T%P6690-4HO:V959#0K
M6B]5,%!Y63@W1&-3,G<O-3=0.$%,*U1(*U4X6&XX;"]K9E S:C5N.51B9FLQ
M-319)B-X03LQ85<R2G)7<&UC-S=F-4AS368U4W<K9GE5.6HV:G9(>E V;6TO
M2F9Z<S,R<$Q6=FY->#9F-T1(*U4X6&XX:TAS8D]E6DAZ4#9K8F]N)B-X03LU
M465B3$Q50F-43F$K;4EP,"M'4FEA>5%V1W8W2&EW>4=8=$A(2TY#*VXS=#)N
M-TIY=VY:-&5V,V4U068X<54X-69Z5VXO23%V*V%-)B-X03MS+VQ41C5T2#AI
M6G4K4'HO04=+:"]*=GIY,S)P<EDY.34S-CEF-69B0B]+5TAU4'E:2'-J560T
M*UHO53$O=T%Q83@X54$Y5S)O3G=0)B-X03M79C5F>5DO>6QH."]K=CA!22MO
M-W@X>BMP;V9K>#4R1S1L=&@O=T$Y;BM8.&U0.$%+94QZ*U,O>5!N-W@X>BMP
M='9Y83@X36%T3&)%)B-X03LQ<E5Z3V0Y=CAJ,D=0.'!99E U2V5X.5(S:C5N
M.5149FMV-3)B-U5L<3-Z;5DY4#EH:B]+94QZ*U-$,DYN4$UJ-6XY4UDV4"M5
M;FUQ)B-X03LP='17:FQA,C58=&PY6&@T>4U2>BMS47EB+T1S3TU:>79,,FAJ
M:UDQ97AV-T,S-$]Y8W-22S8Y56$K,&535W(K4S-N4E=$2SEQ<D1O)B-X03M2
M37=0+T5-="]L4$8U=$$W1GIJ:UDO32]Q8B\U578U,B]W0BM7=CA!>4]B=C$O
M67=F>6YI."]K=CAJ6BLX9DTO<6)(-4TK94(P;'1U)B-X03MT9C<U*W9J.6I(
M*U5S4&XX:R]Y4'%/.&9-+W%D+W=!<6$X.&8W*W1V1"LK9F]F.$%992M0.'!9
M9E U3"]!0U!Q3SAF32]Q8S,U3F5E)B-X03M'3E=M=&ED='I-+V)P*WAJ+TM7
M2'HK4VYS9E5D-"M:+U4P,S5,*V1M1D=K=%-095IJ,$90-5!$2"M5.%AN.&M(
M<V)/97-F;68Q2G U)B-X03MC+TMF>E1P,#DX.7<Q=%,T<TQQ,6HT>4UF,VLX
M4E)++T-.<6YF2W,S84=/4498=$E(-4]2<'5Y<W-$2S8S:5(X+V=L4R]K<C4P
M56=Q)B-X03LY<4-/:$5R5B]W0TE:9"]+94QZ8V-D:35X,6HX+W=":F8O2VU0
M3WA&1$QB54%P+V90,#A0<UE0-51X969Y6"M2<R]E4&UF,4YT*U18)B-X03MN
M:&I6<')9;GA->FYP,"]9>"]L3$0U+TI*-T@Q0C9J-6XY5'8K5DYE94M%971B
M54I"23E:.7E/;C='4#AP6690-4PO22MO-W@X>BMP)B-X03MW+TIN>G5/:W1S
M3V@R;69Q3VXW2'9J+TM73'HK4R]Y4'%/.&9-+W%A+W=#5DUE9'%5.5<Q<%-L
M4%=F<#1F63ES9C54>&5F>5(O23)F)B-X03MV2'I0-FLT.&UF;%@U;C!F>DY9
M86QD=&)',G1N6G!/16I-,4-J3'-#;S=N2V14<CAC.%II3'-U5&]U>7-U3$M*
M;7%#4"]W0U8T,B\O)B-X03M!1F%(+W=#4C0O-G U<F9!.#-D94XU275X+TYY
M-79Y=W,Y06UN2T9&64I-1%%Y3GA19EDW;D%C3F15:DQF4C$W*V)L>EER13$U
M-69M)B-X03MG5UE6:5HU9T%W;W)B9G4Y.6Y(,S1J1&965&QR;VA0*U8T,B\O
M5F]F+VME4"MQ94AW4$Y(:F546B]/*T%!139/*S1Q4#,T*U@X;5!G)B-X03ME
M82M.-4YF.')X="\K<E$O+TDX9CE5.&9!.#$X8GE2=&@K83DU<490<5!L-F$T
M<2]P9U)Z02](>$Q5*W@O2W!/4D]'=7))6F(V27 O)B-X03MZ1#$U3TA0>71D
M3#9J0EDV>6=C;4HT9T0T3S4V65!$2&5N:E!C9V(W.#,U<D(Q:G9.0FQT-4A"
M2W!*34$Q1EEO9'5(.'EK9E)K:&AV)B-X03MQ>$]7=6E'+S58:F(O=T16;V8X
M035(:B]!2W T9D$X,&5.-4YJ.#<T0T-2;S<W0W O9FHU9GE9*T(U<C0S:S$O
M>79',R]W0W)1+SA!)B-X03MY4$@O0494>#A$>EAX=DHS+TLX8F8O<3!0+WE0
M2"]64$AW4$YF1SAL5T0X-D)C4#9C1VE34T]!5S1R34-A2TMK+W=",S194$$X
M,&I.)B-X03LU2SDY*V)6,UE,1S$W-65M=#%L<C9295E!34)3<%@Y,W5.*W5)
M=S,Q4V-T9$5(+WEV1S,O04]R42]W1'E02"]64$0T2&UX.&)Y9"]Y)B-X03MV
M1S,O04]R42]W1'E02"]64$AW4$YF1SAM+SA!;&0X1D,S-DAE9TY$*R](9B]9
M62M"-7(T,VLQ+WEV1S,O=T-R42\X07E02"]!1E1X)B-X03LX1'I8>'9*,R]+
M.&)F+W$P4"]Y4$@O5E!(=U!.9D<X;&$R+T]9,U5V<%<R:'EY>6-79F=K=THT
M;W!::B]!2&9:451G3T1Z4TTQ.48Y)B-X03LO=T1M+U!P.#1G=G1";'0U:6]C
M4G9-065*-D@W2%$P>$='*W%N3%A21&8X04LX8F8O<3!0+W=!:G@O,51W*T(U
M;SAB>60O>79',R\V)B-X03MT1"\X:G@O,51X.$1Z6'AV2G8X03589D)1="MH
M,V]$42]V>#,O=T)H:C1(;79J9518+TLX8F8X039T1"]!4$DX9CE5.&9!.#$X
M8GED)B-X03LO=T%R>'0O*W)1+R]!0U!(+U902'=03F9'.&QA,2]/4G)U57A7
M,FAY>7E"5V-Q<W=*0V]+<V8W=G--0G<Q,5--,3E%6$XK84=P=U=B)B-X03LS
M<W9L<313>FI.2'5$2U!40C4X4'1E;E0W5S)$=V@S<$]1.7E89CA!2SAB9B]Q
M,% O=T%J>"\Q5'E89V5B2'AV2C,O2SAB9B]!2W1$)B-X03LO=T1).&8X0590
M2'=03F9'.&YF.')X="\K<E$O+TDX9CE5.&9!.#$X8GEE6C9E56=U:$IC,FI8
M15%$1#!J5F9I6E-Q;F]F<W1V;#5A)B-X03M1>5,Q.# V5F%497):-E!.86AL
M2$]/2V1W<DUV37AS9FAR.$A.5"]S4C1N2WI!;G$R0UE(4G$W.#(R.39!;#=P
M56PP<U5O83)386%2)B-X03MX2$@X24U1<4]H-#!R,7=I1F1633<V2D9R8SEL
M95AX;C S5&TP*S$T2T)B:&I*46=B;FM11'9K;S=C,G57+TE)2C0U4W%!4G0X
M26]F)B-X03MH4#A!350O2$I)5RMJ3B]V='9U3TLP;DAL=E=P.4AU+U9K:&YM
M=#9-=V=I;&4S+V5&0V=K1'%#4596>FM:4G1L1U9*.#-N,%5K23 V)B-X03LT
M831*57=Y=F-Y;F=6;F518E4S,F)I4$-M,E$X4'I:*THU36(X=V%J3G$R<5,S
M:7=Y>'=T+V11>4\P<%%(-&U!6FA7:&1M8C9C;D55)B-X03M'16I:4S,P2G$P
M.4YQ+TDO3$I-85A*2$M&8V-'*TIA1#14-&<O=T%-5E<K:DXO=G1V=4]+,')7
M445.,49,4&).4$-J079%86IK4$-T)B-X03M-0E-'4E=U=C9(8G1"2DAO8GAY
M>&]5;&1*;4AQ0FUJ3%8K2'5I3W9Y8S5!>%!E>D5H,TQP=DY6=&1%2F8V5DIE
M4DM0,V%3>753:FM")B-X03M72S%(4FEV5$AG.# X9FMK,G-83FQE1T4R5VUM
M>$MH>DU&675'3'585VQ2='A5,'E54EA6:$QF:T5U.4-A=%!4879Y4'EY5$=L
M=VIL)B-X03LY2FPT3E5K2#=*-D%(1E9V;WIF-S=B-VII=$IV;V0Y<'1J1&1R
M9C92*VM*2FQ55W-J37EE:7=$9VUG0C562D=X.$UJ244X:7EI835H)B-X03M/
M3$QZ6F\Y:S!K='8U9DU.>39H56YH;FMH6DMO;V9I549D>4-2.#AG644Y5UEM
M0C!5<GIZ2F\Y>3=34V%#.&QZ>$-P2DQ-.&=Q6D,W)B-X03MS5EIF,GE4=%AA
M=3)%4E!E9WE(8VQM=5@K;5@P9'5U;C92*VIM:35E<39U>FU4;'5+,4%P45I+
M24DU;&I)9SAG;$AO5%9P-F)6*U(K)B-X03M74UDP=45C=G!-=D)Q:V<O6E!1
M031Q=#E'8B]F8F9C8U9P,V]Z9C<W8C=J:71-:3AS-B]9-DY#>E,V4SEZ93%K
M360P:S!K1'%R;VEG)B-X03M":TA)8V%.,% W6'1K2E)V<7IJ2W5I6EA(;F4R
M;G0Q=$ID2VYE,DQL<&]8=4I74U%'-%=507!4:4M"4W9Z,WE0:"MB27HX;4A4
M;WIZ)B-X03M34$A#,&-B35=23GIX53=G5F]/9WDQ<4MZ,$IQ,#E.<2])+TQ&
M860V33,X:F9C8U9P6FEH:R]K,WDY639T-G!U,&53:S!%8U-X>4I')B-X03MX
M-5!6>#A:559:9&AL8S55,G=I0W(K8B]!0W!:86):43-.9VMT22]41C8P<GAS
M=%IO=S!:5&=Z8DAI>"MK67=N9DY:=W)K>$A,1W!E)B-X03LT05=-:G%6<68K
M0TEX4W5T3%=A-W5O<F%%07EZ3TDT=U118VU.0G5C4U9!=&MU;BM1=%9%,7!C
M6#A)+U)S:W%R2UDU141K8V95-')Y)B-X03M),UI0.#8W6E=C9S9.9WAN<7E*
M4'DY,%IO-5!2=&)Y5U=$9W)O>E%R>5ER1WA#.%I7<65033=E4'1V1'A#>CA-
M361(-6,K6EHU,U<R)B-X03MH:5EC-45#97%L5DUF,FQ*2C9R55I0>%%W.$ES
M5V13:G-R9F%5:T@U:DQ'=&-G0E=1;G%&<5 X06=G35946%%V2S)Q-C%(3DY:
M;T=G)B-X03MT;5):>GE65TAQ5G!X1$563S)2;$U";$="3$Y,>CAV.4)I:&UA
M3TLV5U%/66]6:V5(:C9Z;SAK845R268R5U1E;F(S,G%'471P>&AI)B-X03M8
M;51Y=F1A65AU*T-25TQY*VY$1UI69556<G@U2T-4=GA/+U1,27IT<FY#:VIC
M04Q'4C%+,5 X07=21U19330P2'E&04=74%=96DI*)B-X03M*:7AI1G).1E%)
M;T%B:U=98U-'4&9+6EI/-75J:C<P3'$O:RM'93)39E),959&:DTU;BMS4THX
M4TE#.&9!5DIQ154X=F9$1V9E:55/)B-X03LU:4E!.4IJ,T1+069M1&QR57E0
M>51O,FLV=%!.0F57.7IC4U(X6D-,9&M3:T\V<V%U5D9E8DHY1F-R;DEH;FII
M0WE0+T%!3C5F=4E8)B-X03MU3%,P=2]Q>$UQ=WI.3$5+37 T<7)O>'(Y;VEP
M.$LY-EI$>$,R94='265A<DQ3<DLK:G0Y3VIL:E0P,6QB,6U6;DEL2$]-;F=3
M0E=.)B-X03ML4# U8D%K.#)Q64$U2E%14%-5.7EZ06XU05I*:6YF;%!123E8
M;&Y%<4\V4DY!=$EY;TY:6FQ7:#5&97$X=#AH3U9--%)T5S@U*UAB)B-X03MF
M4UIB4U,P9VYH=$QH0U Y24ML>DML0R\R5'-">D$S>&A+,6Y';5!!1#!M4&--
M;T(K64]464HU-4XP-U)T43%'5S(Q3T<U;4AP4$I%)B-X03MT<55"0FI5=3-,
M;5)T>$AB=FM*:V=B331!13=S;6DX;F57>F)Z1U<P=6A.06]-+T=E24MQ:7%L
M<4]187,V3W$Y9"M0:E1+*TUT;D%%)B-X03MG.#<V5&]E;#-.=F)A9$A01DY3
M43-+>D]K9W%R;$)X2T4Y1U)G835::DI03G)Y041K>'=G96MP-VQM0E!Y07EB
M0FU0:V9Y;%EA=%I4)B-X03M81B]B5%1*>C1X3F)Y>$EW0T9F54I74FPR06)Q
M37%Y5$DU3G5/04DS42]N6%%.1C R1TM45%DU;WE:<$EP1FUK:F-G<#(K17-D
M=DAP)B-X03MV,W=W:U1Z4FMI0GE9;FQJ56YV+T%$;R\O87HO04]N9DDK<GE:
M*VYZ8E@O0E@W4#95*VHP34AQ.&LK;GI83B]G,V=/6#96-&)5<C9&)B-X03M/
M.4UF5C5,-F9.6B]Z;R\O04=S+RMN9D0V=DI(<#@S2"]"1S%F,&XW9C=Z-%!6
M-4PV9DYW+W=!159&4#!N6'14-G9J-G9*9E0U<GHO)B-X03M!24\R<BML9F(K
M-'@Y6&MN,"MB9B]/;C!(+TA7<#(O=5!!9G=P:C9V2F94-75(*T1U,S97-B\X
M049(6$@Q95,K;GI5+RMD2"]!3S%N)B-X03LO=T)/*T@Q95-05#5U2"M#3C9F
M<% S+S-N=V5R>5@P*V$U4#A&-SA0,'(W,#E$*T=0<3AK*VYZ6$@O0BLQ9C!T
M,G!8,%!O>#E8:W9P)B-X03LX,7)F-$QP.%@V5G!8979O9&%9*W)Y6# K83 O
M-$DR<BMK+V(O969(,6534%0U<G@O9S-E;C96.39E:#0O=T)C9E8U2CE0;74O
M=T-D)B-X03M2-&8Y3&)H=E0K-7 S<B](2#%E4RMN>E5V*V1)<"\P<S9D+SDU
M.&96-4DY4&TR=BM#<6YJ*VQ+,#-P-DA42#%E4V94-7(O.$%N5'8K)B-X03LQ
M=#%0*RM/=F9(,653*VYZ57HO9VIV.$%P4#A!-F0X9E8U23E0;3<O04HP:6XO
M4WIP,B\S;G@Y6&MV<#@Q>2\T3&]E4#95<"LQ5#!0)B-X03MX>#E8:VXP*V)N
M+W=8='HO045R-V-V42]J:C9V2F94-7)F.$%N4TMF.4Q/;F8O969(,6534%0U
M='(O9VUV=R]P4W9T-D=0<3AK*VYZ)B-X03M82"]",CEF,'(P,R]!3&IP:C9V
M2F94-7)7+W=46#1V,'!8,SE$>'@Y6&MV<#@R=BMD27 O,',V9'8Y-3AF5C5)
M.5!M=50O0F8W2#96)B-X03LK:C!-9E8U2CE0;3 S*T-V,G8P<#E0;UDK<GE8
M,"MB6"]/:B]!4&%Z+W=#;F9$-G9*2' X,R\O6CPO>&UP1TEM9SII;6%G93X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L
M=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @/"]R9&8Z1&5S
M8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B
M"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P
M9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C97(^061O8F4@4$1&(&QI
M8G)A<GD@,3 N,#$\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @
M(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO<&]S
M='-C<FEP=#PO9&,Z9F]R;6%T/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @
M(" @(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL
M86YG/2)X+61E9F%U;'0B/E)A<&ED-R!0<F5L:6UI;F%R>2!0<F]S<&5C='5S
M($IA;G5A<GD@,C Q.#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^
M"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:3YR
M<C4P,S<V.#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @
M(" @(#PO9&,Z8W)E871O<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W0O
M<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C(@H@(" @(" @(" @("!X
M;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O9R\B/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ
M/"]X;7!44&<Z3E!A9V5S/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54
M<F%N<W!A<F5N8WD^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE5')A;G-P87)E
M;F-Y/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^5')U
M93PO>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0^"B @(" @(" @(#QX;7!4
M4&<Z36%X4&%G95-I>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @
M(" @(" @(" \<W1$:6TZ=SXV,3(N,# P,# P/"]S=$1I;3IW/@H@(" @(" @
M(" @(" \<W1$:6TZ:#XW.3(N,# P,# P/"]S=$1I;3IH/@H@(" @(" @(" @
M(" \<W1$:6TZ=6YI=#Y0;VEN=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO
M>&UP5%!G.DUA>%!A9V53:7IE/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@
M(" @(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IF;VYT3F%M93Y!<FEA;$U4/"]S=$9N=#IF;VYT3F%M93X*(" @(" @
M(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^07)I86P\+W-T1FYT.F9O
M;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y2
M96=U;&%R/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G14>7!E/D]P96X@5'EP93PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/E9E<G-I;VX@-2XQ
M,#PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F%R:6%L+G1T9CPO<W1&
M;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y!<FEA;"U";VQD
M350\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z
M9F]N=$9A;6EL>3Y!<FEA;#PO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1&86-E/D)O;&0\+W-T1FYT.F9O;G1&86-E
M/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E
M/"]S=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E
M<G-I;VY3=')I;F<^5F5R<VEO;B U+C X/"]S=$9N=#IV97)S:6]N4W1R:6YG
M/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S
M=$9N=#IC;VUP;W-I=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT
M1FEL94YA;64^87)I86QB9"YT=&8\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=$YA;64^07)I86Q.87)R;W<\+W-T1FYT.F9O;G1.86UE/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;#PO<W1&
M;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86-E/DYA<G)O=SPO<W1&;G0Z9F]N=$9A8V4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT5'EP93Y/<&5N(%1Y<&4\+W-T1FYT.F9O;G14>7!E/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R<VEO;E-T<FEN9SY697)S:6]N
M(#(N-# \+W-T1FYT.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IC;VUP;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&:6QE3F%M93Y!4DE!3$XN5%1&
M/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O
M;G1S/@H@(" @(" @(" \>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(" @
M(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D^665L;&]W/"]R9&8Z;&D^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @
M(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L
M="!3=V%T8V@@1W)O=7 \+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SIG<F]U<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @
M(" @(" @(" @(" @(#QX;7!'.D-O;&]R86YT<SX*(" @(" @(" @(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" \>&UP1SIS=V%T8VA.86UE/D,]-S8@33TV,B!9/30X($L]
M,S(\+WAM<$<Z<W=A=&-H3F%M93X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @/'AM<$<Z='EP93Y04D]#15-3/"]X;7!'.G1Y<&4^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(#QX;7!'.G1I;G0^,3 P+C P,# P,#PO>&UP1SIT
M:6YT/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" \>&UP1SIM;V1E/D--
M64L\+WAM<$<Z;6]D93X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM
M<$<Z8WEA;CXW-BXP-S@S.3<\+WAM<$<Z8WEA;CX*(" @(" @(" @(" @(" @
M(" @(" @(" @(" @/'AM<$<Z;6%G96YT83XV,2XU-C@V,# \+WAM<$<Z;6%G
M96YT83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @/'AM<$<Z>65L;&]W
M/C0W+C@T,S Y.3PO>&UP1SIY96QL;W<^"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(#QX;7!'.F)L86-K/C,Q+C<V-#<P,3PO>&UP1SIB;&%C:SX*(" @
M(" @(" @(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @(" @(" @(" @/"]X;7!'.D-O
M;&]R86YT<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@
M(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO
M;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS
M.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S
M;W5R8V52968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @
M(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HR,$4S-#E$-3$Q,#!%
M.#$Q.#@X0T5#.#9&-S=&-$$X-#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @
M(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HR,$4S-#E$-3$Q,#!%.#$Q
M.#@X0T5#.#9&-S=&-$$X-#PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @
M/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C)",D5",#9&1CE&
M1D4W,3$X,C%#.#-#-#0U1D(X0T(X/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240^"B @(" @(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X
M;7!-33I296YD:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&
M<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T
M4F5F.FEN<W1A;F-E240^>&UP+FEI9#HQ1D4S-#E$-3$Q,#!%.#$Q.#@X0T5#
M.#9&-S=&-$$X-#PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T
M4F5F.F1O8W5M96YT240^>&UP+F1I9#HQ1D4S-#E$-3$Q,#!%.#$Q.#@X0T5#
M.#9&-S=&-$$X-#PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T
M4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YX;7 N9&ED.C)",D5",#9&1CE&1D4W
M,3$X,C%#.#-#-#0U1D(X0T(X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^
M"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S
M=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D
M1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR
M9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS
M879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M:6YS=&%N8V5)1#YX;7 N:6ED.C)",D5",#9&1CE&1D4W,3$X,C%#.#-#-#0U
M1D(X0T(X/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#$X+3 Q+3(S5#$P.C(T.C T*S U.C,P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C
M=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP
M+FEI9#HR,$4S-#E$-3$Q,#!%.#$Q.#@X0T5#.#9&-S=&-$$X-#PO<W1%=G0Z
M:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q
M."TP,2TR,U0Q,SHR,CHU,RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T
M;W(@0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E
M<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z17AT96YS:7-&;VYT4V5N<V4](FAT=' Z+R]W
M=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E;G-E+R(^"B @(" @(" @(#Q%
M>'1E;G-I<T9O;G1396YS93IS;'5G/@H@(" @(" @(" @(" \<F1F.D)A9SX*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT
M2VEN9#Y/<&5N5'EP92 M(%14/"]%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN
M9#X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9A;6EL
M>3Y!<FEA;#PO17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/@H@(" @(" @(" @
M(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/C \
M+T5X=&5N<VES1F]N=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93X*(" @(" @(" @
M(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD^36]N;W1Y<&4@
M5'EP;V=R87!H>3PO17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3X*(" @(" @
M(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^-2XR,#PO
M17AT96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CX*(" @(" @(" @(" @(" @(" @
M/$5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#:&5C:W-U;3XP/"]%>'1E;G-I
M<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @
M(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/C(S
M-38S-#,T.38\+T5X=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE
M8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I#
M:&5C:W-U;3XR,S4V,S0S-#DV/"]%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U
M;3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E!O<W13
M8W)I<'1.86UE/D%R:6%L350\+T5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I
M<'1.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#Y/<&5N5'EP
M92 M(%14/"]%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#X*(" @(" @(" @
M(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D9A;6EL>3Y!<FEA;#PO17AT
M96YS:7-&;VYT4V5N<V4Z1F%M:6QY/@H@(" @(" @(" @(" @(" @(" \17AT
M96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/C \+T5X=&5N<VES1F]N
M=%-E;G-E.D]U=&QI;F5&:6QE4VEZ93X*(" @(" @(" @(" @(" @(" @/$5X
M=&5N<VES1F]N=%-E;G-E.D9O=6YD<GD^36]N;W1Y<&4@5'EP;V=R87!H>3PO
M17AT96YS:7-&;VYT4V5N<V4Z1F]U;F1R>3X*(" @(" @(" @(" @(" @(" @
M/$5X=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX^-2XR,#PO17AT96YS:7-&;VYT
M4V5N<V4Z5F5R<VEO;CX*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N
M=%-E;G-E.DME<FYI;F=#:&5C:W-U;3XP/"]%>'1E;G-I<T9O;G1396YS93I+
M97)N:6YG0VAE8VMS=6T^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/C,V,S8Q-SDW-S0\+T5X
M=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS=6T^"B @(" @
M(" @(" @(" @(" @(#Q%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3XS-C,V
M,3<Y-S<T/"]%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3X*(" @(" @(" @
M(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/D%R
M:6%L+4)O;&1-5#PO17AT96YS:7-&;VYT4V5N<V4Z4&]S=%-C<FEP=$YA;64^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/$5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD/D]P96Y4>7!E("T@5%0\
M+T5X=&5N<VES1F]N=%-E;G-E.D9O;G1+:6YD/@H@(" @(" @(" @(" @(" @
M(" \17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/D%R:6%L/"]%>'1E;G-I<T9O
M;G1396YS93I&86UI;'D^"B @(" @(" @(" @(" @(" @(#Q%>'1E;G-I<T9O
M;G1396YS93I/=71L:6YE1FEL95-I>F4^,#PO17AT96YS:7-&;VYT4V5N<V4Z
M3W5T;&EN949I;&53:7IE/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&
M;VYT4V5N<V4Z1F]U;F1R>3Y-;VYO='EP92!4>7!O9W)A<&AY/"]%>'1E;G-I
M<T9O;G1396YS93I&;W5N9')Y/@H@(" @(" @(" @(" @(" @(" \17AT96YS
M:7-&;VYT4V5N<V4Z5F5R<VEO;CXR+C0P/"]%>'1E;G-I<T9O;G1396YS93I6
M97)S:6]N/@H@(" @(" @(" @(" @(" @(" \17AT96YS:7-&;VYT4V5N<V4Z
M2V5R;FEN9T-H96-K<W5M/C \+T5X=&5N<VES1F]N=%-E;G-E.DME<FYI;F=#
M:&5C:W-U;3X*(" @(" @(" @(" @(" @(" @/$5X=&5N<VES1F]N=%-E;G-E
M.D9O;G1396YS95\Q+C)?0VAE8VMS=6T^,S4U,3 Y-#,Q,CPO17AT96YS:7-&
M;VYT4V5N<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3X*(" @(" @(" @(" @
M(" @(" @/$5X=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M/C,U-3$P.30S,3(\
M+T5X=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M/@H@(" @(" @(" @(" @(" @
M(" \17AT96YS:7-&;VYT4V5N<V4Z4&]S=%-C<FEP=$YA;64^07)I86Q.87)R
M;W<\+T5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@(" @
M(" @(" \+T5X=&5N<VES1F]N=%-E;G-E.G-L=6<^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #U
M DD# 1$  A$! Q$!_\0 'P !  (# 0$! 0$!          8'!0@)! ,* @$+
M_\0 41   00" 0$#" <%! 8) P,%!0(#! 8!!P ($A,4$146%QA6EM0)5UB7
MU=;755F5IM$B.'>V(2,U.76T&20E,71V>).W,K.U-C>4)C1!0U'_Q  = 0$
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M4A27%H(UG00&D.!1.C/]/@G3T])\(KJ\;JZF^H.LWJ'IR8QJ\A/Z04[6J$(
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MK4$C2KCA)(XX\!(X594CZ216-YZ[UZO6X.HZ\V0SIR94;EM*W6JBF;T&V]5
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M&OJIOFO*M^>GKIZQ]>>_E,^* ?SW&X?\B[Z-?53?->5;\]/73UCZ\]_*9\4
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M^>GKIZQ]>>_E,^* ?SW&X?\ (N^C7U4WS7E6_/3UT]8^O/?RF?% /Y[C</\
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MZB6 T]ZBM.QJPT(93(BS,QQT%W(_#1";.[^(E")"G7$][EW![;?1/:+U//\
M857WS>QWQ_\ ?G9/CT_^W[7^9K)"K#]&L%-:P.#]]Z7:>TU:MEVO6L!6\ *P
MU6=VQ-46M=>A"%6#P+M-CG40#]4J<MI\+22H.M.5**'C5D#%'NX/;;Z)[1>I
MY_L*>^=V.^/_ +];)\<9_P#;]L\'1_\ ,U@VI/T<,*<S*"]4M)K<.3F$BV@Z
MYU)#0X/8D03>[+L<- O$.+8$N$HHVTV^PY6H=($RCM>(9I=JDGJ:Q' M.X/;
M;Z)[1>IY_L*I[YO8Z^G.R?K^V?F:_H.9Z# -<FU$9UOQHM9S,;*UP1'ZG:Y#
M9HIJ-;V+O +4^3!F12$-Z":86QF 3F%PA4%-)5RP"BX,E-@/NX/;;Z)[1>IY
M_L*>^;V._ISLGZ_MGYFKIU=U"]#FHJBU3:IU.Z<>@J.6JTDR1W<M3,'#UJO-
MG+7.X6,P0?+I[XB?LYTJ6D-168@V$J7B")'CA<:'!CNX/;;Z)[1>IY_L*>^;
MV._ISLGZ_MGYFK#]M/I"^TYHC[TZ9^,<=P>VWT3VB]3S_84]\SL=?3G9/U_;
M/S-/;3Z0OM.:(^].F?C''<'MM]$]HO4\_P!A3WS.QU].=D_7]L_,T]M/I"^T
MYHC[TZ9^,<=P>VWT3VB]3S_84]\SL=?3G9/U_;/S-/;3Z0OM.:(^].F?C''<
M'MM]$]HO4\_V%/?,['7TYV3]?VS\S4U/]16@ZK6JM<K-N;6("I7AJ2_3;*8N
MU>' [2S#PUF6[7R<H@U#+-QL/LY?7!=>2UWK?;SCMI\L"-LQM',E3(,2Q7:3
M-MZDIG1&($EV1#4O4$)DLH;+C)44JTAQ*<Z3CHK9R]LMDH$*!<IVTMBB6^Z)
M6NVSI-TALQ)Z6].\5#?<>2U("-:=1:4H)U#/2*A7MI](7VG-$?>G3/QCD_N#
MVV^B>T7J>?["M9[YG8Z^G.R?K^V?F:>VGTA?:<T1]Z=,_&..X/;;Z)[1>IY_
ML*>^9V.OISLGZ_MGYFGMI](7VG-$?>G3/QCCN#VV^B>T7J>?["GOF=CKZ<[)
M^O[9^9I[:?2%]IS1'WITS\8X[@]MOHGM%ZGG^PI[YG8Z^G.R?K^V?F:>VGTA
M?:<T1]Z=,_&..X/;;Z)[1>IY_L*>^9V.OISLGZ_MGYFGMI](7VG-$?>G3/QC
MCN#VV^B>T7J>?["GOF=CKZ<[)^O[9^9I[:?2%]IS1'WITS\8X[@]MOHGM%ZG
MG^PI[YG8Z^G.R?K^V?F:>VGTA?:<T1]Z=,_&..X/;;Z)[1>IY_L*>^9V.OIS
MLGZ_MGYFGMI](7VG-$?>G3/QCCN#VV^B>T7J>?["GOF=CKZ<[)^O[9^9I[:?
M2%]IS1'WITS\8X[@]MOHGM%ZGG^PI[YG8Z^G.R?K^V?F:>VGTA?:<T1]Z=,_
M&..X/;;Z)[1>IY_L*>^9V.OISLGZ_MGYFL@(ZO>E8^5& @G49I4N:-$(0D0*
M';*J4P@3*$9+<,>/@1&"JWY4R;+>:C18S*%NOONH:;2I:L8SB?V)VPC,O2)&
MR]^98CM.//O.VJ:AIEEI!6ZZXM3(2AMM"5+6I1 2D$D@"LT?LB;!2Y#$6+MG
MLQ(DR7FH\>.S?+<Z\^^\M+;++3:)!6XZZXI*&T)!4M:@E()(%96X=4/3?KZQ
MDJA>M[ZDI]J#JC)+5RR7^L!C8U4V%&(Q$SAL\DQ+BJDP)D68QAYI&78TAEY'
ME;<0K.&#LCM3<XK4ZW;.WJ=#?UEF5%MLM^.[NW%M+W;K;2D+T.(6VK2HX6E2
M3Q!%9[CMUL7:)KUNNNU>SUMGQB@2(4Z[P(LI@NM(>;#K#SZ'&]XRXVZC4D:F
MUH6,I4"8U[:?2%]IS1'WITS\8Y+[@]MOHGM%ZGG^PJ%[YG8Z^G.R?K^V?F:>
MVGTA?:<T1]Z=,_&..X/;;Z)[1>IY_L*>^9V.OISLGZ_MGYFGMI](7VG-$?>G
M3/QCCN#VV^B>T7J>?["GOF=CKZ<[)^O[9^9I[:?2%]IS1'WITS\8X[@]MOHG
MM%ZGG^PI[YG8Z^G.R?K^V?F:>VGTA?:<T1]Z=,_&..X/;;Z)[1>IY_L*>^9V
M.OISLGZ_MGYFGMI](7VG-$?>G3/QCCN#VV^B>T7J>?["GOF=CKZ<[)^O[9^9
MI[:?2%]IS1'WITS\8X[@]MOHGM%ZGG^PI[YG8Z^G.R?K^V?F:>VGTA?:<T1]
MZ=,_&..X/;;Z)[1>IY_L*>^9V.OISLGZ_MGYFGMI](7VG-$?>G3/QCCN#VV^
MB>T7J>?["GOF=CKZ<[)^O[9^9I[:?2%]IS1'WITS\8X[@]MOHGM%ZGG^PI[Y
MG8Z^G.R?K^V?F:>VGTA?:<T1]Z=,_&..X/;;Z)[1>IY_L*>^9V.OISLGZ_MG
MYFI]KW?^CMM%)@/5^WM;[",CAZBL\73+D!L9"$,3(CQ%$)403.E/L0TRI4:/
MF0XA+6'I#+65=MQ&,ZVY[-[065EN1=[)=+8PZYN6WI\&3%;<=TJ7NT+>;0E2
M]"%*T@DZ4DXP#6VL^UVRVT+[L6Q;166\2662^\Q;+E$FO-,!:&R\XW'=<4AO
M>.(1K4 G4M*<Y(JW>:6NBK_GM319,J;L21@Z>15!?,$IJ8$.1,S#'1)+BI9"
M5B.VYF/"BI4E4B4]V&&<*3EQQ.,XY^ES;S+,>*7G6VMXEAIO>N);WCJT (;1
MJ(U.+/P4)RI7@!K\?7H[\B7-##+SY:7)?=#+:W"VPVXHN/.:$JT--@@K<5A"
M01J(K%*%DDX?RH=.3B*IY,K*HDC&(RH\B/$D)?SEOR,J8E2XD9[#G9RU(E1V
M5]EQYM*LN^9.G#K7/"2COB.<%I6M!3QYP4AM:TXSJ2A:AD))$8L/@+)9= ;*
M@X2VL!!0M#:POAS2AQQM"M6-*W$).%*2#GU4"]H=GL+I5M0^*9CR"C*JV92Z
M-8F8=S$?GMYA87#9E88?S'<D8;0_AEW+2E=VOR1A<[:4MJ%P@E+RE)94)<?2
MZI&G6EL[S"U(U)U!.2G4G.,BIAL]W"GD&UW$+CI0N0DP9(4PAW5NE/)+66DN
M:%Z%+"0O0K23I./&FHVM1(@'36+"HN)BKG%!20I+)(;":PRIV80@XC>*AQ6T
MR(ZER)#3;*,/LY4O&'4=K(9T(--/F9%##RPVR\9#6Z=<.K"&G->AQ9TJPE!)
M.E6!P-8A;K@7WHH@3#)CMEV1'$5\OL-)"2IQYK1O&FTA:"5K2E("TY/.&?%#
M!FB$S(^ '*3B"7FXZH,,?+DS$OO.8998S&996]AYUW.&FV\H[:W,X0E.59QC
MF1R3':0'79#+;12I0<<=;0@I2-2E!:E!)2E/%1S@#B>%8VHDIYPLLQI#KP4E
M!::9<<<"U*TI06T)*@I2N:E.,E7 #-9MW7U]8<BLOTBWLO39_FJ&T[6C+;DL
MIW3C_FV*A<+"GY_<,O/>#:PN1W33CG=]A"LXCINEM4%J3<8*DMM[YQ29<<A#
M.H)WJR',);U*2G6K"=1 SDBI2K-=T*0E=JN25.O<G:2J#*2IR0$J66$ M K>
MT)4K=)RO2E2M. 36-=J]F8A1R3]=.LCI:)KD2>Z((-PI38W#F2*X\I<?##R!
M^&7LS5-N*Q%PTYW^6^PKR94S8:G%,IEQE.H+86TE]HN(+N-T%("]22YJ3NP0
M->H:<Y%8%0)Z&D/KA2TLN!U3;RHSR6G QJWY0X4!"PSI5O2DD-Z5:\8-8A^/
M(BN99DL/1GL(:<RT^TMES"'FD/,KRAQ*580ZRXVZTKR>1QI:'$YRA2<YSI6E
M8U(4E:<J&I)"AE*BE0R"1E*@4J'@4"#Q!J,M"VU:7$*0K"3I6DI5A20I)PH
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M !I=.>;]EW^;K:7_ !,#^]H%>N=@C^=C9#_*+G_<=SJA>K/^]3U,?^H'<O\
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M6^%W"WZ4(452 \MF"MA<N.6(RF5H:E+2A:4E:5[X[>QEBX!VS,+[8RKLAQ:
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M/\FKY_GS_P !$K;^ZK_E?LY_9O\ \SG5P_Y] 5\MTXI3BE;'=.4>NOE[;@W
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M:XPE#2N3';D\F0T_& [U)V28N=BG6]-A$*[;67.-=K=-;@34VJWH59TK9_\
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M/:^U:DN.-GP)>GO2&G .E4)&>@5I_P#3J_W@]/\ ^#>/\[6CG;^YY_DU?/\
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MKO<[_/\ V3/NME_=M/1'Z(WZU>L_^ ZX_*7'+>S7\S;"?>+I^?IVN]SO\_\
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M-^M7K/\ X#KC\I<<M[-?S-L)]XNGY^G:[W._S_V3/NME_=M/1'Z(WZU>L_\
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M;QJ#LFU(:M[\:#;DRWTR0T%F8MV.\RM0W2=.X88 R<@\,:V^B/T1OUJ]9_\
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MTC@PS)E,,.O$G #+;KB5N9/#F!7'ATU)B6B[3V7Y,"UW&;'BC,F1$A29+,<
M:LONLM+0T,<<N*3PX]%1[ XAD>HMB#,R*1,;'+)XBOY'H(.L.26H*IO8\,F8
MY&9=D-Q<N8?6PTXZE&6T*5B3O6MZ&-XWOBV70SK3O2T%!!<#>=9;"U)25XTA
M1"2<D"H>Y>W)D;IWDX=#)?W:]R'E(4M+1=QH#JD)4L-ZM90E2@, FBAQ!(]L
MLJ#,2*>F/#F2:HK^![I",Q'DR(+<W*/#+F1XTN+(>BI<R^TQ)CNN(2V\VI3>
MM%TL!QO?);2ZIG6G>AI2E(2X6\ZPVI:%I2LC25)4D'*2 ++P9$@M.B.IU3*7
MRVO<J>0A"UM!W&@NH0XA:FPK6E"T*( 4"<FW4[2ZS)D-5H^XQ##,V*8^V&(K
M9BU^3G"8YV2XF-E# :1E2<,DW5)A.Y5C"'U9SCF(S884A!EQ@IQ]45"2^T%+
MDHXKCH!7E3Z?Z3(!<3X4BLXM\]25K3!F*0U&3,<6(SQ2W#7P1+6H(PB,L_!?
M40TKP*->2*$,SX$XK!$%)@L8]!CDB46!+D0!\@FXXR-8G3&6EQXCQ!UIUJ"U
M(<;7+<;<0PEQ2%8Q>N1':<;9<?9;>=2XMII;J$..H9 4ZIM"E!2TM)(+BD@A
M (*B :Q-Q9+S3K[49]UAA32'GFV7%M,K?44L(=<2DH;4\I*DM)607% A )!J
M7$M2;6#0)94OK+80H9 97)G$25,L<&!#CMX\KC\N9*&M1X[*,?Z5NO.(0G'_
M 'JQR$U>[,^XAEB[6QYYQ00VTU/BN..*/0E"$.E2E'P!()/Q5L7MGMH(S3DB
M18[Q'8:25NO/6R:TTTA/2MQQQA*$)'A4H@#PFHO7ZU8K:48!U4 :LQJ5AQ48
M/7Q4XR4D):3E;JF!XYB3+=PVC&5N9;95A"<94KR8_P!/)<F7%A,JD3),>)'1
M@*?DO-L,I)X *==4A R> RH9\%08<&;<7T1;?#E3I3F2B-#CNR7UZ1DZ&6$+
M<5@<3A)P.FLU%UML6<9*5R#0;I,L(3"<F@,6K')!D1A>4I1DH+9@KG0,*RM.
M$YEL-=K*DXQY<YQY<"[K:VV&93ER@-QI&=Q(7,CH8?QT[EY3@;<Q@YT*5C%2
M6[)>79+\)JT7-R9%QRJ(W E+DQLXQOV$M%UG.1C>(3G(QTU\C6OK]6Y N)8J
M1;P$LV^N*%C&JT:%R"\EM<=MR.+9G0F'"#[;DN*A;41+KB5R8Z5)QEYO"JL7
M.VRDO+BW"#)1'2%R%L2X[R6$$*(4\IMQ0:20A9"EE((0HYYIQ;)L]WA+8;F6
MNXQ')2BB*W)@R6%R5I*$E#"76D*>4"XV"EL*(+B 1E2<_*Q46[U C#$6RG6J
MKEB#;;L 78J\7"$9S3R\-,N0X1*'&DR6W7,X;;6RTM*UYPA.<JSY.71;C;YK
M3C\*=#ELM$AUZ+*8D--E(RH..-+6A!2.)"B"!Q/"J3+3=;<\U&N%LN$"0\$E
MEB9#DQ7G0HA*2TT^VA;@4H@)*4D$D <:]QO6.R:R/<+637MXKXME3:'21NIG
MA(]I;J\-M(<F3X$>.A3KBDH;2IS&5KSA*<9SG&.8X]WM4MP,Q;G;Y+R@2EJ/
M-C/.$ 9)#;;JE$ <3@<!TUEE6*]P652)MGNL..DI"GY5OEQV4E1"4A3KK*$
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MR&]^I$DBRZ ?K.I:=J[I^V!=JB*V67JG5T.78D6469!:0F;\UU5:30*[9K6
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M*UN,X[E:LM_V>09UAL=S?:E7*S6NX26,!B1-M\24^T$G4D-NOM+6@)4=0"5
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M^KW':[W0/S_8_0VC]RT[;^Y:^B^TOWB^?\Q4]/\ Z#[ZD-U?Q;8_ZO<=KO=
M_/\ 8_0VC]RT[;^Y:^B^TOWB^?\ ,5/3_P"@^^I#=7\6V/\ J]QVN]T#\_V/
MT-H_<M.V_N6OHOM+]XOG_,5/3_Z#[ZD-U?Q;8_ZO<=KO= _/]C]#:/W+3MO[
MEKZ+[2_>+Y_S%3T_^@^^I#=7\6V/^KW':[W0/S_8_0VC]RT[;^Y:^B^TOWB^
M?\Q5^B+IO(ZJ+:'U//T?%S U,_20N**/7F0J4.",QL1VQQ)4N5.EK,0)#3\,
MTN7.G2UEF9JY,R4_EQ]SYEVH:O#.T5Y;V@7O+RFX2.V+HTZ'9"EE2G6@A#:
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MN"_ <,>*MEUYUM]2! V3V^A[+VARS'9YBY1KK.G+VA>D3);4F3;9-L<M$>'
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MNX0KBRVZ"6G'8,EJ2VAP#!+:UM!*P.)23BMI6NH/2H\C>AP75.Q(M+V[5KB
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M1.H^J05KA>E$$*<0*1M54[J#J,]<(F$P^81O(%9 C9"'%L%</A&EUM-@\2N
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M/(NS%CV3L+#]PES.3-1MG'43)+B46U^W25.7"?"M3J6U2N3H8C/QI3,UF2I
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M<<N.%A&-+)<66PDK5G^7]A7Z5_HE7BX2<9)+,?Z^S&GO^UW8F1[A7_635?\
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MLF;>I 2G:BYA*0  %M< !@#^*\ KS178=[&*U*4K8RT%2B5*)0_DJ)R2>_\
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M3C$SR82E.,8QC'^C&,>3GIZ;7;BE),*-DI'_ $2/B_17FZKE<-2OX9(^$?\
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MB0RM=.UEM.?X%&X'![RGX@>'#CP(XCAX.D&JFY7 8/+'^(R.^D^$CCQX'(/
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M[A6E7\-7]97^\UEJ93SM^LHVJ5N.Q(+$_&+;\7,BCH,6&-@2BQ8F1(SG6(<
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MV(F8EPY9X57A.79!)XLZ')14F*PH$4SXO%Z8;:%)6EQX%(2%86$!P-K4XV'
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M%QX3MCE[,=VU*M",16F)#!UZXOR7E26)#<=(J2^$;BH&+\/BB+;%;*2A*PI
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M)%6"@(5==JPD(*$2\0@HF0*O =Y@4\0*$"49/A=@V#,9C,]R$,5YN9$Q8$*
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MV>YD6=7F];?;[;\/Q%C?[;LCMI[[$_QS">Z1W#+'E=[P$GAWQ9QG.0WQ_3A
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M$/>AMF8-01LZ32"%9/2&S**]*GSJ*%H+$Z;)0B!'&2(TUUVC8G:X^\Y0&P7
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M-.A)(R%$C.9:E0DF&4B.4%Q@2 0@D)/!XE.["Q@9)5K.#@@=&//K*V](9>F
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MS7[@VZ%+D/DFD,IGM09!>%5!2YD>8P5'1)N6A3S&'77$P7F77)(TNOMMJCO
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>G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K;#FOK85__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
